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Abstract 
Introduction 
Chronic diseases such as cardiovascular disease (CVD) and diabetes are the greatest contributors to 
the rapidly increasing public health burden worldwide. About two thirds of mortality reported 
globally was attributed to chronic diseases, to which these two conditions contribute significantly, 
and the disadvantaged are mostly affected, dying prematurely. Accelerating rates of deaths from 
chronic diseases have been reported in developing countries and poorer population groups in 
developed countries. This situation relates to the Aboriginal people of Australia, who suffer about 
two and half times greater burden of disease than the general Australian population with chronic 
diseases accounting for 70% of the health gap, to which CVD and diabetes are chief contributors. It 
is widely documented and accepted that elevated waist circumference (WC), causes, or aggravates a 
number of medical conditions, and is also associated with reduced life-expectancy. Aboriginal 
people have experienced higher and rising rates of diabetes and related outcomes such as CVD and 
kidney disease. And while WC has been linked to increased risk of CVD and Type 2 diabetes in the 
Aboriginal population, cut-off points which are often used for defining central obesity for 
population screening and health promotion are not available for Australian Aboriginal people.  
This thesis has four objectives: 
1. Assess the relationship WC has with morbidity outcomes (CVD and Type 2 diabetes) and 
all-cause mortality in a remote Aboriginal Australian community  
2. Determine which of WC, body mass index (BMI) and waist-to-hip ratio (WHR) has the 
strongest association with CVD and Type 2 diabetes; and which of WC and BMI had 
stronger association with all-cause mortality 
3. Provide estimates of gender-specific absolute risks of CVD and Type 2 diabetes for specific 
WC and age values and 
4. Generate gender-specific WC values derived from equivalent BMI points with same 
absolute risks of CVD and Type 2 diabetes. 
 
Methods  
Three datasets collected from Aboriginal people in the Tiwi Islands in the Northern Territory of 
Australia were utilized: 
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1. Baseline dataset: collected at a community screening program from 1992 to 1998, including 
976 adult participants.  
2. Hospitalization dataset: consisting of Northern territory hospital records of participants from 
1992 to 2012.  
3. Mortality dataset: collected from 1992 to 2010 from death registry records. 
Eligible participants for the studies in this thesis were adults (18 years and over), who had WC 
measures and were free of the outcome of interest at baseline screening. Survival analysis was 
conducted in all the studies, which included eligible participants being followed up prospectively 
for up to 20 years from the baseline screening measurement until the occurrence of the end point of 
interest for each participant as recorded on the hospitalization and/or mortality datasets. Statistical 
methods used include: Cox proportional hazards regression model to test the associations of WC 
with the risk of CVD, Type 2 diabetes and all-cause mortality; and Weibull accelerated failure-time 
model to provide absolute risk estimates of CVD and Type 2 diabetes using WC values. 
 
Results 
Objective 1: WC was statistically significantly associated with CVD and Type 2 diabetes in crude 
and multivariable analyses. Association of WC with all-cause mortality was statistically significant 
in the crude analysis and in multivariable analysis after adjusting for BMI and other covariates. 
There was no statistically significant difference between the genders in the association between WC 
and any study outcome. 
Objective 2: Waist circumference compared to BMI or WHR had the strongest association with 
CVD in females; and with Type 2 diabetes in both males and females. WC had stronger 
associations than BMI with all-cause mortality. 
Objective 3: Absolute risk of CVD and Type 2 diabetes increased as WC and age increased for 
males and females. 
Objective 4: For CVD, coronary artery disease (CAD) and heart failure (HF), WC equivalent to 
overweight BMI (>=25 kg/m
2
) ranged from 91 to 93 cm; and obesity BMI (>=30 kg/m
2
) ranged 
from 99 to 103 cm for males and females. The derived WC for equivalent overweight (BMI of 25 
kg/m
2
) were 91.5 for males and 90.9 cm for females; and for obesity (BMI of 30 kg/m
2
), equivalent 
WC were 105.7 cm and 102.3 cm for males and females respectively for Type 2 diabetes. 
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Conclusions 
The findings of this thesis show that WC was associated with CVD, Type 2 diabetes and all-cause 
mortality. The absolute risks of CVD and Type 2 diabetes increased as WC and age increased. 
Despite their high WC averages, females were not different from males in their risk of disease or 
death in relation to WC. The absolute risk findings are useful in creating awareness and educating 
the Aboriginal people in the study community on the risk associated with elevated WC and CVD 
and Type 2 diabetes. Future studies should examine the risks in other Aboriginal populations to 
further contribute to guidelines required for the recommendation of WC cut-off points for 
Aboriginal people in Australia. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 CHAPTER OVERVIEW 
In this chapter, a general introduction of the burden of chronic illnesses in the Aboriginal Australian 
population is presented, with emphasis on cardiovascular diseases (CVD) and Type 2 diabetes. 
Next, there is a brief discussion on the importance of the use of waist circumference (WC) in 
identifying risk of diseases, and the heterogeneity of WC in the Aboriginal group which vary in 
different communities. Finally, the aims and objectives of the thesis are discussed, and an overview 
of the thesis structure as well as the description of the methods used was presented.  
 
Background 
The Aboriginal people of Australia, also referred to as Aborigines, are people who identify 
themselves as Indigenous to the Australian continent. Over time, numerous evidence has emerged 
of Indigenous Australians (Aboriginal people and Torres Strait Islanders) being at a disadvantage in 
the Australian population, which extends to issues concerning their health and wellbeing (1, 2). 
Specifically, Australian Aboriginal people have significantly poorer health and have a lower life 
expectancy, dying at younger ages than non-Aboriginals. From 2010 to 2012, there was reported 
10.6 and 9.5 years decrease in life expectancy of Aboriginal males and females respectively (3). In 
Australia, chronic diseases are the main cause of morbidity and mortality, accounting for 90% of all 
deaths in 2011 (4). Also, there is a disproportionate distribution in risk of chronic diseases in 
Australia with Aboriginal people being affected most, and also at much younger ages (5). Chronic 
illnesses contribute to two-thirds of the gap in life expectancy between Aboriginal people and non-
Aboriginals (6). Obesity-related chronic illnesses such as CVD and Type 2 diabetes are significant 
contributors to the burden of ill health in Australia.  Risk factors that contribute to these two 
obesity-related conditions are mostly excess body weight (obesity and central/abdominal obesity), 
behavioural/lifestyle (poor nutrition, physical inactivity, smoking and excessive alcohol 
consumption), biomedical (excess body weight, high blood pressure and cholesterol, and impaired 
glucose tolerance), environmental, genetic/ family history of disease and demographic factors (7).  
In the Aboriginal population, abdominal obesity measured by waist circumference (WC) has been 
linked to increased risk of developing CVD and Type 2 diabetes (8-10). Moreover, some studies 
have reported WC as a better predictor of CVD and Type 2 diabetes in comparison to other 
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anthropometric measurements such as body mass index (BMI), waist-to-hip ratio (WHR), hip 
circumference and weight (8, 9). The importance of WC in health assessment in relation to chronic 
illness prevention for Aboriginal people is well recognized in the current Australian guidelines and 
policies such as the National guide to preventive health evaluation in Aboriginal and Torres Strait 
Islander peoples by National Aboriginal Community Controlled Health Organisation (NACCHO).  
However, there is a lack of WC cut-off points for identifying high risk Aboriginal individuals. The 
currently recommended WC cut-off points of 94 and 102 cm for men and 80 and 88 cm for women 
derived from BMI of 25 kg/m
2 
and 30 kg/m
2
 respectively, mostly used by Australian non-
Aboriginals, have been suggested as unsuitable for Aboriginal people due to differences in body 
habitus profiles (11). Aboriginal females have been reported as having significantly higher WC 
measures compared to Aboriginal males and non-Aboriginal females (12). Furthermore, significant 
variations in WC profiles have been documented in different Aboriginal communities which signal 
a need for caution when generalising body composition in this heterogeneous Australian group (12). 
More often than not, the method that optimises sensitivity and specificity is employed to generate 
WC cut-off values in epidemiological studies. However, this method may over-simplify the 
complexity for defining WC cut-off values, as optimal cut-offs vary substantially across 
populations, with variations mainly driven by the population WC mean levels (13). Therefore, in 
relation to the substantial differences in WC mean values in diverse Aboriginal communities 
(subpopulations), a consensus might not be reached with the application of the currently used 
optimising method as optimal WC cut-off values will vary across different communities. There 
have been suggestions for future research to focus more on searching and applying alternative 
methods (13).  
 
1.2 RESEARCH AIMS AND OBJECTIVES 
This thesis focused on one remote homogenous Aboriginal community and aimed to use the 
absolute risk method to provide epidemiological evidence of the importance of WC in association 
with CVD and Type 2 diabetes to contribute to the information needed for the development of WC 
cut-off points for Aboriginal people in Australia. As high WC has been associated with these two 
conditions in the Aboriginal population (8-10), identifying the level of risk of high WC on these 
two related chronic disease and mortality outcomes is potentially useful for planning effective 
health policy in the context of chronic disease associated burden on the health of Aboriginal people 
in the community. Also, as the current trend of maximising sensitivity and specificity to determine 
cut-off values may over-simplify the complexity for defining WC cut-off points, the absolute risk 
method was used in this thesis to generate the level of risk of CVD and Type 2 diabetes at different 
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WC points. Also provided, were derived WC values with equivalent absolute risk of CVD and Type 
2 diabetes to BMI points, providing some evidence required for the establishment of WC cut-off 
points in the Aboriginal population.  
More specifically, the research objectives for the thesis are as follows: 
1. Assess the relationship between WC and disease outcomes (CVD and Type 2 diabetes) as 
well as all-cause mortality in a remote Aboriginal Australian community  
2. Determine which of WC, BMI and WHR has the strongest association with each of the CVD 
and Type 2 diabetes in the Aboriginal community; and which of WC and BMI had stronger 
association with all-cause mortality 
3. Provide estimates of gender-specific absolute risks of CVD and Type 2 diabetes for specific 
WC values and 
4. Provide WC values corresponding to equivalent BMI values with same absolute risks of 
diseases (CVD and Type 2 diabetes) for both males and females. 
  
1.3 OVERVIEW OF THESIS STRUCTURE AND DESCRIPTION OF METHODS USED 
The thesis comprised of ten chapters, and incorporates six individual research studies. A brief 
contextual introduction prior to each study has been added to integrate them into the thesis 
document. 
Chapter 2 provides a literature review on anthropometric indices (BMI, WC, and WHR) and the 
epidemiology of CVD, Type 2 diabetes and mortality with further focus on Aboriginal people. 
Also, there was discussion on some underlying biological mechanisms of WC associated with CVD 
and Type 2 diabetes. Lastly, this chapter provides a comprehensive description of the absolute risk 
method used in the study chapters.  
Chapter 3 is an extension of the literature review and presented as a systematic review conducted to 
assess the level of heterogeneity of WC levels in various Aboriginal and non-Aboriginal population 
studies while examining the differences between males and females WC. Furthermore, this chapter 
examined if the gender differences found in these two Australian populations could be explained by 
their height and weight. 
Chapter 4 describes the methods, and provides details of the datasets and study sample used in the 
current research.  
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Chapters 5 to 7 are research studies that used the prospective cohort study design with a maximum 
of 20-year follow-up to assess associations of WC with CVD, Type 2 diabetes and deaths among 
adult participants in the study community. The Cox proportional-hazards regression was used in the 
analysis. In addition to the results derived in chapters 5 and 6, further calculations using the Weibull 
accelerated failure-time model were carried out to generate the absolute risks of each of CVD and 
Type 2 diabetes according to WC and age values to show changes in the risk of disease outcomes 
with changes in WC and increasing age. 
In chapters 8 and 9, all individuals with baseline WC and BMI measurements were followed up for 
up to 20 years. Using the Weibull accelerated failure-time model, WC points with equivalent 
absolute risks to various BMI values were generated for CVD and Type 2 diabetes.  
Chapter 10 summarises the entire thesis, and discusses the implications of the findings from the 
research studies. In conclusion, possible directions for future research in Aboriginal populations and 
the thesis’s contribution to Aboriginal health were discussed.  
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CHAPTER 2 
BACKGROUND AND LITERATURE REVIEW 
 
This chapter describes in Section 2.1, the relevant historical background theory and research that 
provides the justification for this Doctorate. Sections 2.2 and 2.3 cover the epidemiology of chronic 
diseases such as cardiovascular disease (CVD) and Type 2 diabetes from the descriptive 
epidemiology to the aetiology through to the management and treatment). Section 2.4 describes the 
risk factors and burden of mortality in Australia, with emphasis on Aboriginal people. Section 2.5 
reviews obesity and central obesity with more focus on waist circumference (WC) and this was 
followed by discussion on some underlying biological mechanisms of WC associated with CVD 
and diabetes. Next, the lack of WC cut-off points for Aboriginal Australians was discussed. Finally, 
section 2.6 describes the absolute risk method used to present the results in this thesis. 
 
2.1 HISTORICAL BACKGROUND  
The history of Aboriginal people, the first settlers in Australia, was believed to have spanned from 
40,000 to 80,000 years before European settlement. Prior to colonization by Europeans, Aboriginal 
people lived as nomads, hunter-gatherers and fishermen (14). There was not much reported on the 
burden of chronic illnesses and infections among them until post-colonization. The colonization of 
Australia in the 18
th
 and 19
th
 century introduced changes in diet, housing and lifestyle which 
replaced the primitive traditions of strenuous but healthy living of Aboriginal people (15). The 
effect of colonization was and is profound as reflected in their lack of wellbeing which took 
dominance over their previous wellness. According to Colquhoun and Dockery (2012), “the 
wellbeing of Indigenous people is enhanced when they maintain their ‘traditional’ culture” (16).  
The embrace of this different lifestyle, and particularly with the readily available energy-dense food 
and more sedentary living, which results in more weight gain, have increased the trends and risk of 
developing long-term chronic illnesses and premature deaths over the last few decades.  
 
Weight gained due to lifestyle and behavioural factors leads to excess fat in the human body, and 
escalates the risk of disease conditions. As human body fat continues to be extensively researched, 
there has been much focus on the measurement indices and methods of measurement. 
Anthropometric measurements have been used to estimate body composition, in order to investigate 
individual or population’s growth, development and nutritional status (17). Body mass index (BMI), 
which measures overall general body fat, and indices such as WC and waist-to-hip ratio (WHR) that 
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measure regional body fat (in this case, abdominal fat), are mostly used to measure body adiposity. 
Obesity (BMI≥30 kg/m2) and abdominal obesity (WC>=102 and 88 cm mostly used in men and 
women of European descent) have been considered over time to have deleterious consequences as a 
result of the high energy food intake and low levels of physical activities (18). There have been 
evidence indicating that WC coupled with BMI predicts obesity-related health risk better than does 
BMI alone (19, 20). Professor Jean Vague, in 1947, was the first to identify the effect that regional 
distribution of body fat had on the risk of metabolic abnormalities as compared to excessive general 
fat (21). Epidemiological studies in the early 1980s also confirmed the link between elevated WC 
and increased chronic disease morbidity and mortality rates (22, 23). Aetiological associations 
between excessive abdominal fat and the development of chronic diseases, such as CVD and Type 2 
diabetes, have been well established. More recently, among Aboriginal people in Australia, 
abdominal obesity measured by WC has been implicated as a risk factor, showing stronger 
associations than BMI with CVD and Type 2 diabetes (8, 9).  
 
2.2 CARDIOVASCULAR DISEASE (CVD) 
CVD, a condition that develops over time, is a collective term for disorders of the heart (cardio) and 
blood vessels (veins and arteries). Generally, CVDs include coronary heart disease (ischemic heart 
disease), cerebrovascular disease (stroke), heart failure and other vascular diseases (24). CVD can 
also result in severe disability, particularly among those who survive a myocardial infarction or 
stroke, and can also lead to death (25). Coronary artery disease is the most common form of CVD in 
Australia, manifesting as acute myocardial infarction and angina (26). The common underlying 
problem of coronary artery disease is atherosclerosis, which causes a fatty substance called plaque 
to build up in the walls of the arteries, causing thickening and loss of elasticity (26). 
 
2.2.1 Risk factors for CVD 
In addition to the non-modifiable risk factors which include age, genetics and family history of 
CVD, researchers have identified a range of modifiable CVD risk factors such as unhealthy diet, 
physical inactivity, smoking and excessive alcohol consumption. Those modifiable risk factors 
increase the risk of biomedical determinants- overweight and obesity which includes 
central/abdominal obesity, high blood pressure, high blood cholesterol and diabetes which in turn 
heightens the risk of developing CVD and its complications (27). About 70% of the burden of CVD 
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is related to these modifiable risk factors (28). Physical inactivity, high-energy packed diets and 
high prevalence of tobacco use are common among Aboriginal people (29).  
Risk factors due to poor beginnings such as intrauterine growth restriction (IUGR) and prematurity, 
and their causes, which include lack of essential nutrients, toxins, maternal smoking and alcohol 
consumption and stress, have been identified as contributors to early CVD in adulthood (30). In 
addition to this, there is also strong evidence of an association between low birth weight and CVD 
(31). Women with history of preeclampsia and pregnancy complicated by IUGR have been known 
to have an increased risk of CVD in later life (32, 33). Another factor is high density micronutrient 
deficient diet, which has been shown to increase the likelihood of obesity and linked to higher risk 
of CVD (34). Ongoing inflammation or infection throughout the life course also contributes to the 
risk of developing CVD. The role of C-reactive protein (CRP), a marker for inflammation has been 
documented in the cardiovascular disease process (35, 36). CVD markers such as hypertension and 
high cholesterol are silent and build up over a time period. Other symptoms are more noticeable and 
include signs of a heart attack or stroke, for example: discomfort or pain in the centre of the chest; 
discomfort or pain in the arms, left shoulder, elbows, jaw or back (27). In addition symptoms may 
include irregular heartbeat, dizziness, weakness, nausea, vomiting, numbness, fatigue and shortness 
of breath. 
 
2.2.2 Management and treatment of CVD 
There are a number of ways of managing and treating CVD. The most common types of obesity-
related CVD include coronary artery disease and heart attack. One important aspect of obesity-
related CVD management is lifestyle changes (physical activity, healthy diet, reduction of salt in 
diet, and smoking cessation and maintenance of a healthy weight). With the management of 
lifestyle and behavioural determinants, risk factors such as blood pressure and cholesterol are better 
controlled (37). Implementation of interventions targeting modification of lifestyle and behavioural 
factors with focus at the population level, more importantly with emphasis on different ethnic 
groups, can be beneficial in reducing CVD risk. Likewise at the individual level, preventing 
obesity-related CVD using health-care interventions will produce great results if focus is more on 
individuals at high CVD risk or those with risk factors above the conventional thresholds, such as 
hypertension and hypercholesterolemia (27).  
Established guidelines on absolute CVD risk showing the likelihood of an individual experiencing a 
CVD event within the next 5 years are used to provide guidance in the management of CVD in 
Australia. These guidelines target among others, adult Aboriginals, aged 35 years and above (38). A 
number of risk factors including WC are incorporated in the guidelines. However, while the 
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guidelines considered WC thresholds of Asians, there was no focused consideration for WC 
thresholds for Aboriginal people. 
  
2.2.3 Burden of cardiovascular disease in Australia 
Cardiovascular disease is the major cause of death and disability globally, with an estimated 17.5 
million deaths from CVD in 2012, which represents about 31% of all deaths worldwide (39). In 
Australia, CVD is the leading cause of death; it accounted for nearly 44,000 deaths in 2013 (40), 
and remains a significant burden on the country’s health system, contributing immensely to rising 
health care costs (40, 41).  An estimated 3.7 million Australian adults had one or more CVD 
according to a 2011/12 report (42). While the prevalence of the disease is similar for men and 
women, the older age group (>64 years) are at higher risk than those <54 years (42). In 2012, three 
in ten mortality outcomes were due to CVD (43). The level and impact of the burden of CVD is 
substantially higher among Aboriginal people than in non-Aboriginals in Australia. CVD is the 
leading cause of premature and overall deaths for Aboriginal people, as it is for non-Aboriginals in 
Australia (44, 45). In 2012-2013, 1 in 8 (13%) Aboriginals reported having a form of CVD (46). Of 
these, 4% were attributed to heart disease, stroke and vascular diseases (46, 47).  Aboriginal people 
are among those with the highest hospitalizations resulting from CVD in Australia (40). Heart-
related conditions are 1.2 times more common among Aboriginals than non-Aboriginals (48). 
Furthermore, the heart attack rates in adults are about 2.6 times as high in Aboriginal people 
compared to non-Aboriginals (49). There are excess CVD deaths in every age group and across all 
jurisdictions where reliable data are available (50). The rate of death from CVD is particularly high 
among young and middle aged Aboriginal adults (28, 44) compared to non-Aboriginals; and in 
2009-2010, death rates in five Australian regions for all coronary artery disease were 7 to 13 times 
higher among Aboriginal people in the 25-39 and 40-54 years age groups than the rates for non-
Aboriginals (51). From the gender perspective, more Aboriginal women than men reported having 
CVD (14% to 11%) in 2012-2013 (48). 
 
2.3 TYPE 2 DIABETES 
Type 2 diabetes mellitus is now the most common form of diabetes. About 85-90% of those with 
diabetes have Type 2 diabetes (52, 53). This condition is a progressive condition, and occurs when 
the body becomes resistant to the insulin produced by the pancreas and/or the amount produced is 
insufficient to meet the body’s needs (54). Obesity and sedentary lifestyle trigger the development 
9 
 
of insulin resistance (55). The cause of this condition is complex and probably results from a 
combination of genetic and environmental factors (53). This condition can be life-threatening and 
can result to other complications such as chronic CVD, renal disease, blindness, limb amputation, 
retinopathy and death (52, 56, 57). Symptoms of Type 2 diabetes include increased thirst, dry 
mouth, nausea, increased urination, fatigue, increased hunger, slow healing of sores and wounds, 
frequent itchy skin infections, blurred vision, dizziness, leg cramps, headaches, mood swings and 
weight gain. Furthermore, Type 2 diabetes affects psychological wellbeing contributing to 
depression (58).  
 
2.3.1 Risk factors and diagnosis of Type 2 diabetes  
Increased risk of Type 2 diabetes is associated with overweight/ obesity/ abdominal obesity, 
advancing age (over 45 years, or over 35 years and of Aboriginal background), high blood pressure, 
physical inactivity, family history of diabetes, low HDL cholesterol or high triglycerides, low birth 
weight, gestational diabetes and poor living standards.  
Type 2 diabetes can be diagnosed in the following ways: 
1. Oral glucose-tolerant test (OGTT): also referred to as glucose tolerant test (GTT) is used to 
determine whether the body has difficulty metabolising sugar or carbohydrate intake. The 
patient fasts for at least 8 hours, but not more than 16 hours, the night before the test. 
Afterward, the patient’s fasting blood sugar is tested (59). The patient is then asked to take a 
glucose drink and their blood glucose level is measured at intervals after taking the sugary 
drink (59).  
2. Fasting blood sugar: The test is easy to perform. After an overnight fast, blood is drawn 
early in the morning and test is carried out to examine whether blood sugar is within the 
normal range (70-99 milligrams per decilitre- mg/dl, or <5.5 mmol/L). A fasting blood 
glucose test result between 5.5-6.9 mmol/L should be investigated further with OGTT or by 
measuring the blood sugar level (60). 
3. Random blood sugar: A level of ≥11.1 mmol/L in the blood sample indicates diabetes and 
should be further investigated with a fasting blood glucose test. 
4. Haemoglobin A1C test (HbA1c): HbA1c value of 48 mmol/mol (6.5%) or greater is 
recommended as the blood level for diagnosing diabetes (61). 
10 
 
 
2.3.2 Burden of Type 2 diabetes in Australia  
Until recently, Type 2 diabetes was mostly common among the older age group, and the prevalence 
of the disease was higher in developed countries than in developing countries, and thus was 
considered to be a disease of the affluent. However, the dynamics of the disease is changing, 
affecting people in every country worldwide with increasing proportions in low- and middle-income 
populations and among the younger age group (62), indicating it as a worldwide epidemic. The 
World Health Organisation (WHO) reported 9% diabetes prevalence among adults (+18 years) (63) 
of whom 90% were Type 2 diabetes (64).  
In Australia, describing Type 2 diabetes as a ‘huge’ and growing problem is not simply a play on 
words. As expected, the incidence and prevalence of diabetes are substantial, different between 
Indigenous and non-Indigenous peoples. In 2012-2013, 11% of Indigenous adults had diabetes, and 
a further 4.7% at risk of developing diabetes (65). Indigenous adults were 3.3 times (age-
standardised rates) as likely to have diabetes as non-Indigenous adults (65). The incidence of Type 
2 diabetes increases with far greater burden among Aboriginal children and adolescents, compared 
to their non-Aboriginal counterparts (66-68). According to a 2004-2005 report, the prevalence of 
this condition increases with age, with the increase occurring at younger ages among Aboriginal 
people (69). The reported prevalence in Aboriginals aged 35-44 years is about five times that of 
non-Aboriginals. Diabetes is a notable contributor to mortality among Aboriginal people, being the 
underlying cause of about 8% of overall deaths (70). This condition inflicts significant financial and 
human cost on the Australian government and community. The higher incidence of Type 2 diabetes 
among Aboriginal people is strongly related to a modern lifestyle that comprises of high-energy and 
fatty food and sedentary lifestyle, which has increased the rates of obesity. It was reported in 2012-
2013 that Indigenous adults who were obese were 7 times as likely as those of normal weight and 
underweight to have diabetes (17% compared to 2.4%) (65).   
 
2.4 MORTALITY 
2.4.1 Risk factors for mortality 
The adverse consequences of obesity and central obesity on multiple health aspects presume that 
these conditions increase premature mortality. Overweight and obesity alongside high blood 
pressure, tobacco use, high blood glucose, and physical inactivity are listed as the top five leading 
global risks for mortality in the world (71). These factors are responsible for increasing the risk of 
chronic diseases such as CVD, Type 2 diabetes, cancers and other causes (22, 71-73). In Australia, 
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these factors as well as poor nutrition and lower utilisation of health services, have been identified 
as contributors to the excess Indigenous mortality (74). 
 
2.4.2 Burden of mortality in Australia 
There is substantial inequality in mortality rates in the Australian population despite the relatively 
high standards of health care in the country. Although mortality rates of Aboriginal Australians are 
understated as a result of incomplete identification of Aboriginal status in death records (75), and of 
the delays in registration in deaths which is common among this group (76), the overall mortality 
rate of Aboriginal people in 2009-2011 was almost as twice as that of non-Aboriginal people, and 
five times as high among adults aged 34 to 44 years (77). The mortality gap between Aboriginals 
and non-Aboriginals was about 10.6 and 9.4 years for males and females respectively (77). 
Generally, Aboriginal people have a much younger population structure and mortality rates are 
higher at younger ages, with a greater percentage of deaths occurring before a significantly 
advanced age (3). Between 2008 and 2012, about 65% of Aboriginal deaths occurred before the age 
of 65 years (3). In 2012, CVD was the leading cause of death among Aboriginal people, with a 
crude rate of 102 deaths per 100,000 population, and responsible for 25.2% of deaths (78). During a 
5-year period (from 2008 to 2012), a total of 11,612 deaths were registered for Indigenous people 
from five Australian jurisdictions (New South Wales, Queensland, Western Australia, South 
Australia and the Northern territory), representing 2.3% of all deaths in these regions (65). Based on 
this report, the most common cause of death among Indigenous Australian people was CVD (about 
25% of total deaths), with Indigenous people dying from CVD at 1.5 times the rate of non-
Indigenous people (65). Endocrine, metabolic and nutritional disorders (including diabetes) are also 
common causes of death among Indigenous people (9.1% of deaths). Other common causes of 
death include cancers, respiratory and digestive diseases. The overall diabetes death rate in 
Aboriginal people was 7 times higher than that in non-Aboriginal people in the year 2012-2013 
(79). There was a significant decline (16%) in the age-standardised mortality rate for Indigenous 
Australians between the 1998 and 2012 period, with a significant narrowing (by 17%) in mortality 
gap between Indigenous and non-Indigenous people (65). During this period, for Indigenous people, 
the age-standardised mortality rates reduced for CVD (40%) (65). 
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2.5 OBESITY AND CENTRAL OBESITY 
2.5.1 Obesity 
Aetiology of obesity  
Obesity is defined as an excess amount of body fat accumulation in adipose tissue that results in an 
energy imbalance over a sustained period. This may have adverse effect on health, leading to a 
reduced life expectancy (80). When body fat due to long term energy intake (mostly from food) 
exceeds energy expenditure (physical activity), the result is the accumulation of adipose tissue 
which contributes to the epidemiology of obesity (81, 82). The human body, on average, stores 
around 50,000 to 60,000 kilocalories of energy in adipocytes (83). Obesity predisposes to many 
chronic conditions, which themselves are associated with mortality. It involves a complex, 
multifactorial process influenced by genetics, environmental, lifestyle (high-energy diets and 
physical inactivity), socio-cultural factors, or as a result of medications which promote weight gain 
(82, 84). Among Aboriginal people in Australia, factors such as geographical, historical, social, 
economic and infrastructure contribute to obesity among them (85, 86). The amount of body fat 
varies between populations and depends on the regional distribution of the amount of excess fat 
stored in the body which could pose as a risk for chronic illnesses. An increased overall body fat 
mass, in particular excess fat stored in the abdominal area, contributes significantly to an increased 
fat content in the liver and deposition of fat in areas such as heart, blood vessels and kidneys, 
leading to impaired function of these organs (87). 
 
Obesity measurement 
In general, the assessment and classification of overweight and obesity are dependent on practical 
definitions mostly based on BMI. BMI relates weight to height, and calculated as weight (kg) 
divided by height (m
2
). BMI is the most commonly used parameter for defining underweight, 
overweight and obesity (88). Although, this measure does not separate fat mass from muscle mass, 
it is highly correlated with both adipose tissue and muscle mass (89). Based on the strength of 
association between BMI and chronic diseases, the World Health Organisation (WHO) has adopted 
standardised cut-off points that defines underweight as having a BMI of less than 18.5, normal 
weight from 18.5 to 24.9, overweight as 25 to 29.9 and obese as BMI of 30 or greater (90) (Table 
2.1). Obesity also ranges in degree of severity, with class I (BMI 30-34.9), II (BMI 35-39.9) and III 
(BMI≥40) (90). In Australia, guidelines for healthy weight correspond with the WHO BMI cut-offs 
(91). 
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Table 2.1 The International Classification of adult underweight, overweight and obesity 
according to BMI  
Classification BMI(kg/m2) 
 
Principal cut-off 
points 
Additional cut-off 
points 
Underweight <18.50 <18.50 
     Severe thinness <16.00 <16.00 
     Moderate thinness 16.00-16.99 16.00-16.99 
     Mild thinness 17.00-18.49 17.00-18.49 
Normal range 18.50-24.99 
18.50-22.99 
23.00-24.99 
Overweight ≥25.00 ≥25.00 
     Pre-obese 25.00-29.99 
25.00-27.49 
27.50-29.99 
     Obese ≥30.00 ≥30.00 
          Obese class I 30.00-34.99 
30.00-32.49 
32.50-34.99 
          Obese class II 35.00-39.99 
35.00-37.49 
37.50-39.99 
          Obese class III ≥40.00 ≥40.00 
Source: Adapted from WHO, 1995, WHO, 2000 and WHO 2004 (90).  
 
In the Asian population, different cut-off values have been recommended- 23.0 and 27.5 kg/m
2
 for 
overweight and obesity respectively (92). There have been earlier suggestions that the appropriate 
BMI range for Australian Aboriginal people is between 17 and 22 kg/m
2
, with increased risk of 
metabolic conditions above 22 kg/m
2
 (93, 94). However, this is yet to be confirmed for in the 
Aboriginal population. 
 
Uniqueness and limitations of the use of BMI 
The major advantage of BMI is that it is relatively cheap and easy to measure; and a convenient, 
non-intrusive measurement of obesity for large epidemiological studies. It is a universally accepted 
measure that allows for comparison across populations. Moreover, the same BMI cut-off can be 
applied to all ages and both genders. However, a number of limitations should be considered when 
employing BMI as an indicator of body fat. BMI cannot differentiate between fat mass and lean 
body mass (7). And while height and weight are simple measures with some level of accuracy, 
muscular individuals with low proportion of body fat may be misclassified as overweight or obese 
(95). The use of BMI can also be misleading especially during the aging process and menopausal 
transition when muscle mass can be converted to body fat mass which does not necessarily 
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implicate a change in BMI (96). BMI vary between individuals and populations (7) and the use of a 
universal BMI classification is unlikely to account for ethnic differences in body fat distribution 
(97). Differences in fat distribution between Aboriginal and non-Aboriginal Australians have been 
well reported, suggesting that the currently used BMI thresholds might be inappropriate for 
Aboriginal people, who tend to have lower BMI mean estimates compared to non-Aboriginals, 
particularly among men (12, 98). There is a possibility of incorrectly estimating health risks 
attributable to overweight and obesity depending on the BMI threshold employed. 
 
Burden of obesity in Australia 
In Australia, the prevalence of overweight and obesity is on a dramatic increase among adults and 
children, Aboriginal and non-Aboriginal peoples, and people from every socio-economic 
background (85). This condition ranks as the second largest contributor to burden of disease in 
Australia with about 63% of Australian adults being overweight or obese, and over 25% of the total 
are classified as obese (99). Based on data from the Australian national surveys for the period 
between 1995 and 2012 (100), the prevalence of overweight and obesity increased from 56.3% to 
62.8% in adults aged 18 years and over. The likelihood of being overweight or obese was higher 
among adults that reside in regional and remote areas (69.5%) compared with those in the major 
cities (60.2%) (100).  
The problems of overweight and obesity vary across the Australian population with higher 
prevalence among Aboriginal people (80), rural dwellers (101) and the low socio-economic 
background (85). According to a 2012-2013 Health survey report, Indigenous adults were 1.5 times 
as likely to be obese as non-Indigenous Australians (rate ratio of 1.4 for males and 1.7 for females) 
(102). The same report also stated that about 30% of Indigenous children aged 2-14 years and 66% 
of Indigenous adults 15 years and over were overweight or obese. Figure 2.1 shows the percentage 
of people 15 years and older according to BMI category and Indigenous status (103). 
There have been reports of lower BMI among Aboriginal men compared to their non-Aboriginal 
counterparts (12, 98). In a study comparing body fat distribution among Australian Aboriginal and 
non-Aboriginal peoples, BMI was reported to be significantly lower for Aboriginals compared to 
non-Aboriginal men (P=0.01) (98). Also, another study assessed body habitus in three remote 
Aboriginal communities in Australia and compared with those of the general Australian population 
and reported that Aboriginal males were less often overweight and/or obese by BMI than non-
Aboriginal males (P<0.001) (12). The latter study found the proportion of Aboriginal males with 
BMI≥25kg/m2 was smaller when compared to non-Aboriginal males (37% vs. 68%, P<0.001). 
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Figure 2.1 Proportion of persons 15 years and over (age-standardised) by BMI category and 
Indigenous status, 2012-2013  
SOURCE: ABS and AIHW analysis of 2012-13 AATSIHS 
 
BMI has been found to be consistently associated with an increased risk of CVD, Type 2 diabetes 
and mortality. This condition contributes 16% of the health gap between Aboriginals and non-
Aboriginals in Australia (28). Obesity-related health conditions such as CVD and Type 2 diabetes 
impose substantial economic burden not only on individuals and families, but also on the 
community and government. In 2008/2009, the estimated direct and indirect costs of obesity and 
obesity-related conditions in Australia was about $37.7 billion (104). An estimated 7,200 
Australians die every year as a result of obesity and related illnesses (104). 
 
2.5.2 Central Obesity 
There is growing evidence suggesting abdominal obesity as detrimental to health and wellbeing 
(105). The two most common measures of central obesity are WC and WHR. These two indices 
have been reported to have strong associations with incident CVD events (106, 107), metabolic risk 
factors (108) and mortality (109). Although this thesis focused on WC as a measure of central 
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obesity, WHR alongside WC was used to assess associations with study outcomes in relevant result 
chapters.  
 
2.5.2.1 WC 
What is WC and how is it measured 
WC refers to the numerical measurement of the body girth at the level of the abdomen. As there is 
currently no consensus as to how and where to measure WC, protocols for measurement existing in 
research literature on clinical studies are based on identifying anatomical landmarks which also 
requires the individual in a standing position, bare midriff, with feet touching, arms hanging, 
without holding one’s breath (110). Measurement is usually done with a measuring tape made of 
material that is not easily stretched, placed perpendicular to the long axis of the body and horizontal 
to the floor and applied with tension without compressing the abdominal wall (110). The different 
anatomical landmarks for determining the exact location for measuring WC in clinical studies 
include: 
1. midpoint between the lowest rib and the iliac crest 
2. at the umbilicus 
3. the narrowest (minimum) or widest (maximum) WC 
4. just below the lowest rib 
5. just above the iliac crest (111). 
WC has standard thresholds to identify individuals at high risk of chronic diseases. The defined cut-
offs for WC, that is, the point at which an individual has a greater risk for chronic disease, differ by 
gender and ethnicity. The WHO recommended WC gender-specific thresholds are presented in 
Table 2.2 (112).  
 
Table 2.2 Waist circumference categories 
WC Classification Males Females 
Normal-weight <94 cm <80cm 
Overweight 94-102 cm 80-88 cm 
Obese >102 cm >88 cm 
 
These thresholds have been recognised and used mostly in European populations or in ethnic 
regions where there is absence of specific recommendations. The International Diabetes Federation 
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(IDF) recommends lower WC thresholds and ethnic-specific cut-off values for Asian adults (112). 
These thresholds are (men/women): ≥90/≥80 cm for South Asians; ≥90/≥80 cm for Chinese; and 
≥85/≥90 cm for Japanese (11).  
 
Uniqueness and limitations of the use of WC 
WC assessment provides a measure of fat distribution that cannot be obtained by measuring BMI. 
Although WC is a crude measurement, it is cheap, easy to measure, interpret and better correlated 
with total body fat measured by BMI (113) and visceral fat mass, and is a surrogate marker for 
abdominal fat mass (110). WC is a practical tool to evaluate abdominal fat before and during weight 
loss (114). The measurement of WC is simple, more reliable and feasible when compared to WHR, 
(115). Despite the high correlation between WC and BMI, they measure different body fat 
characteristics. While BMI assesses overall adiposity and is unable to separate lean from fat mass, 
WC measures abdominal fat and contributes information about overall body fat independent of BMI 
(116). In addition, WC provides an independent prediction of risk over and above that of BMI 
(114). Studies have found that abdominal fat increases the risk of metabolic syndrome (117, 118). 
More specifically, the International Diabetes Federation has reported that WC increases the risk of 
the metabolic syndrome (119). WC can serve as a screening tool to identify individuals in need of 
further assessment for obesity-related chronic illnesses, targeting health actions in communities 
(120). High WC could be an indicator of the level of internal fat deposits which coats the heart, 
kidneys, liver and pancreas, and increase the risk of chronic diseases (121). Excessive abdominal fat 
could be an indicator of a greater risk of health problems in adults such as hypertension (122), 
diabetes (123, 124), dyslipidemia (122, 125), CVD (126, 127), metabolic syndrome (128, 129) 
breast cancer in women (130), colon cancer (131, 132) and mental illnesses (133). Risk of Type 2 
diabetes with WC for any level of adiposity is amplified by the excessive abdominal fat mass (134). 
While WC is important and useful in epidemiological and clinical settings to assess the risk of 
obesity-related conditions, there are some limitations to this index. In some situations, WC might be 
an inaccurate central adiposity measure for pregnant women or for people who suffer from medical 
conditions which cause distention of the stomach (7). Next, WC measurement procedure has not 
been standardized and could result an under- or overestimation of WC measured, depending on the 
method used for the measurement. This could lead to a potential measurement bias. Moreover, WC 
may be difficult to measure and less accurate in obese individuals, particularly when measured at 
the umbilical level (135). Although there is good reproducibility of WC at all sites (136), arguments 
have been raised by experts on the variability of WC measurements which could differ in 
measurements when taken by the same healthcare provider or between healthcare professionals 
(137, 138). 
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2.5.2.2 WHR 
What is WHR and how is it measured 
WHR is determined by dividing waist measurement by hip measurement. Hip circumference is 
measured at a level parallel to the floor, around the widest portion of the buttock using a stretch-
resistance tape that is wrapped snugly around the subject but not pulled so tight that it is 
constricting (138).  
The WHO suggested WHR greater than 0.9 for men and greater than 0.85 for women as indicators 
of increased health risk (59), and these standards are mostly used in populations of European origin. 
However, different studies have suggested cut-offs suitable in specific populations (139-141). 
 
Uniqueness and limitations of the use of WHR 
WHR is correlated with body fat; it is inexpensive and has been shown to be associated with the 
development of CVD, Type 2 diabetes and death in adults (7). This measure can be used to indicate 
the prevalence of abdominal obesity, to evaluate health promotion and disease prevention and to 
monitor progress towards national public health policy (142). However, there are some limitations 
to using WHR. The first is that it is prone to measurement error as it requires two measurements 
(waist and hip measurements). Second, hip circumference measurement may be more difficult than 
measuring WC alone. Third, WHR is less dependent on body size and height, and might not be a 
suitable measure to assess fatness and weight loss as theoretically it could remain unchanged during 
weight loss (143). It has been suggested that WHR is insensitive to weight gain (144). 
There has been evidence of the importance of WHR in identifying Aboriginal people at risk of 
chronic illnesses. Wang et al., showed that WHR compared to BMI, WC, hip circumference and 
waist-to-height ratio, was a strong predictor of diabetes (Odds ratio= 2.44(95%CI: 1.94-3.06) and 
estimated coronary heart disease risk in Aboriginal people from Central Australia (145). 
 
2.5.2.3 Waist circumference of Aboriginal people in Australia 
Variations in WC levels of Aboriginal and non- Aboriginal Australians has been reported in public 
health researches in Australia (12, 146-148). Chapter 3 of this thesis reviews the gender differences 
in WC of Aboriginal and non-Aboriginal peoples (149). 
Aboriginal people have a lower sitting-height to stature ratio, relatively short trunks, long legs, 
central fat deposition (150-153) and higher percentage of body fat (12, 98, 154). Despite the 
significance of WC in detecting obesity-related health risks, until recently it has been seldom used 
in both clinical and population health settings in Aboriginal Australia. Lately, WC is being 
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acknowledged and used alongside other anthropometric alternatives such as BMI, WHR, and 
weight in the assessment of chronic diseases in the Aboriginal population (8, 9, 155, 156).  The 
central fat deposition evidenced by the elevated WC relative to the body weight, particularly among 
females, has been a topic of considerable interest (9, 10, 12, 157). This has significant implications, 
considering that central or abdominal obesity mostly measured by WC has been known to bear 
strong linkage with the risk of cardiovascular disease (9) and diabetes (158). However, the higher 
WC in Aboriginal people is beyond the simple generalization that inappropriate eating is the main 
cause. There have been some speculations on the causes and potential biologic mechanisms of high 
WC which includes adaptation to hot climate particularly in the tropical environment (159). Some 
potential mechanisms for high level WC observed in other populations include older age (160-162), 
behavioural/lifestyle factors (162, 163), genetic factors (163, 164), medical conditions which cause 
distention of the stomach (7), inflammation as a result of highly sensitive c-reactive protein (CRP) 
concentration (165, 166), and parity or menopausal status (161, 167). Although the biological 
mechanisms that explain the increased health risk predicted by WC in the Aboriginal population are 
not well-known, it is often proposed that the added risk is explained by the complex and multi-
determinant phenomenon associated with elevated abdominal obesity (168). It has been reported 
that specific hormones, cytokines, and free fatty acids secreted by adipose tissue contribute 
significantly to the mechanism (169). As WC correlates highly with central fat mass (170) and 
associated with cardio metabolic risks (118), WC cut-off points are mostly required to identify 
individuals at high risk of diseases. In 2012-2013, three in five Indigenous male adults (≥18 years 
old) and four in five Indigenous females had WC that associated with increased chronic disease 
risk. However, the WC cut-off points (112) used to identify these Indigenous individuals were 
based on individuals of European origin and might be unsuitable for Indigenous people in Australia.  
Increasing research had indicated WC as an important risk factor for disease and mortality (171-
173). Obesity-related problems such as diabetes and CVD are still on the increase in Australia (174) 
with rising incidence in spite of intervention efforts and considerable health care costs (175). As 
Aboriginal people in Australia have the tendency to store abdominal fat rather than a more 
peripheral distribution of body fat (9, 12), it is not surprising that their risk of developing CVD and 
Type 2 diabetes is high compared to their non-Aboriginal counterparts. Clustering of a number of 
the risk factors mentioned earlier (smoking, excessive alcohol consumption, physical inactivity and 
poor diet) confers a higher risk of chronic diseases and premature deaths in the Aboriginal 
population (176, 177).  
The observational studies reporting on association of WC with CVD and Type 2 diabetes have 
varied considerably in relation to their study design, participant characteristics and their method of 
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data collection. A cross-sectional study of 117 Aboriginal adults in a large urbanised community in 
Queensland reported strong associations between WC, CVD and diabetes in women (178). Also, 
McDermott et al, in their follow-up study of 225 indigenous adults in North Queensland, reported 
WC increased the risk of Type 2 diabetes with rate ratio of 2.0 (95%CI: 1.1-3.6) (10). Wang and 
Hoy reported significant associations between WC and CVD and Type 2 diabetes in Aboriginal 
people in a remote Northern Territory community using cross-sectional study design (8, 9). They, 
and other studies, also provided evidence that WC was a better predictor than BMI and WHR for 
CVD and Type 2 diabetes in their researched Aboriginal communities (9, 145, 146, 178). According 
to Wang and Hoy, the relative risks of CVD after adjusting for diabetes, cholesterol, systolic blood 
pressure and smoking status, were 1.31 (95%CI: 1.11-1.54), 1.29 (95%CI: 1.09-1.53), 1.28 (95%CI: 
1.08-1.52) and 1.10 (95%CI: 0.93-1.30) per standard deviation increase in WC, BMI, hip 
circumference and waist-to-hip ratio respectively (8). They also found that WC had the highest odds 
ratio for type 2 diabetes (2.16 (95%CI: 1.75-2.66) associated with 1 standard deviation increase in 
WC as compared to BMI, weight, WHR and hip circumference (9).  
 
 
2.5.2.4 Underlying biological mechanisms of waist circumference associated with CVD and 
diabetes 
Although it is unknown the extent to which the elevated waist measure observed in Aboriginal 
people is modifiable, several potential biological mechanisms may be responsible for the increase in 
the risk of chronic diseases and premature death associated with high WC.  
High waist circumference: a genetic chronic disease risk factor in Aboriginals 
As mentioned earlier, compared to non-Aboriginals, Aboriginal people in Australia generally have 
higher WC levels in relation to their body weight (12). Also, studies have observed higher WC 
estimates in Aboriginal women compared to the men in Aboriginal communities (9, 10, 12, 157). 
The reasons for the significantly higher WC among Aboriginal women remains elusive, although 
hormonal factors could be a possible mechanism. In general, in the transition from pre- to post-
menopausal, there are changes in body composition of women, with fat redistribution in locations 
towards the upper body, which can occur in the absence of changes in the total body fat mass (179, 
180). This suggests that abdominal fat mass accumulation is accelerated by menopause in women. 
There might be independent casual links between genes that predispose to preferential deposition of 
fat in abdominal depots and obesity-related conditions (84). Therefore, the interaction between 
genes and environment/ lifestyle would be beneficial for future research on the genetics of high WC 
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among Aboriginal people, as the propensity of fat accumulation is influenced by the genetic 
characteristics of individuals or populations (181). 
 
High waist circumference: Lifestyle (diet, physical inactivity, smoking and alcohol consumption)  
There have been suggestions that the obesity rates of Aboriginal people escalate with 
‘Westernization’ compared to other population groups (11). Since colonization, Aboriginal 
Australians have experienced rapid lifestyle changes, with increase in the consumption of processed 
foods and dramatic reduction in physical activities, shifting from the traditional hunter-gatherer 
lifestyle. These in turn have been accompanied by an epidemic of increased body fat and chronic 
diseases such as CVD, Type 2 diabetes and their sequeale leading to pre-mature deaths (182). There 
are limited reports on how lifestyle choices affect the association between WC and obesity-related 
diseases among Aboriginal people. The knowledge, attitude and practise of diet pattern and physical 
activity have been assessed in few qualitative and quantitative studies (183), but the role of diet and 
level of physical activity on changes in WC have not been explicit. Routine physical activity has 
been shown to improve body composition by reducing weight and abdominal adiposity and enhance 
the general well-being (184, 185). In a social survey on Aboriginal people in 2004-2005, low levels 
physical activity were reported among them, which was 1.5 times higher than in non-Aboriginals 
(186). Environment impacts on individual and population’s likelihood of obesity (and central 
obesity) through high energy-dense food intake or a reduction in energy expended with sedentary 
living (84). Furthermore, smoking and alcohol consumption increase the risk of obesity (84) and 
visceral fat accumulation, thereby accelerating the development of obesity-related disorders (187). 
There is the potential of maintaining a healthy WC and reducing the risk of CVD and Type 2 
diabetes if behavioural factors in terms of healthy nutritious diet, physical activity and reduced 
smoking and alcohol consumption are channelled appropriately. Moreover, adequate nutrition and 
balanced diet are required for healthy living and survival. However, caution should be exercised 
when proposing on the healthy lifestyle that comes with weight loss in the Aboriginal population, as 
the practice of energy-dense but nutrient-deficient diet is common among them due to limited 
availability and affordability of healthy nutritious food (188). 
 
High waist circumference: older age 
Substantial redistribution of fat tissues depot has often been linked with the ageing process, and the 
positive association of age with an increase in visceral adipose tissue (VAT), independent of sex 
have been documented (189). WC increases with age, so does the risk of other chronic diseases. 
Epidemiological studies have reported on the association between ageing and increase in WC, with 
22 
 
women showing a greater increase in WC than men of the same age and ethnicity, which increases 
throughout their lifespan (190-192), independent of body weight (189, 193). The increase in WC as 
age increases has been mostly attributed to a disproportionate increase in visceral adiposity (161, 
193). 
 
High waist circumference: a marker of the inflammatory process  
C-reactive protein (CRP) is made and released by the liver, mainly in response to the cytokine 
interleukin-6 (IL-6) (194). It is a marker for inflammation as it increases in the presence of 
inflammation in the body. A few studies have identified high-level CRP among Aboriginal people 
in Australia (195, 196). These studies also reported that CRP levels were higher in females than 
males. Wang and Hoy showed geometric means of CRP were 4.1 (95% CI: 3.7-4.6) and 7.3 (95% 
CI: 6.6-8.1) for males and females respectively (195). And the overall levels were the highest 
reported in any population to date. Data from the Diabetes and Related conditions in Urban 
Indigenous people in the Darwin Region (DRUID) study showed higher CRP levels among women 
compared with men (196). In the DRIUD study, after including WC in the multivariate analysis, the 
odds of high CRP (>3.0 mg/L) relative to another national population-based study data were no 
longer statistically significant. This could indicate a possible correlation between CRP and WC. In a 
study conducted in another remote Aboriginal population, over 50% of participants had high risk 
CRP (over 3.0 mg/L), with higher levels found in women than men (157).  Wang and Hoy 
commenting on higher CRP levels in this particular Tiwi study community (195), remarked on 
common skin infections and other infections among Aboriginal children (197, 198).  
Elevated  CRP has been suggested to be associated with WC (165, 199),  diabetes and coronary 
artery disease (200, 201), with clearly recognized links in their pathophysiological mechanism 
(202). Additionally, WC as well as high CRP levels, are strong markers of CVD risk (203). 
Prospective epidemiological studies have reported on the predictive ability of CRP in the 
development of CVD (35, 36).  
 
High waist circumference: a contributor to inflammatory process 
Elevated WC is one in the group of metabolic risk factors that increases the risk of heart diseases 
and diabetes. Other factors include high triglycerides, impaired fasting glucose, low high-density 
lipoprotein and elevated blood pressure (204). Interestingly, large WC contributes to the increased 
risk of hypertension (205) although they are both factors of metabolic abnormalities. Elevated WC 
is the most prevalent manifestation of metabolic abnormalities and has a considerable influence on 
inflammatory process (206). Increased adipose tissue has been thought to promote resistance to 
insulin, resulting in increased levels of fatty acids that are toxic to the liver, thereby causing a drop 
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in insulin clearance, increased glucose production and dyslipidemia (87, 108). The mechanism for 
developing insulin resistance stems from macrophage infiltration in the abdominal tissue and the 
unbalanced production of adipocyte protein factors and the hormone, adipokines (55). Also, visceral 
fat depots within the abdominal cavity have been implicated in the role of high metabolic and 
inflammatory cavity (207). The inflammation status linked with the increased secretion of 
adipokines from excess adipose tissue (208), and the change in fatty acid metabolism are involved 
in insulin resistance pathogenesis (209). Insulin resistance, which is associated with central fat 
mass, and a key etiological factor for Type 2 diabetes, increases the risk for CVD which is a major 
cause of death for those with Type 2 diabetes. 
 
High waist circumference: a correlate for other comorbidities 
CVD and Type 2 diabetes may be caused by, or be a complication of, one or more other diseases. 
Risk factors such as central obesity do not necessarily work in isolation, and can involve the 
synergy and combination of other determinants. Elevated WC is associated with comorbidities such 
as obesity, hypertension, gallstone disease (210, 211) and sleep disordered breathing (212) which 
may be competing risks with the development of CVD (213).  
Risk of gallstone disease is higher among individuals with diabetes. Although there are 
controversies regarding risk factors such as BMI, sex and age for gallstone disease in diabetics 
(214), one potential reason is their level of overweight and elevated WC. These factors in turn are 
important and independent determinants for gallstone disease (211, 214, 215). Type 2 diabetes, 
usually linked to insulin resistance, is also associated with increased colon cancer risk (216).  
 
High waist circumference: social determinants and cultural status 
Finally, understanding biological factors cannot fully explain the association central obesity has 
with CVD and Type 2 diabetes without considering socio-economic, psychological and cultural 
influences. In Australia, the gap between Aboriginal people and non-Aboriginals is not limited to 
health alone but embraces the aspect of socioeconomic status which includes income, educational 
attainment, home ownership, and employment. In all these areas, Aboriginal people are 
disadvantaged (217, 218). However, socioeconomic and health disparities between these two 
Australians groups are complex and exist simultaneously. The relationship between socioeconomic 
determinants and WC although understudied, could be influenced by non-modifiable factors like 
sex, age and ethnicity, as well as modifiable factors such as physical activity and knowledge. This 
relationship may be complicated by the fact that low socioeconomic status individuals, particularly 
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remote and rural dwellers, often have less access to health care services and limited knowledge of 
weight management. 
An important factor to consider in terms of culture is the perception and awareness of elevated WC 
in relation to chronic diseases. This includes the knowledge, attitude and practices of a population 
towards issues pertaining to health. This factor is vital in implementing interventions and policies. 
Aboriginal people have a holistic approach to health which encompasses land, body, community, 
relationships, environment and law (186). Programs to raise awareness on obesity-related chronic 
illnesses in Aboriginal settings will benefit greatly and involve sustainable participation if targeted 
to incorporate all aspects of what is considered vital to health and wellbeing by this Australian 
group.  
 
2.5.2.5 Lack of WC thresholds for Aboriginal People  
Guidelines such as the ‘National guide to a preventive health assessment in Aboriginal and Torres 
Strait Islanders peoples’ and the ‘Clinical Practice Guidelines for the Management of Overweight 
and Obesity in Adults’ recognize the importance of WC in health assessment. The Central 
Australian Rural Practitioners Association (CARPA) Standard Treatment Manual also recommends 
the inclusion of WC measurements in all yearly Adult Health Checks (219). While high WC is well 
recognized for increasing the risk of CVD and Type 2 diabetes in Aboriginal people, there is a lack 
of WC cut-off points for identifying Aboriginal individuals at high risk of chronic diseases. WC 
cut-off points are thresholds used to identify individuals at increased risk of chronic diseases, and is 
one of the strategies for weight management in health promotion and intervention. WC cut-off 
points have been estimated in a number of cultures and ethnic communities worldwide (115, 139, 
220-222). The differences in disease risk levels with WC in different populations make it 
inadvisable to identify universally applicable risk thresholds (11, 223). Currently, the only available 
WC cut-off points for weight management for Australians are those proposed by the National 
Institutes of Health and the World Health Organization (115, 223). Those cut-off points were based 
on studies in populations of European origin (11), therefore more suitable for non-Aboriginals than 
Aboriginal Australians. Those thresholds are above 80 cm for women and 94 cm for men as an 
indication of increased risk of developing chronic diseases; while WC over 88cm for women and 
102 cm for men as a sign of a greater disease risk. The Australian Government launched the 
Measure-Up Campaign in 2008, to increase awareness of the high waist size and healthy choices to 
prevent lifestyle-related chronic diseases. Among other initiatives, the campaign highlighted the 
link between high level WC and risk of heart disease and Type 2 diabetes, advising on the need to 
measure WC monthly to stay within low disease risk levels.  
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A number of population studies have developed prediction models for risk of cardiovascular disease 
(CVD). However, the studies have been based on non-representative samples and WC was neither 
an exposure nor covariate variable for prediction. These studies include the Systematic Coronary 
Risk Evaluation (SCORE) project (224), the Framingham coronary heart disease prediction scores 
(225), European system for cardiac operative risk evaluation (EuroSCORE) (226) and Prospective 
Cardiovascular Muster (PROCAM) (227). The present guidelines for CVD risk in Australia 
included Aboriginal people from the age of 35 years and non-Aboriginals. However, WC, which 
has been reported as a good predictor of CVD and Type 2 diabetes among Aboriginal people was 
not included (8, 9, 178).  
The Receiver operating curve (ROC) and Youden Index have been mostly used to give ‘optimal’ 
WC cut-points in several populations worldwide (13, 228). Wang et al. conducted a literature 
review of 75 relevant articles defining WC cut-off points in different populations worldwide using 
the ROC approach (13).  They found the derived WC cut-off points from ROC do not take into 
account variations in WC levels. Rather, this method optimises the sum of two statistical 
measurements of sensitivity and specificity to obtain the ‘optimal’ WC cut-off value for a given 
outcome. Therefore, the suitability in the Aboriginal population is questionable due to the variations 
in WC in different communities. This approach has its limitations in the differences in cut-off points 
based on differences in population characteristics such as average body size or disease prevalence 
(138). As noted by Wang et al (13, 229), this method will not give a consensus on WC cut-off 
values for Aboriginal people in Australia due to the variations in WC mean values in different 
communities (12) which also changes over time in the same community.  
In light of the gaps in the literature thus highlighted, the goal of this research work was to address 
some of these concerns in Aboriginal people by examining CVD, Type 2 diabetes and mortality 
outcomes in relation to WC of both adult males and females. Identifying the effect of WC on related 
chronic disease outcomes is useful for planning effective health policy in the context of chronic 
disease burden in Aboriginal people.  
 
2.6 THE ABSOLUTE RISK METHOD 
Absolute risk is the likelihood that a disease-free individual in a population under study will 
develop a disease over a specified time interval, given current age and individual risk factors, and in 
the presence of competing risks (230). This method determines an individual’s overall disease risk 
level over a defined time period. Mostly expressed in percentage, this method is a meaningful way 
of measuring a person’s actual disease risk, and is suited to predicting risk for individuals. 
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Important properties of the absolute risk method include (230): 
1. Estimates using the absolute risk can be done in reference to a specified time interval which 
is dependent on time span and could be short, long or lifetime span. Absolute risk increases 
with increasing time span which varies with the severity of the disease being investigated.  
2. In some cases, this method can be influenced by competing risks or competing causes of 
disease which could be different from the disease under study.  
The absolute risk method is useful in a number of ways. First, it is convenient for counselling, as 
the method provides an individual’s probability of disease occurrence. Second, the method can be 
used to design trials and define eligibility criteria in intervention studies. Third, this method is not 
only useful in clinical settings in defining individual patient management, but it is important in 
decisions regarding public health (231). 
 
In a cohort study, parametric and non-parametric estimation of absolute risk can be worked out 
under several models. This thesis used the Weibull model to present the absolute risk estimates 
presented in the results of the studies carried out. Details of how this statistical method was used in 
the thesis are explained in ‘Research Methods’- Chapter 4, under the ‘Statistical analysis’ section 
(4.8). 
The absolute risk approach used in this research work takes into account both additive and 
synergistic effect of clusters of risk factors of specific diseases (232) to give evidence of risk 
associated with CVD and Type 2 diabetes according to WC and age for Aboriginals in the study 
community.  It is an informative measurement of the probability of developing CVD and/or Type 2 
diabetes at a particular WC and specific age (233). The absolute risk method also gives information 
on health effects of potential risk factors which indicates easy interpretation by both health 
professionals and patients (233). 
 
2.7 CONCLUDING REMARKS 
Current Australian guidelines acknowledge the importance of WC measurement in the prevention 
of chronic diseases. However, none of those guidelines have been able to recommend WC cut-off 
points specifically for Aboriginal people. This thesis used data from an Aboriginal community to 
present results of relationship between WC and two disease outcomes (CVD and Type 2 diabetes), 
and took a further step to calculate WC values that corresponded with equivalent BMI points for 
CVD and Type 2 diabetes using the absolute risk method.  
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The next chapter is a systematic review and meta-analysis of studies on Aboriginals and non-
Aboriginals conducted to assess the differences in WC of males and females, in order to provide a 
background to the work presented in subsequent chapters. 
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CHAPTER 3 
SYSTEMATIC REVIEW AND META-ANALYSIS ON WAIST CIRCUMFERENCE OF 
ABORIGINAL AND NON-ABORIGINAL PEOPLES 
3.1 INTRODUCTION AND AIM 
As described in Chapter 2, generally, Aboriginal people in Australia have the tendency to store 
abdominal fat (central obesity) relative to their weight and are at greater risk of obesity-related 
chronic diseases than non-Aboriginals. However, there are not many studies that have assessed the 
differences in waist circumference of Aboriginal people and non-Aboriginals in Australia. The aims 
of this chapter are: 
1. To conduct a systematic review of all available published literature till June 2013 reporting 
WC estimate (mean or median) among Aboriginal and non-Aboriginal Australians. 
2. To conduct a meta-analysis of available estimates to assess the differences between 
Aboriginal men and women, and also in comparison to their non-Aboriginal counterparts. 
3. To examine whether height and weight could explain the high WC found in Aboriginal 
females. 
 
In this chapter, Section 3.2 details my contributions to the review. The results of the review have 
been published in a peer-reviewed journal. The reference for this publication is:  
Adegbija O.O and Wang Z. Gender variations in waist circumference levels between Aboriginal 
and non-Aboriginal Australian populations: A systematic review. Obesity Research and Clinical 
Practice 2014; 8(6): p. e513- e524. 
 
 
3.2 CONTRIBUTION TO THE STUDY 
The concept, design of methodology for the systematic review and meta-analysis of the study were 
formulated by me with the assistance of Dr Zhiqiang Wang. I conducted the systematic review and 
was responsible for the collection and management of data, which Dr Wang and I abstracted from 
each of the studies. Data analysis was conducted by me and the interpretation of the results was 
discussed with Dr Wang. I was responsible for writing the manuscript, taking into account 
contributions from Dr Wang. 
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ABSTRACT 
 
Objectives 
To compare gender-specific waist circumference (WC) levels of Aboriginal Australians with non-
Aboriginal Australians. 
 
Methods  
A systematic search on Medline, PubMed, EMBASE and Google Scholar databases was conducted 
to identify papers that reported gender-specific waist circumference (WC)  estimates of participants 
from the age of 15 years and above among Aboriginal and non-Aboriginal Australians. Means and 
their 95% confidence intervals of gender differences in WC, height and weight were recorded or 
calculated where they were not provided. Gender-specific WC, height and weight mean estimates 
were pooled and the I
2
 statistic was used to test heterogeneity among Aboriginal and non- 
Aboriginal Australians. 
 
Results 
Of 17 selected cross-sectional studies, 9 focused on Aboriginal and 8 on non- Aboriginal 
Australians. Seven studies reported significantly higher WC estimates among Indigenous females 
than males. On the other hand, non-Indigenous males had significantly higher WC levels than 
females. Males had greater height and weight estimates than females in both groups. 
 
Conclusion 
Although Indigenous women were shorter and had lower weight estimates, they had greater WC 
levels than Indigenous men. This is the first systematic review to assess the gender-specific 
differences between Aboriginal and non- Aboriginal Australians. The findings of this review 
warrant more efforts to understand and reduce the high prevalence of central obesity and related 
chronic diseases among Aboriginal women. 
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INTRODUCTION 
A number of studies have emerged in the last decade that provide evidence of waist circumference 
(WC), a proxy for central obesity, as a better tool for predicting a number of sequelae related to this 
condition in some Aboriginal communities in Australia (9, 145, 146, 178).  Prior to this time, body 
mass index (BMI) and waist-to hip ratio (WHR) were the main reported anthropometric indices for 
the Aboriginal Australian group (234, 235). Evidence of variations in the body habitus, including 
waist circumference (WC) levels of Aboriginal and non- Aboriginal Australians (12, 146-148) has 
been the subject of numerous work in the field of Australian public health. Recent reports have 
shown that adult Aboriginal females have the propensity for greater central adiposity when 
compared to the males in this populace and therefore have higher WC levels (9, 10, 12, 157), the 
reverse appears to be apparent for non- Aboriginal Australians (98, 236). This has significant 
implications particularly for Aboriginal females, considering that central or abdominal obesity 
mostly measured by WC has been known to bear strong linkage with the risk of chronic diseases 
such as cardiovascular and diabetes (9, 158).  
Nationally, there have been reports of a higher risk of chronic diseases among Aboriginal 
Australians in comparison with non- Aboriginal Australians, so much so that there is an 
unacceptable gap in the life expectancy between these two populations as a result of chronic 
diseases (5). The Australian Institute of Health and Welfare (AIHW) reported a mortality gap of 
80% between the Indigenous and non-Indigenous groups among individuals aged 35-74 years 
between 2005 and 2007 due to chronic diseases (5). Since the indigenes have the tendency to store 
abdominal fat rather than a more peripheral distribution of body fat (9, 12), it is not surprising that 
the risk of developing chronic diseases is high among them compared to their non-Aboriginal 
counterparts.  
In this review, we analysed the data from 9 studies in Aboriginal Australians and 8 in non-
Aboriginals (focusing on Australians of European descent) with the aim of assessing gender 
differences in WC levels and to explore the heterogeneity of the variations in gender among studies 
in different Australian regions. The first hypothesis we tested was that adult Aboriginal females 
have higher WC levels in comparison to the males and that generally Aboriginals have different 
WC levels when compared to the non-Aboriginals in Australia. Also, we investigated whether 
height and weight explained the higher WC levels of adult Aboriginal females. Understanding if 
higher WC in Aboriginal women than in the men are a common phenomenon is an important step to 
alert policy makers and health professionals of the need for a more concentrated effort on 
Aboriginals particularly for women to promote weight management with the aim of preventing and 
controlling chronic disease risks.   
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METHODS 
Search strategy 
This systematic review and meta-analysis was conducted according to the preferred reporting items 
for systematic reviews and meta-analysis (PRISMA) guidelines (237). Keyword searches were 
completed on Medline, PubMed, EMBASE and Google scholar for reports published from 
inception to June 2013. Search terms were: - ‘Waist circumference OR Waist girth OR WC Central 
obesity OR Body mass index OR BMI OR Abdominal adiposity’ and ‘Aboriginal OR indigenous’ 
AND ‘Australia OR Australians’ AND ‘adults’. The reference lists of all eligible articles and 
reviews were thoroughly scanned to identify additional studies for inclusion. 
Note: BMI was included in the search terms to identify studies that reported WC levels that 
correspond to well established BMI estimates, recommended by the World Health Organisation 
(WHO) for overweight and obesity. 
 
Study selection 
A comprehensive literature search of electronic databases was conducted to identify publications 
reporting WC mean values in Aboriginal and non-Aboriginal regions. For the non-Aboriginal 
Australian group, we focused on Australians of European origin (or at least 90-93% of the 
participants in the study were of European descent). The selected studies targeted the adult 
population, however, a number of studies that included participants from the age of 15 years along 
with the adult population were also included in the analysis.  
Studies were excluded if they focused on children and/or adolescents or pregnant women or men 
alone; presented overall WC estimates without stratifying by gender; focused on chronic diseases 
without reporting population WC means or median; the dataset from a particular Indigenous 
community had already been selected as meeting the inclusion criteria; and if papers were not 
published in English. 
 
 
Data Extraction and quality assessment 
Articles were reviewed independently by the two authors and data items extracted as per Tables 3.2 
and 3.3. All titles were screened for relevance using exclusion criteria, duplicates were removed and 
abstracts reviewed within inclusion and exclusion criteria. Next, a thorough review of the full-text 
of remaining articles was done. The reference lists of all eligible articles and reviews were 
thoroughly scanned to identify papers additional studies for inclusion. Quality was assessed by 
abstracting information on the study population, measurement of WC, ascertainment of means and 
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95% confidence intervals (Table 3.1). Gender-specific WC, height and weight- means, standard 
deviation, or gender comparative estimates with their 95% confidence intervals were extracted or 
calculated from relevant studies and coded according to the combinations of the following 
divisions: (1) demographic factors: age range, gender, group (Aboriginal and non-Aboriginal 
Australians) (2) WC, height and weight according to gender. 
 
 
Table 3.1Quality Assessment of Studies Included in Systematic Review 
 Author Population Source WC Ascertainment 
 Population-
based cohort 
Clinical-
based cohort 
Measured by 
Investigators 
Self-
reported 
Not 
Stated 
Aboriginal studies 
Bambrick, H.J (178) X  X   
Burke et al (238) X  X   
Hodge et al (196) X  X   
Kondalsamy-Chennakesavan et al 
(12) 
X  X   
Li & McDermott (146) X  X   
Maple-Brown et al (239) X  X   
Piers et  al (98) X  X   
Shemesh et al (157) X  X   
Wang & Hoy (9) X  X   
 
Non-Aboriginal studies 
Craig (240) X  X   
Janus et al (241) X  X   
Maclnnis et al (242) X  X   
Piers et al (98) X  X   
Snijder et al (243) X  X   
Welborn (244) X  X   
Molarius (245) X  X   
Molarius (245) X  X   
OAC (246) X    X 
OAC (246) X    X 
OAC (246) X    X 
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Data synthesis and statistical analysis 
WC mean estimates were stratified by gender as it has been shown that significant differences in 
WC levels exist between Aboriginal and non-Aboriginal males and females. Where possible, 
sample population WC mean estimates comparing males and females, as well as the 95% 
confidence intervals (CI) in males and females were directly obtained from original reports, 
otherwise 95% CI were calculated from extracted WC means and standard deviation estimates. We 
extracted data for participants without disease from studies that compared diseased and non-
diseased people. Meta-analysis was conducted to assess heterogeneity among studies in the gender 
differences in WC, height and weight within Aboriginal and non-Aboriginal groups using the I
2
 
statistic by Higgins et al (247). STATA 12.0 was used for all analysis (248). 
 
Ethical issues 
Ethical clearance was not required for this review as we extracted data from already existing 
studies. 
 
 
RESULTS 
The search strategy yielded a total of 996 papers of which 894 were excluded (28 were duplicates). 
A total of 102 studies were retained because of eligible titles but after a thorough check of the 
abstract and results sections, fourteen of the studies were retained. There was an additional three 
articles identified and included by secondary searches of reference lists of included publications as 
well as Google scholar. Of the 88 studies that were excluded, fourteen presented BMI values but did 
not present a specific WC values; in nineteen studies, the prevalence and trends of the chronic 
disease outcomes were presented without evidence of WC levels; five were studies on women or 
pregnant women; three were studies on only men; fourteen gave overall WC values without 
separating the gender; nine had datasets from other included studies; nineteen were studies of 
children only; and five did not contain data (commentaries, narrative reviews etc.). Consequently, a 
total of 17 cross-sectional studies were retained for the final analysis. Figure 3.1 below illustrates 
the selection process of included articles. 
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A Systematic Flow Diagram of Study Selection Process 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.1 Study selection flow chart  
Note: Exclusion criteria A- focused on chronic diseases without reporting population WC means or median. Exclusion 
criteria B- focused on the prevalence of chronic diseases and their relationship with WC but without WC population 
estimates. Exclusion criteria C- focused on women or included pregnant women in their analysis. Exclusion criteria D- 
were studies conducted to include men only. Exclusion criteria E- gave overall WC estimates without separating the 
gender. Exclusion criteria F- used the dataset from studies already included in the review. Exclusion criteria G- were 
studies focused on children. Exclusion criteria H- contained no data (commentaries and narrative reviews). 
 
 
 
996 results from 
Medline, PubMed, 
EMBASE and Google 
Scholar Databases.  
102 Eligible titles 
14 studies met the 
inclusion criteria and 
none of the exclusion 
criteria 
17 Papers retained for 
final analysis 
894 excluded (28 
duplicates and 
866 ineligible 
titles). 
Abstracts and 
results section 
screened for 
eligibility. 
14 unsuitable- Exclusion A 
19 unsuitable- Exclusion B 
  5 unsuitable- Exclusion C 
  3 unsuitable- Exclusion D 
14 unsuitable- Exclusion E 
 9 unsuitable –Exclusion F 
19 unsuitable- Exclusion G  
5 unsuitable- Exclusion H 
3 papers found from 
secondary searches of 
reference lists and Google 
scholar 
9 Aboriginal 
studies  
8 non-Aboriginal 
studies 
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Characteristics of the study 
Overall 17 cross-sectional studies were included in the final analysis with 9 focusing on the 
Australian Aboriginal population (9, 12, 98, 146, 157, 178, 196, 238, 239) and 8 on the non-
Aboriginal Australians (98, 240-243, 245, 246). The participants included in these studies were 
aged between 15 and 88 years. The sample size ranged from 54 to 1641 in Aboriginal participants 
and from 393 to 41253 in non-Aboriginal participants. Aboriginal communities included were from 
different regions of Australia: one of the studies was conducted in Western Australia (Kimberley, 
Perth Aboriginal community) (238), one in south eastern Queensland (North Stradbroke Island and 
Redland bay and Torres Strait Island) (178), one in Central and Northern Australia (98), one in 
Northern Queensland (146)  and five focused on the Northern Territory (NT) (9, 12, 157, 196, 239). 
Data relating to non-Aboriginal Australians were from several population based surveys including 
the AusDiab (Australian Diabetes, Obesity and Lifestyle Study) (243), MONICA (MONitoring 
trends and determinants of CAdiovascular Disease) study (245), Melbourne Collaborative Cohort 
study (MCCS) (242), Obesity in Asia Collaborative study (246), the third Risk Factor Prevalence 
Study of the National Heart Foundation of Australia (244), staff of Central Sydney Area Health 
Service (240), staff and students of Deakin University in Melbourne (98), and two cross sectional 
studies in the Great Green Triangle region of South-Eastern Australia (241). 
Tables 3.2 and 3.3 present the summary mean values of WC, height and weight for both male and 
female Aboriginal and non-Aboriginal Australians. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Table 3.2 Descriptive summary of demographic characteristics and WC estimates of selected 
Aboriginal and non-Aboriginal studies 
 
Author Study 
year 
Area of 
Residence 
Age 
range 
(years) 
Sample 
(n) 
Mean WC (95%CI)- cm 
 
     Males Females 
Aboriginal studies 
Bambrick, H.J 
(178) 
2000 South-East 
Queensland 
18-66 117 99.9 (95.9-104.1) 109.0 (104.8-113.2) 
Burke et al 
(238) 
1988-
1989 
Western Australia 15-88 487 88.5 (86.9-90.1) 94.4 (92.4-96.4) 
Hodge et al 
(196) 
2003-
2005 
Northern 
Territory 
>=15 512 99.9 (97.8-102.0) 97.5 (95.7-99.3) 
Kondalsamy-
Chennakesavan 
et al (12) 
2000-
2003 
Northern 
Territory 
25-74 814 92.2 (90.9-93.5) 96.7 (95.4-98.1) 
Li & 
McDermott 
(146) 
1999-
2001 
Northern 
Queensland 
15-74 1641 89.7 (88.7-90.8) 92.2 (91.1-93.3) 
Maple-Brown 
et al (239) 
2001-
2002 
Northern 
Queensland 
47 54 91.1 (84.5-97.8) 94.1 (90.2-98.0) 
Piers et  al (98) 1995-
1997 
Central & NE 
Australia 
18-35 250 79.7 (78.1-81.3) 77.7 (75.7-79.7) 
Shemesh et al 
(157) 
2001-
2003 
Northern 
Territory 
>=15 379 82.4 (80.3-84.4) 86.6 (84.6-88.5) 
Wang & Hoy 
(9) 
1992-
1995 
Northern 
Territory 
18-74 915 86 (84.8-87.2) 91 (89.6-92.4) 
 
Non-Aboriginal studies 
Craig (240) 2001 Sydney 26-47 393 92.7 (90.9-94.5) 80.7 (78.9-82.5) 
Janus et al 
(241) 
2004-
2005 
Victoria & South 
Australia 
25-74 806 101.2 (99.8-
102.5) 
92.2 (90.8-93.7) 
Maclnnis et al 
(242) 
1990-
1994 
Melbourne 
(MCCS) 
40-69 5879 91.7 (91.3-92.1) 78.0 (77.7-78.3) 
Piers et al (98) - Melbourne 18-35 147 80.7 (78.4-83.0) 68.5 (67.5-69.5) 
Snijder et al 
(243) 
1999-
2000 
AusDiab >=25 8400 96.3 (95.9-96.7) 83.4 (83.0-83.8) 
Welborn (244) 1989 Metro Centres in 
Australia 
20-69 9206 90.0 (89.7-90.3) 77.0 (76.7-77.3) 
Molarius (245) 1987-
1992 
Newcastle- 
MONICA Project 
25-64 1349 95.0 (94.2-95.8) 83.0 (82.0-84.1) 
Molarius (245) 1987-
1992 
Perth- MONICA 
Project 
25-64 1272 92.0 (91.3-92.7) 78.0 (77.2-78.8) 
OAC (246) 2002 OAC 26-66 9276 90.4 (90.1-90.7) 76.5 (76.2-76.8) 
OAC (246) 2002 OAC 26-66 11104 97.5 (97.2-97.8) 85.4 (85.1-85.7) 
OAC (246) 2002 OAC 26-66 41253 93.5 (93.4-93.6) 80.0 (79.9-80.1) 
Note: All estimates of waist circumference (WC) are in centimetres (cm).  Study year- Year the study was conducted. 
QLD: - Queensland, WA: - Western Australia, ACT: - Australia Capital Territory, AUS: - Australia, NE: - North-
Eastern, LCI: - Lower Confidence Interval, UCI: - Upper Confidence Interval, AusDiab: - Australian Diabetes, Obesity 
and Lifestyle Study, MONICA:- MONitoring trends and determinants of CAdiovascular Disease survey, MCCS- 
Melbourne Collaborative Cohort Study, OAC:- Obesity in Asia Collaboration 
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Table 3.3 Descriptive summary of the height and weight estimates of selected Aboriginal and 
non-Aboriginal studies 
 
Author Year Area of Residence Mean Height (cm)  Mean Weight (kg) 
   Males Females Males Females 
Aboriginal studies 
Bambrick, H.J (178) 2005 South-East Queensland - - - - 
Burke et al (238) 2007 Western Australia - - 70.3 65.5 
Hodge et al (196) 2010 Northern Territory - - - - 
Kondalsamy-
Chennakesavan et al (12) 
2008 Northern Territory 174.7 163.7 74.5 71.2 
Li & McDermott (146) 2010 Northern Queensland 171.5 160.1 72.7 67.8 
Maple-Brown et al (239) 2005 Northern Queensland 174.8 161.3 71.2 65.7 
Piers et  al (98) 2003 Central & NE Australia 172.1 160.2 66.8 57.3 
Shemesh et al (157) 2007 Northern Territory - - - - 
Wang & Hoy (9) 2004 Northern Territory - - 67.8 63.0 
 
Non-Aboriginal studies 
Craig (240) 2001 Sydney 177.0 163.8 83.0 69.2 
Janus et al (241) 2007 Victoria & South Australia 175.6 162.4 87.1 75.8 
Maclnnis et al (242) 2013 Melbourne (MCCS) 173.5 160.8 80.2 67.2 
Piers et al (98) 2003 Melbourne 178.8 165.8 76.3 60.2 
Snijder et al (243) 2004 AusDiab 176.3 162.8 83.7 69.3 
Welborn(244) 2003 Metro Centres in Australia 175.0 162.0 79.0 65.0 
Molarius(245) 1999 Newcastle- MONICA 
Project 
- - - - 
Molarius(245) 1999 Perth- MONICA Project - - - - 
Obesity in Asia 
Collaboration (246) 
2008 Obesity in Asia 
Collaboration 
- - - - 
Obesity in Asia 
Collaboration (246) 
2008 Obesity in Asia 
Collaboration 
- - - - 
Obesity in Asia 
Collaboration (246) 
2008 Obesity in Asia 
Collaboration 
- - - - 
Centimetres (cm). Kilogram (kg). 
 
 
Meta-analysis 
Waist circumference: - The mean gender differences of the WC levels of Aboriginals and non-
Aboriginals are illustrated in Figure 3.2. Seven of the nine studies in Aboriginal Australians showed 
that women had higher WC levels than men while two showed that men had higher WC than 
women. On average, WC was 3.1 cm (95% CI: 2.3-3.9, P<0.001) higher in women than in men. On 
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the other hand, in non-Aboriginal Australians, all studies consistently showed that  men had higher 
WC than their women counterparts with an average difference of 13.2 cm (95% CI: 13.1-13.4, 
P<0.001).  Heterogeneity tests were significant with I
2
 = 82.6% within Aboriginal studies (P<0.001) 
and I
2
= 90% (P<0.001) within non-Aboriginal studies. The pooled average WC levels were 89.1 cm 
(range: 79.7 to 100.0 cm) for Aboriginal men, 92.9 cm (range: 77.7 to 109.0) for Aboriginal 
women, 93.5 cm (range:  80.7 to 101.2 cm) for non-Aboriginal Australian men and 80.3 cm (range: 
77.0 to 92.2 cm) for non-Aboriginal women. 
 
 
Figure 3.2 Meta-analysis and pooled waist circumference estimates (cm) of Males and 
Females in Aboriginal and non-Aboriginal communities 
 
 
Height: - Four Aboriginal studies and six non-Aboriginal studies gave height estimates for males 
and females.  Generally, height estimates in both groups showed males were taller than the females 
by at least 11 cm (Figure 3.3). On average, pooled height estimates for Aboriginal males and 
females were 173.2 cm and 161.3 cm respectively and men were 11.4 cm (95% CI: 10.8-12.0) taller 
than women. The gender differences in height was homogenous (I
2
= 22.7%, P=0.27). Pooled height 
mean estimates for non-Aboriginals was 176 cm for males and 162.9 cm for females indicating 
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males had 13.1 cm (95% CI: 12.9-13.3) height advantage over the females. However, the difference 
in height was not significant (I
2
= 58.6%, P=0.03). 
 
 
 
Figure 3.3 Meta-analysis and pooled height estimates (cm) of Males and Females in 
Aboriginal and non-Aboriginal communities 
 
 
Weight: - Twelve studies reported weight estimates from Aboriginal (n=6) and non-Aboriginal 
(n=6) communities. Similar to what was observed for height, males generally had higher weight 
estimates than females (Figure 3.4). For the Aboriginal group, pooled weight estimates showed 
females had lower mean weight values than males with 65.1 kg versus 70.1 kg and men were 5 kg 
(95% CI: 4.4-5.7) heavier than women. For the non-Aboriginal populations, on average, males had 
81.6 kg weight and weighed 13.6 kg (95% CI: 13.3-13.9) more than the females whose average 
weight was 67.8 kg. Non-Aboriginal males were 11kg heavier than their Aboriginal male 
counterparts; however, the difference among the females was relatively small (2.7 kg), with non-
Aboriginal females having the higher value. Gender differences in weight were heterogeneous 
among studies within Aboriginal and non-Aboriginal groups. 
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Figure 3.4 Meta-analysis and pooled weight estimates (kg) of Males and Females in 
Aboriginal and non-Aboriginal communities 
 
 
DISCUSSION 
This review study has shown differences in WC levels between Aboriginal and non-Aboriginal 
Australians. It appears to be a common phenomenon that Aboriginal women have significantly 
higher WC levels than Aboriginal men, although there was significant heterogeneity among 
different studies. In the non-Aboriginal Australian population, WC in men was over 10 cm higher 
than in women.  
In seven of nine Aboriginal studies, women had higher WC levels than men by a range of 2.5 to 9.0 
cm. However, this remarkable observation was not explained by the size of their body frame as 
Aboriginal women were on average 11 cm shorter than Aboriginal men, similar to that of the 13cm 
in the non-Aboriginal Australian population. Furthermore, Aboriginal males had greater weight 
than the females in the studies that presented weight values. Differences in weight estimates for 
males and females ranged from 3.3 kg (12) to 9.5 kg (98). The higher WC in Aboriginal women 
with lower height and weight levels indicated that they had higher abdominal fat than Aboriginal 
men.  
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The phenomenon of higher waist circumference in women has also been reported in some other 
populations in Tonga (249) and Oman (139). They showed females had higher WC estimates or cut-
off points than males but the differences between the genders within studies did not appear to vary 
significantly.  
Although regional differences (urban and rural) were not the focus of this review, it is worthy of 
note that the significant heterogeneity within Aboriginal and non-Aboriginal groups could be due to 
differences among study populations. WC estimates were lower for Aboriginals residing in the rural 
regions in comparison to those in the urban areas. On the other hand, non-Aboriginals in the rural 
areas showed higher WC levels than those in the urban settings. We cannot elucidate on the reasons 
for these remarkable differences; however, possible explanations are the effects of urbanization due 
to the western lifestyle which could be positive or negative.  
A number of studies conducted earlier in Australia on Aboriginals and non-Aboriginals reported 
WHR and BMI rather than WC (234, 235, 250). BMI measures relationship between weight and 
height and does not adequately reflect fatness (or adiposity) (251); and WHR is less dependent on 
body size and height, therefore may be inappropriate to assess fatness and weight loss as 
theoretically it could remain unchanged during weight loss (143). These two indices may 
misclassify highly muscled individuals with high muscle mass in the body and around the hip 
region (244) in the category of overweight. On the other hand, WC relates to both body weight and 
fat distribution identifying it as the best indicator for changes in intra-abdominal fat during weight 
loss (115). Furthermore, measurement of WC is simple when compared to WHR, and more reliable 
and feasible compared to WHR (115, 127).  Therefore, our focus on WC which several studies have 
shown to be a better index for predicting some chronic diseases in Aboriginal communities is 
unlikely to lead to a bias in both Aboriginal and non-Aboriginal populations.  
We utilized measurements of weight and height across studies instead of the commonly used BMI, 
to assess how these two relate to WC in both populations, particularly among Aboriginals. While 
none of these two measures solely explain frame size on its own, we are keen to know if 
measurement of each could explain reasons for the size of WC in these populations.  
Our findings have several potential implications. First, Aboriginal women may be more sensitive to 
lifestyle transition which may be due to sedentary lifestyle. However, the paucity of information 
about the daily routine of Aboriginal women is conflated with the limited amount of intervention 
research among this Australian group, resulting in little evidence about whether lifestyle or genetics 
is responsible for the higher WC levels among women. Also, with the high levels WC reported as 
predictor of the risk of chronic diseases among Aboriginals (9, 178) and Aboriginal women at 
higher risks of diabetes and coronary heart disease than men (252-254),  further analysis is needed 
to assess to what degree the increased risk of chronic diseases in Aboriginal women is contributable 
42 
 
to the higher WC levels. Second, our finding of the higher WC levels in Aboriginal women and 
further understanding why such a phenomenon exists in this population are important for planning 
effective intervention efforts.  
 
Strengths and Limitations 
To our knowledge, this is the first systematic review comparing WC, height and weight levels of 
Aboriginal and non-Aboriginal Australians. Also, no study was identified outside Australia that 
compared WC differences between Indigenous and non-Indigenous groups.  
There are limitations to our review. First, there is a possibility that not all the relevant studies have 
been included in this review, however, the search strategy was broad, identified studies and 
reference lists of selected studies were thoroughly checked by the authors. Second, few studies have 
been conducted on waist circumference levels of Indigenous Australian people making it impossible 
to compare estimates of diverse Indigenous Australian communities in other parts of the country. 
There is not adequate information from other regions to establish enough evidence of the 
differences in levels of WC in the different Australian regions; therefore, the Aboriginal population 
for this review was restricted to studies mostly from Australian Northern Territory, Queensland and 
one from Western Australia that met the inclusion criteria. The studies may over-represent 
Aboriginal people in remote communities. Although our results may not be representative of the 
whole Australian Aboriginal group, they provide novel ethnic-based information comparing WC, 
height and weight of males and females Australian Aboriginals and non-Aboriginals. Third, WC 
measurement across studies was a potential measurement bias as methods of measuring varied 
across studies and also depended on the accuracy of individuals carrying out the measurements. 
Fourth, age was imbalanced across studies as most studies did not stratify into age groups but gave 
the age range of participants. There is a possibility of age biasing the measured outcome as older 
age is commonly associated with greater WC and poorer health outcomes. Therefore the younger 
participants in studies were likely to have lower WC values than those in older age group. However, 
none of the study acknowledged controlling for age as a confounder, and as we do not have access 
to original data, age was not adjusted for in this study.  
We did not control for group factor (Indigenous and non-Indigenous) as we separated and focused 
on Aboriginals and separated Aboriginals from TSI for studies that worked on indigenous group 
(146). Although, Hodge et al (2010) utilized data from the DRUID study (255), where 85.85% of 
participants were Aboriginals and 4.95% were TSI, this is unlikely to affect the our results since the 
proportion of Aboriginals was high and a sample was drawn from the entire DRUID study which 
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will further reduce the number of TSI participants. Likewise for the non-Aboriginal group, we 
targeted only Australians of European descent. 
We were unable to compare incidence and prevalence of central obesity which have been on the 
increase over time between the two groups. This is due to the few numbers of studies selected for 
this review as well as the large amount of variability about the time point of studies’ conduction. A 
working cut-off standard for WC is non-existent for Aboriginals as the present standard by Lean et 
al (115) classified more Aboriginal overweight than by BMI criteria (147). This could potentially 
affect the comparison of the increasing prevalence of central obesity that is apparent for this 
Australian group and the non-Indigenous population. In their study of Indigenous Australian group, 
Li & McDermott stated a contrast exists in the optimal WC cut-offs found in North Queensland and 
the existing cut-offs (146). Nonetheless, four of the Aboriginal studies selected used the existing 
standards while others provided no WC cut-off definition. Lastly, while we did not include studies 
that focused on pregnant women, we are not able to ascertain if our analysis comprise of those 
pregnant as none of the study stated whether pregnant women were included in the analysis. 
 
CONCLUSION 
This review found considerable variation in WC of males and females and Aboriginal and non-
Aboriginal Australians. Aboriginal females had higher WC levels than the males and these 
differences were independent of both height and weight as the males consistently had higher weight 
and height estimates. The findings of this review are vital for informing public health policies and 
programs more focused and targeted to Aboriginal women in the control of central obesity which is 
a risk factor for developing chronic diseases.  
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CHAPTER 4 
RESEARCH METHODS 
4.1 INTRODUCTION 
This chapter describes briefly the study population and an overview and description of datasets used 
for the original research in the thesis. This is followed by the study design used in sample selection 
for the subsequent chapters. Next, study variables which include the exposure, outcome and 
confounding variable are described. Finally, discussions on the process of data management, ethical 
approval and statistical analysis are provided. 
 
4.2 STUDY POPULATION 
Tiwi Islands are remote Aboriginal populations located in Australia’s Northern Territory (NT), 80 
km to the north of Darwin. The NT is a federal Australian territory in the centre and central 
northern regions. The Tiwi Islands comprise Melville Island, Bathurst and nine smaller uninhabited 
Islands. There are approximately 2,228 people on the Islands, based on the 2001 Census. The map 
of the Island and surrounding communities is presented in Figure 4.1. 
 
 
Figure 4.1 A map of the study population and surrounding communities 
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4.2.1 Baseline dataset 
The baseline data was collected by Prof Wendy Hoy and her team, which involved population-
based baseline records of 1490 participants in Tiwi Islands from 1992 to 1998. Over 80% of the 
population are of Tiwi origin. Health screening examinations were offered to every Aboriginal 
individual aged between 5 and 76 years, who resided in the communities on the Islands. People in 
hospital, in old age care, on dialysis, resident elsewhere, or out of community at the screening 
period did not participate in the health screening. Over 80% of eligible adult community members 
were participants at the baseline screening examination (256). Data were collected at baseline 
examination through interview questionnaires. Some of the baseline data included age (years), waist 
circumference (WC- cm), weight (kilograms), height (centimetres), sex (male or female), smoking 
status (smoker or non-smoker), alcohol consumption status (drinker or non-drinker), and diabetes 
status (yes or no). Body size measurements were single measurements made by one field worker 
and two Aboriginal health workers. More detailed descriptions of the baseline data collection have 
been presented in earlier studies (9, 147, 257, 258). Individuals were included in the thesis analysis 
if they fitted the following inclusion criteria: 
1. Participated in the baseline health screening program 
2. Were ≥18 years old at baseline screening 
3. Had WC data recorded at baseline examination 
Of 1490 participants at the baseline screening survey, 976 were adults aged between 18 and 76 
years, which represented over 70% of the (1,328) total age-eligible population, based on  the 2001 
Census. As adults were the focus of this thesis, data of the 976 adults were utilized. Out of 976 
adults, a total of 935 individuals (474 males and 461 females) had WC measures at baseline and 
were eligible to participate and included in this research project work. Figure 4.2 is a flowchart of 
the process of participants’ selection for analysis. 
The mean ages of the eligible participants were 33.9 years (ranging from 18 to 73) for males and 
36.9 years (ranging from 18 to 76) for females. Their WC ranged from 63 to 138 cm in males and 
60 to 135 cm in females. WC means were 87.6 cm (SD=13.0) for adult males and 91.0 cm 
(SD=14.5) for females. Body mass index (BMI) mean was 23.6 kg/m
2
 for males and 24.7 kg/m
2
 for 
females. 
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Figure 4.2 Study selection process 
 
 
Study community 
N=2,228 
Number of people who did not participate in baseline 
health screening program 
n=738 
Number of people who participated in the baseline health screening program  
n=1490 
Children (age˂18 years) 
n=514 
Adults (age≥18 years) 
 (n=976) 
935 had baseline WC measurement and were 
eligible for inclusion in the thesis analysis 
Males 
n=474 
Females 
n=461 
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4.2.2 Follow-up datasets 
4.2.2.1 Hospitalisation dataset 
The hospitalisation dataset used for this study was obtained from the Northern Territory Department 
of Health. It included the records of hospitalisation and emergency admissions of individuals who 
had been hospitalised within the public health system in the Northern Territory. Each condition 
diagnosed during the hospitalisation was recorded according to the International Classification of 
Disease: English Revision International Classification of Diseases (ICD-9 code) code and 
International Statistical Classification of Diseases, 10th Revision (ICD-10- AM code). 
Hospitalisation data were collected for 20 years (from 1992 to December 2012). To identify 
morbidity outcomes, patients’ hospitalization records were filtered using ICD-9 and ICD-10 codes. 
A morbidity event was defined as the first identified ICD code representing the disease of interest 
after baseline examination. Each participant was identified through hospital admissions by Hospital 
Registration Number (HRN). 
 
4.2.2.2 Mortality dataset 
Mortality data from January 1992 to December 2010 among study participants were collected by 
the Centre of Chronic Disease Research team led by Prof Hoy. Death records were obtained through 
community networks, records at the local clinics and hospital and the death registry records. There 
were 218 adult deaths during the follow up period. Death causes were divided into: 
1. Injury deaths (including acute intoxications, accidents, drowning, suicide, homicide, etc.) 
2. Natural deaths included fatality from old age, cardiovascular (heart attack, cardiac arrest, 
acute myocardial infarction, congestive heart failure, pulmonary oedema, aortic valve 
disease, atherosclerosis, coronary artery disease), diabetes, renal (death with terminal renal 
failure without dialysis, maintenance dialysis commenced, acute renal failure), pulmonary 
(pneumonia, bronchitis, bronchiectasis, respiratory failure, chronic obstructive pulmonary 
disease, primary pulmonary hypertension, acute respiratory disease), cancers (throat, breast, 
larynx, nasal, lung), others (liver failure, rheumatic heart disease, cirrhosis, colloid cyst, 
congenital abnormalities, sepsis, epilepsy).  
The methods of the mortality data have been described in detail elsewhere (257). Death outcomes 
were identified to assess their relationship with WC and BMI to provide mortality estimates in 
Chapter 7.  
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4.3 STUDY DESIGN 
Prospective cohort study design 
This research project was a prospective cohort study where all adults (≥18 years old), with WC 
measurements and free of the outcome of interest at baseline examination were followed up for a 
maximum of 20 years for disease or mortality outcomes. This study design allows evaluation of the 
temporal sequence between exposure and outcome; and permits direct calculation of incidence rates 
in both the exposed and unexposed groups. 
 
4.4 SAMPLE SELECTION 
4.4.1 Disease outcomes 
All participants were followed-up from baseline screening examination until December 2012 in the 
hospitalisation dataset. For events of CVD and Type 2 diabetes, the first ever incident cases for 
participants were included in the analysis. For individuals who had been diagnosed as having an 
endpoint event during the follow-up period, their follow-up duration was calculated as the period 
from the time of the baseline screening visit when WC was measured to the time of the outcome 
diagnosis. Those who had survived and had not reached the endpoint were considered “censored” 
on 31 December 2012. Participants who had been free from the endpoint event and died from other 
causes before the end of the follow-up were censored at the time of death. 
 
4.4.2 Mortality outcomes 
4.4.2.1 All-cause mortality: The mortality records were ascertained from mortality records at the 
local clinics and hospital records. Participants were followed up from baseline examination (1992-
1998) to December 2010 as recorded on the mortality dataset. Those who died during the follow-up 
time were considered to have had the event, while those who had not reached the endpoint were 
considered ‘censored’ at December 2010.  
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4.5 STUDY VARIABLES  
4.5.1 Exposure Variables  
4.5.1.1 Waist circumference (WC) 
WC was measured on a horizontal plane using a tape measure while the participants were wearing 
light clothing. WC was measured midway between the lower border of the ribs and the iliac crest 
(9). As there are no WC cut-points to classify normal, overweight and obese for Aboriginal people, 
baseline WC as a continuous variable was grouped (into quartiles or tertiles) separately for males 
and females in the analyses. 
 
4.5.1.2 Body mass index (BMI) 
BMI was calculated as weight divided by height squared (kg/m
2
). For the purpose of the analysis 
for mortality, we categorised participants by baseline BMI into sex-specific tertiles. BMI tertiles for 
males were as follows: tertile 1= 14.20-20.98 kg/m
2
, tertile 2= 20.99-25.10 kg/m
2
 and tertile 3= 
25.11-41.80 kg/m
2
. BMI tertiles for females were as follows: tertile 1= 13.58-21.14 kg/m
2
, tertile 
2= 22.22-27.12 kg/m
2
 and tertile 3= 27.14-43.74 kg/m
2
. 
 
4.5.2 Outcome variables (Disease outcomes) 
Morbidity outcomes for this study were CVD and Type 2 diabetes, as ascertained from 
hospitalization records. The diseases were determined according to the 9th (ICD-9) or 10
th
 (ICD-10) 
revisions of the International Classification of Diseases (ICD-9 and ICD-10) codes (259, 260) as 
illustrated in Table 4.1.  
 
Table 4.1 ICD 9 and 10-AM codes 
Disease ICD 9 code ICD 10 code 
CVD 390-458 I00-I99 
Type 2 diabetes 250 E11 
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4.5.3 Covariates 
A number of confounding factors were considered in the analyses, including age (years), cigarette 
smoking status (smokers and non-smokers) and alcohol consumption status (drinkers and non-
drinkers), as measured at the baseline examination. These confounding factors were controlled for 
during the analysis stage through multiple regression analysis.  
 
4.6 DATA MANAGEMENT 
After baseline screening, all participants were de-identified and each participant was assigned a 
unique Study Identification Number (SIN). Each individual’s SIN number was also assigned to 
their hospitalization record(s) and mortality record (for those that had died). The SINs were used to 
merge the baseline data to the hospital and mortality data to identify morbidity and mortality 
outcomes. 
All data were coded and entered into Stata. Participants were grouped according to gender-specific 
WC categories or BMI groups. Datasets were stored in computers that require passwords to access 
them to ensure confidentiality. 
 
4.7 ETHICAL APPROVAL 
The protocol of the baseline screening program was approved by the Ethics Committee of the 
Menzies School of Health Research and Territory Health Service, and the Aboriginal community. 
This project was approved by the Behavioural and Social Science Ethical Review Committee of the 
University of Queensland (#2011001232). All participants gave informed consent to participate. 
 
4.8 STATISTICAL ANALYSIS 
Means (standard deviations) were calculated for continuous variables such as age, BMI, WC and 
waist-to-hip ratio (WHR). Categorical variables including smoking (smokers and non-smokers) and 
alcohol consumption (drinkers and non-drinkers) were expressed in numbers (percentages).  
To assess the association of WC and each of the outcomes (CVD, Type 2 diabetes and mortality), 
hazard ratios (HRs) and their 95% confidence intervals were estimated using the Cox proportional-
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hazards model adjusting for potential confounding factors (age, smoking and alcohol consumption 
status). The formula used for fitting the Cox regression model was: 
 
ℎ(𝑡|𝑥𝑗) =  ℎ0 (𝑡) 𝑒𝑥𝑝(𝑥𝑗  𝛽𝑥) 
 
where ℎ0 (𝑡)  is the baseline hazard, 𝑋𝑗  represents WC or BMI or WHR variables and 𝛽𝑥 is the 
regression coefficients to be estimated from the data (261). 
The modelling that takes place in the model is inherent to the linear predictor below (261): 
𝑥𝛽𝑥   =  𝛽1𝑥1 + 𝛽2𝑥2 + ⋯ + 𝛽𝑘𝑥𝑘, for k covariates 
 
Baseline WC, BMI and WHR values were converted into gender specific z-scores (or SD score) 
thereby eliminating the differences in units to ensure that the magnitude of the HR results for both 
measures were directly comparable (262), and also to assess which had the strongest association 
with disease outcomes (263).  
First, the means (µ) and SDs (σ) of each WC, BMI and WHR were calculated separately for males 
and females. Next, the mean and SD of the measure (WC or BMI or WHR) and gender (male or 
female) to be examined was substituted into the formula (264) below: 
 
Z-score (or SD-score) = (measured value-average value of the reference population)/standard 
deviation value of reference population 
Z-score = (x-µ)/σ 
 
An interaction term was included in the model to examine the difference between males and 
females in the association between WC and diseases as well as mortality (265).  
The Weibull accelerated failure-time model was fitted to assess the gender-specific absolute risk of 
each disease outcome according to different WC and age values (261).  
 
Absolute risk of each outcome was presented graphically. The probability of having an endpoint 
according to WC values up to a specific time point was calculated as: 
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𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 = 1 − exp[−{𝑒𝑥𝑝(−𝛽0 −  𝑋𝑗 𝛽𝑗) 𝑡𝑗}
𝑝
] 
 
Where 𝛽0 and 𝛽𝑗  are coefficients from the Weibull model, p is an ancillary shape parameter from the 
data, t is time, and 𝑋𝑗  represents WC variables including linear and nonlinear components and other 
covariates (261). All analyses were carried out on Stata (248). Statistical significance was set at 
P<0.05 and the stability of the estimates were shown by 95% confidence interval (CI). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
CHAPTER 5 
WAIST CIRCUMFERENCE AND CARDIOVASCULAR DISEASE RISK AMONG 
ABORIGINAL PEOPLE IN A REMOTE AUSTRALIAN COMMUNITY 
 
5.1 INTRODUCTION AND AIM 
Aboriginal people in Australia have a high risk of developing cardiovascular disease (CVD). CVD 
contributes significantly to the reduced life expectancy of Aboriginal people. Waist circumference 
(WC) is an important risk factor that has been associated with the risk of CVD in Aboriginal 
communities. Creating tools to alert individuals of the risk of CVD and associated risk factors such 
as WC among others, in Aboriginal communities has the potential to make a significant difference 
in CVD-related health outcomes. Presently, the risk chart for identifying people at high risk of CVD 
in Australia targets only middle-aged Aboriginals aged 35 to 44 years, without considering body 
habitus such as WC. There is a need to bridge the gap on the risk of elevated WC and CVD among 
Aboriginal people in Australia.  
Therefore, the aims of this chapter are: 
1. To assess the association between WC and CVD among individuals who participated in the 
baseline community screening program from 1992 to 1998 in Tiwi Islands. 
2. To examine which of WC, body mass index (BMI) and waist-to-hip ratio (WHR) has the 
strongest association with CVD in the study population. 
3. To provide a simple tool which shows levels the absolute risk of CVD with changes in WC 
and age. 
  
In this chapter, Section 5.2 provides a summary of my contributions to the study. Results from the 
study have been published in a peer-reviewed journal. The reference for this publication is: 
Adegbija O, Hoy W and Wang Z: Prediction of cardiovascular disease risk using waist 
circumference among Aboriginals in a remote Australian community. BMC Public Health 2015; 
15(1): p. 57. 
5.2 CONTRIBUTION TO THE STUDY 
I, with the assistance of Dr Wang formulated the concept of the study. I was responsible for the data 
management, data analysis and interpretation of the results, with close supervision by Dr Wang. I 
was also responsible for writing the manuscript, taking into account the comments and suggestions 
of Dr Wang and Dr Hoy. 
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ABSTRACT 
Background 
Elevated waist circumference (WC) is an important risk factor for cardiovascular disease (CVD). 
Aboriginals in Australia are at higher risk of CVD compared to non-Aboriginals. We examined the 
association between waist circumference and CVD, and developed a model for projecting absolute 
risk of cardiovascular disease using WC and age in one high risk Australian Aboriginal community. 
 
Methods 
We followed up 920 (470 men, 450 women) participants (more than 80% of the eligible population) 
aged 18 to 76 years, without CVD at baseline, for up to 20 years. Hazard ratios were estimated 
using Cox proportional hazards models adjusting for potential confounding factors. Absolute risk 
was estimated using the Weibull regression model. 
 
Results 
Of 920 study participants, 156 males and 177 females developed CVD in the follow-up period. 
Incidence rates for males and females in the 4th WC quartile (Q4) were 38.3 (95% CI: 29.6-49.7) 
and 47.2 (95% CI: 37.1-60.3) per 1,000 person-time respectively. Crude hazard ratios of CVD for 
Q4 WC group using Q1 (quartile 1) as the referent quartile were 2.9 (95% CI: 1.8-4.6) for males 
and 3.5 (95% CI: 2.2-5.5) for females. Association remained after controlling for age, smoking 
status and alcohol drinking status (HR = 1.8 for males and HR = 3.1 for females). At 45 years of 
age with baseline waist circumference of 100 cm, a male had an absolute CVD risk of 32.5%, while 
a female had a 30.6% risk of the disease. 
 
Conclusions 
Risk of CVD among participants increased with increasing WC, and the relationship was 
accentuated with increasing age. The prediction model provides a tool for understanding the 
combined effects of WC with age on CVD events in the Australian Aboriginal community. It is 
simple and easily understood and will assist in identifying individuals at risk of CVD in relation to 
WC values. 
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INTRODUCTION 
Cardiovascular disease (CVD) is the second largest contributor to the total disease burden in 
Australia, accounting for about 16% of the total disease burden and recorded as the underlying 
cause of 46,100 and 45,600 deaths in 2009 and 2011 respectively (266-268). Inequality exists in the 
number of those affected by CVD with greater impact on the Aboriginals than non-Aboriginals in 
Australian (267, 269, 270). Among the Australian Aboriginal population, CVD is the leading cause 
of disease burden and deaths and lists as one of four chronic conditions that accounts for 70% of the 
indigenous Australian health gap (266). Australian hospitalization records for CVD were reported at 
about 1.7 times among Aboriginals in comparison to other Australians (270). As CVD is a 
substantially significant contributor to illnesses, disability and premature death particularly among 
the Aboriginal group (270, 271), there is a need to alert them of health risks associated with greater 
CVD risk among them. 
In the management of CVD, guidelines have been provided to predict CVD in the presence of a 
number of the modifiable and non-modifiable risk factors. However, most of the available 
guidelines are based on non-specific populations resulting in unsuitability of the tool for some 
groups of individuals. Some modifiable risk factors identified with CVD include overweight and 
obesity, tobacco smoking, diabetes, unhealthy diet, high blood pressure, high blood cholesterol and 
physical inactivity. Incidence of CVD also increases with non-modifiable risk factors such as age 
and ethnicity. Australia’s cardiovascular risk chart related an individual’s diabetes status, sex, 
smoking history and age with systolic blood pressure and cholesterol levels to present the risk of 
CVD (272). However, the CVD risk chart focused on the non-Aboriginal Australian population 
while also targeting middle aged Aboriginals (35 to 44 years of age) only, without considering 
differences in body habitus of Australians. Aboriginal Australians vary in their body habitus which 
includes waist circumference (WC) compared to non- Aboriginal Australians (12, 146-148). This 
Australian group also has the tendency of abdominal fat storage, particularly in women, having 
relatively large WC measurements (12, 273). The phenomenon of higher waist circumference in 
Aboriginal females compared to males, have been reviewed in a meta-analysis conducted to 
compare WC estimates in Aboriginal and non-Aboriginal Australian populations (149). Some 
studies in Australia that examined the relationship between WC and risk of CVD included other 
anthropometric indices such as body mass index (BMI) and waist-to-hip ratio (WHR) to present the 
best predictor of the disease and the findings have been controversial. While WHR compared to 
WC and BMI was found to be the most useful obesity measure in identifying individuals with CVD 
risk among non-Aboriginal Australians (158), WC better predicted CVD compared to BMI and 
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WHR among Aboriginals (8, 274). Due to the differences in WC profiles and the higher level of 
CVD risk of Aboriginals compared to non-Aboriginals in Australia, this study evaluated the 
relationship between WC and risk of developing CVD during the 20 years of follow-up study 
period. Also, we developed a simplified cardiovascular prediction model by estimation of absolute 
risk of CVD using different waist circumference (WC) values, over a 10 year period in Aboriginal 
subjects between the ages of 20 to 65 years in a remote Australian community. This prediction tool 
can be used to educate and alert Aboriginals of the risk of developing CVD according to WC and 
age. Furthermore, this tool will be helpful for the planning and conducting obesity-related health 
education programs for the prevention and management of CVD in Aboriginal communities in 
Australia. 
 
METHODS 
Study design 
This was a prospective cohort study in a remote Aboriginal community in Australia designed to 
follow up adult individuals with WC measurement at baseline for up to 20 years to identify newly-
diagnosed CVD events. 
 
Study population 
The original cohort included 1490 participants from a remote Aboriginal community in Australia’s 
Northern Territory (NT), whose baseline data were collected from 1992. Those participants were 
followed for up to 20 years until 31st of May 2012. 
Eligible participants recruited from the study group fulfilled the following criteria: 1) aged between 
18 and 76 years, 2) had WC measurement at baseline and 3) free from known CVD at baseline. A 
total of 920 (470 men and 450 women) participants met the study criteria. CVD events were defined 
according to the English Revision International Classification of Diseases (ICD-9 code) codes 390 
to 458 and International Statistical Classification of Diseases, 10th Revision (ICD-10 code) codes 
I00 to I99. CVD outcomes were classified as hypertensive heart and renal diseases, coronary artery 
disease, pulmonary circulation, cardiac arrest, heart failure, myocardial infarction, stroke, 
cerebrovascular disease, diseases of arteries and veins, which were identified by patient 
hospitalization records using ICD-9 codes 402-404, 410-417, 427.5, 428, 430-459 and ICD-10 
codes I11-I13, I20-I28, I50, I60-I89. We eliminated those with hypo- and hypertension (high blood 
pressure) and hemorrhoids as these occurrences may be physiologic (as with hypotension) rather 
than a disease, or with no obvious underlying medical cause (primary hypertension). Each study 
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participant had been assigned a unique Study Identification Number (SIN) to merge the baseline, 
follow-up morbidity data sets and the mortality data (death records helped identify those who had 
died as a result of CVD but had not been recorded in the hospital records, to add to our list of those 
who developed the disease). Our end point was incidence of CVD among study participants. 
Therefore, participants were followed up to identify cases of newly diagnosed CVD. Written 
informed consents were obtained from all participants at baseline measurements. The original 
baseline data collection was approved by the relevant Aboriginal community and the Menzies 
School of Health Research Ethics Committees and the hospitalization data collection for the current 
project was approved by the University of Queensland. 
 
Baseline measurements 
Existing baseline dataset was used for the analysis of this study and has been described elsewhere 
(9, 258). In summary, characteristics of participants were collected through interview questionnaires 
and they included demographic and clinical variables such as age, gender, WC, height, weight, 
WHR, smoking status and alcohol consumption. WC was measured using flexible tapes on a 
horizontal plane, midway between the lower border of the ribs and the iliac crest. Height and weight 
were measured with subjects wearing light clothing and no shoes and BMI was calculated as weight 
in kilograms divided by height in meters squared. Due to the disparity in WC of Australian 
Aboriginals and non-Aboriginals, the currently recommended WC cut-off points which were 
developed for individuals of European origin might not be applicable to this population (275). 
Therefore, for the current study, waist circumference was grouped into gender-specific quartiles. 
Quartiles for males (Q1 = 63–78 cm, Q2 = 79–85 cm, Q3 = 86–95 cm, Q4 = 96–138 cm). Quartiles 
for females (Q1 = 60–79 cm, Q2 = 80–90 cm, Q3 = 91–101 cm, Q4 = 101.5-135 cm). Q1 was the 
reference group for comparison. 
 
Statistical analysis 
Continuous variables were expressed as mean and standard deviation. We expressed categorical 
variables as frequencies and percentages. Using the Cox proportional hazards model, we assessed 
the association between WC and CVD outcomes adjusting for potential confounding factors (age, 
smoking status and alcohol consumption status). Age was a continuous variable, while smoking 
(smokers and non-smokers) and alcohol consumption (drinkers and non-drinkers) were categorical 
variables. Separate hazard functions were calculated for males and females. Survival was calculated 
using the Kaplan Meier proportional survival probability estimates. To predict 10-year risk of CVD 
using WC and age as covariates, we treated both age and WC as continuous variables. We used the 
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Weibull regression to estimate the absolute risk of developing CVD. The absolute risk formula used 
was  
 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 = 1 − exp[−{𝑒𝑥𝑝(−𝛽0 −  𝑋𝑗 𝛽𝑗) 𝑡𝑗}
𝑝
] 
 
where β0 represented the baseline coefficient, βj was the regression coefficient for covariates (WC 
and age), Xj represented the value of the covariates (WC and age), t = time and p = the shape 
parameter that indicates the hazard level (261). To compare the associations of WC, BMI and WHR 
with CVD between males and females, we converted original WC, BMI and WHR values into 
gender specific z-scores for both genders while also controlling for age, smoking and alcohol 
consumption status. An interaction term was included in the model to examine the gender effect in 
the association between WC and CVD (265). Data were analysed using Stata 12 (248). A P-value of 
<0.05 was considered to be statistically significant. 
 
RESULTS 
Baseline characteristics of study participants 
The baseline characteristics for 920 study participants who met the study criteria for cardiovascular 
(CVD) are presented in Table 5.1. The mean (SD) ages at baseline screening for men and women 
were 33.5 (11.5) years and 36.2 (12.9) years respectively. WC mean (SD) for men was 87.3 (13.0) 
cm and 90.6 (14.5) cm for women. BMI mean was slightly lower in males than in females (23.5 
kg/m
2
 versus 24.5 kg/m
2
). The mean (SD) WHR for males and females were 1.0 (0.1) and 0.9 (0.1) 
respectively. Men had higher mean body weight estimate compared to women (69.3 kg versus 63.4 
kg). 373 (80%) males and 296 (67%) of females were smokers. 394 (85%) males and 153 (35%) 
females were alcohol consumers from the total population. 
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Table 5.1 Baseline descriptive statistics and clinical data of male and female participants 
 Males Females 
Demographics n=470 n=450 
Age, years- mean (SD) 33.5 (11.5) 36.2 (12.9) 
Waist circumference (cm)- mean (SD) 87.3 (13.0) 90.6 (14.5) 
BMI (kg/m
2
)- mean (SD) 23.5 (4.6) 24.5 (5.9) 
Waist-to-hip ratio- mean (SD) 1.0 (0.1) 0.9 (0.1) 
Weight (kg)- mean (SD) 69.3 (14.8) 63.4 (15.9) 
Height (cm)- mean (SD) 171.6 (6.3) 161.0 (5.8) 
   
Lifestyle factors- n (%)   
Current smoker 373 (80.0) 296 (67.0) 
Current alcohol drinker 394 (84.6) 153 (34.7) 
SD: Standard Deviation. 
 
During the 20 year follow-up period, 333 (36.2%) people- 156 men and 177 women were diagnosed 
as having CVD. A total of 87.3% of the cohort were observed for at least five years, and 1.6% was 
observed for one year or less. 24.3% of the CVD events have occurred within the first 5 years of 
follow- up in 35 men and 46 women, and the percentage increased to 50.5% within 10 years of 
follow-up with a further increase to 82.0% at 15 years follow-up. Participants that developed CVD 
at the end of the follow up period had mean age estimate of 38.5 years, mean WC estimate of 94.0 
cm and mean BMI estimate of 25.4 kg/m
2
. 26.5% of those who developed CVD were non-smokers 
while 41.2% were non-alcohol consumers. 
 
Incidence rates of CVD 
The incidence rate of developing hospital diagnosed CVD was 23.8/1,000 person-years for males 
while the incidence rate for females was 28.5/1,000 person-years. Because of the differences in WC 
of males and females, waist circumference was categorized into gender-specific quartiles. Table 5.2 
shows numbers of CVD cases and incidence rates by WC quartiles. Rates ranged from 13.8 (95% 
CI: 9.5-20.0) in Q1 WC quartile to 38.3 (95% CI: 29.6-49.7) per 1,000 person-years in Q4 for males 
and 14.3 (95% CI: 9.7-21.2) in Q1 to 47.2 (95% CI: 37.1-60.3) per 1,000 person-years in Q4 for 
females. As shown in Figure 5.1, CVD incidence rate among participants increased considerably 
with increasing WC and females had higher rates than males in the 4th WC quartile. 
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Table 5.2 WC quartiles and rate per 1,000 (95% confidence interval) of participants during 
the 20-year follow-up 
 Males Females 
Waist 
quartiles(cm) 
CVD 
cases 
Person-
years 
Rate (95% CI) CVD cases Person-
years 
Rate (95% CI) 
Q1 28 2029.0 13.8 (9.5-20.0) 25 1748.3 14.3 (9.7-21.2) 
Q2 27 1687.5 16.0 (10.9-23.3) 37 1567.8 23.6 (17.1-32.6) 
Q3 44 1349.7 32.6 (24.3-43.9) 50 1529.1 32.7 (24.8-43.1) 
Q4 57 1488.3 38.3 (29.6-49.7) 65 1377.1 47.2 (37.1-60.3) 
Quartiles for males (Q1 = 63–78 cm, Q2 = 79–85 cm, Q3 = 86–95 cm, Q4 = 96–138 cm). 
Quartiles for females (Q1 = 60–79 cm, Q2 = 80–90 cm, Q3 = 91–101 cm, Q4 = 101.5-135 cm). 
 
  
 
Figure 5.1 Rate per 1,000 person-years of males and females by WC quartiles measured in cm 
 
Association between WC and CVD 
Table 5.3 shows the hazard ratios of CVD for different WC quartiles. The crude association 
between WC and CVD were statistically significant for both genders. In comparison to the referent 
WC quartile (Q1), crude HR for males in Q4 was 2.9 (95% CI: 1.8-4.6), while HR for females in 
Q4 was 3.5 (95% CI: 2.2-5.5). After adjusting for age, smoking status and alcohol status, 
association between WC and CVD remained strong for both males and females. When WC and age 
were included in the same multivariable model (results not shown in Tables), the HRs for Q2, Q3, 
Q4 in comparison to Q1 were 0.9, 1.6 and 1,6 respectively for men and 1.5, 1.9 and 2.9 accordingly 
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for women. The model that included WC and smoking gave HRs for Q2 = 1.2, Q3 = 2.5 and Q4 = 
3.0 for males and Q2 = 1.8, Q3 = 2.5 and Q4 = 3.6 for females. Multivariable model including WC 
and alcohol consumption were same as WC and smoking for both males and females. To assess the 
gender effect using WC quartiles, HR = 1.1 (95% CI: 0.9-1.4) showing women had slightly higher 
risk of CVD than men. However, there were no significant differences between males and females, 
P-value = 0.4. 
 
Table 5.3 Crude and adjusted association between WC and CVD 
 Crude Adjusted 
Males HR (95%CI) P-value HR (95%CI) P-value 
WC Quartiles     
Q1 1 <0.0001 1 <0.0001 
Q2 1.2 (0.7-2.0)  0.9 (0.5-1.5)  
Q3 2.5 (1.5-4.0)  1.6 (1.0-2.7)  
Q4 2.9 (1.8-4.6)  1.8 (1.1-2.9)  
Females     
WC Quartiles     
Q1 1 <0.0001 1 <0.0001 
Q2 1.7 (1.0-2.8)  1.7 (1.0-2.8)  
Q3 2.4 (1.5-3.8)  2.1 (1.3-3.5)  
Q4 3.5 (2.2-5.5)  3.1 (1.9-5.0)  
Adjusted for age, smoking status and alcohol consumption status. 
HR: Hazard ratio; CI: confidence intervals. 
Quartiles for males (Q1 = 63–78 cm, Q2 = 79–85 cm, Q3 = 86–95 cm, Q4 = 96–138 cm). 
Quartiles for females (Q1 = 60–79 cm, Q2 = 80–90 cm, Q3 = 91–101 cm, Q4 = 101.5-135 cm). 
 
 
Assessing WC, BMI and WHR and the risk of CVD 
WC had the strongest association with CVD compared to BMI and WHR particularly among 
women as shown in Table 5.4. We converted original WC, BMI and WHR values into standard 
deviation scores (z-score) to make their associations with CVD comparable. For males, 1 standard 
deviation (SD) increase in WC, BMI and WHR increased CVD risk by 1.6 (95% CI: 1.4-1.8), 1.3 
(95% CI: 1.2-1.6) and 1.6 (95% CI: 1.4-1.8) respectively. For females, 1 SD increase in WC, BMI 
and WHR increased CVD risk by 1.5 (95% CI: 1.3-1.8), 1.3 (95% CI: 1.2-1.6) and 1.3 (95% CI: 
1.1-1.5) respectively. When WC, BMI and WHR were independently included in models containing 
62 
 
other risk factors of CVD (age, cigarette smoking and alcohol consumption status) to assess 
association with CVD, statistical significance was observed in the results of both genders. While the 
independent inclusion of each of smoking and alcohol consumption made minimal difference to the 
association of WC, BMI, WHR and CVD, the adjustment for age alone resulted in HRs of 
1.3(95%CI: 1.1-1.6) and 1.4(95%CI: 1.2-1.7) for males and females respectively in the association 
between WC and CVD, 1.2(95%CI: 1.0-1.4) and 1.3(95%CI: 1.1-1.5) for males and females 
respectively in the association between BMI and CVD, and 1.4(95%CI: 1.2-1.7) and 1.2(95%CI: 
1.1-1.4) for males and females respectively in the association between WHR and CVD.  
 
Table 5.4 Hazard ratios of z-scores of crude and adjusted estimates of WC, BMI and WHR 
Variable Crude Adjusted 
 HR (95% CI) P-value HR (95% CI) P-value 
Waist Circumference (cm)     
Males 1.6 (1.4-1.8) <0.0001 1.4 (1.2-1.7) <0.0001 
Females 1.5 (1.3-1.8) <0.0001 1.4 (1.2-1.7) <0.0001 
Body mass index (Kg/m
2
)     
Males 1.3 (1.2-1.6) <0.0001 1.2 (1.0-1.5) 0.01 
Females 1.3 (1.2-1.6) <0.0001 1.3(1.1-1.5) <0.0001 
Waist-to-hip ratio     
Males 1.6 (1.4-1.8) <0.0001 1.4 (1.2-1.7) <0.0001 
Females 1.3 (1.1-1.5) <0.0001 1.2 (1.1-1.4) <0.0001 
Adjusted for age, smoking status and alcohol status. 
HR (Hazard ratio); 95% CI (95% confidence interval). 
 
 
Absolute risk of CVD by WC and age 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑀𝑎𝑙𝑒𝑠) = 1 − exp [−{𝑒𝑥𝑝(−5.9099 −  (−0.0157 ∗ 𝑊𝐶 − 0.0305 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.4143
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐹𝑒𝑚𝑎𝑙𝑒𝑠) = 1 − exp [−{𝑒𝑥𝑝(−5.6569 −  (−0.0174 ∗ 𝑊𝐶 − 0.0198 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.3965
] 
 
Based on the coefficients of the final Weibull models above, we estimated 10-year absolute risks 
according to age and WC values. The predicted risk estimates (shown as percentages) for 10-year 
CVD were calculated and presented in Figures 5.2 and 5.3. The risk of CVD was driven by both age 
and WC values and it increased with higher WC values and increasing age. 
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Figure 5.2 Absolute 10-year risk (%) of cardiovascular disease for males, using waist 
circumference (cm) and age (years) 
 
 
Figure 5.3 Absolute 10-year risk (%) of cardiovascular disease for females, using waist 
circumference (cm) and age (years) 
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The use of Figures 5.2 and 5.3 to make CVD predictions is best illustrated by example. Specifically, 
individual men less than 32 years of age with WC<80 cm had a 10 year absolute CVD risk of 5-
10%; those between 42 and 49 years with WC range of 100–112 cm had a 10 year absolute risk of 
15-20%; and those above 50 years and WC above 90 cm had 10 year absolute risk of above 50%. 
For women, participants less than 30 years with WC less than 70 cm had a 10 year absolute CVD 
risk of 5-10%; individuals between 48 and 57 years with WC between 90 and 100 cm had an 
absolute risk of 15-20%; and above 57 years and WC above 105 cm had 10 year absolute risk above 
50%. 
Gender effect for the same absolute WC risk was not significant HR = 1.0 (95% CI: 0.8-1.3, P=0.9), 
indicating males and females were not different in their risk of CVD given a WC value. 
We next examined the absolute risk of CVD using age and the currently recommended WC-cut-off 
values for obesity (102 cm for males and 88 cm for females) [19]. As shown in Figure 5.4, at the 
age of 30 years, absolute risk of CVD was less than 20% for obese individuals. Obese males and 
females aged 50 years had an absolute CVD risk of about 40% and 26% respectively. Absolute 
CVD risk was higher in males than females with these WC cut-off values. 
 
 
 
Figure 5.4 Absolute risk (%) of CVD for males and females with currently established WC 
cut-off values for obesity 
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DISCUSSION 
In the present study, we followed up Aboriginal Australians participating in a community screening 
program for a maximum of 20 years for first episode of cardiovascular disease. Females in this 
study had higher WC estimates in comparison to the males. On the other hand, men were taller, had 
higher weight estimates, and were twice more likely alcohol drinkers and 1.2 times likely smokers 
when compared to the women. There were no distinctive gender differences in CVD risk for a 
particular WC value. WC measured at baseline predicted the risk of CVD as the risk increased with 
increasing WC, with the highest risk in the 4th WC quartile for both genders. The hazard ratio of 
WC was attenuated with the adjustment of age in the same multivariable model. However, adjusting 
for smoking and alcohol made little or no difference on the association between WC and the risk of 
CVD in the model. WC compared to BMI and WHR was a better predictor of CVD particularly in 
women. Finally, the absolute risks of CVD increased with increasing WC values and age in this 
population. This simple tool will help alert individuals in the study community of the future risk of 
CVD according to WC and age. It can also serve as an adjunct for planning and conducting public 
health education programs for CVD and augment preventive strategies for Aboriginal communities. 
The scarcity of reports on absolute risk of CVD and risk factors such as WC and age in indigenous 
populations of Australia and other countries makes it difficult to compare our findings on absolute 
risks of CVD morbidity and WC. Nonetheless, our results are in general consistent with the findings 
from other ethnic populations on the risk associated with high WC and development of CVD (276-
278). Hans et al. used the currently recommended WC-cut off points to assess differences in the risk 
of CVD among overweight and obese individuals, and reported individuals with WC in the obese 
group had higher CVD risk compared to those in the overweight category (278). Likewise, two 
studies in the United States used the Physicians’ Health Study for men (276) and the Nurses’ health 
Study cohort for women (277) to assess abdominal adiposity and coronary heart disease (CHD) and 
found that the highest WC quintile had higher risk of developing CHD than those in the lowest 
quintile. In our study, risk of developing CVD increased as WC increased with the highest risk in 
the 4th WC quartile. Although, females in the highest WC quartile had higher risk than their male 
counterparts (from results of hazard ratios in Table 5.3), the gender effect was not statistically 
significant. This effect could potentially be due to small sample size or some other possible reasons 
which we cannot explain. 
The uniqueness of the present study is reflected in the absolute risk graphs presented to provide a 
general overview of the combined effects of WC and age on CVD in the Aboriginal community. 
The currently used Australian CVD risk chart targeted the Australian population while combining 
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the effects of some risk factors without considering WC which is strongly associated with risk of 
CVD among Aboriginals (8). Importantly, our study targeted a specific Aboriginal community 
where WC was strongly associated with risk of CVD (8). Also, we included age in the absolute risk 
prediction due to the association of increasing age with CVD risk (279). The effect combination of 
WC and age to predict absolute risk of CVD in this community would assist in efficiently 
identifying unrecognized CVD in this community. Furthermore, this study shows how absolute risk 
of CVD changes with WC values as age increases. We adjusted for smoking in our analysis as it has 
been found to be a CVD risk factor that affects body weight (280, 281). Our findings showed men 
tend to develop CVD at a younger age than women while the reverse was apparent for females who 
were more likely to develop CVD with greater WC than increasing age. This is understandable as 
WC of Australian Aboriginal women have been shown to have higher estimates than that of men. 
The currently recommended WC cut-off values for obesity, 102 cm for men and 88 cm for women 
(115) contradict our findings. Applying these cut-off values to Aboriginal men and women, the 
absolute risks were much higher for males than females Figure 5.4). Risk of developing CVD 
increased to 70% and 41% among obese males and females respectively. As shown by our analyses 
in the incidence rates and hazard ratio estimates, females showed higher risk particularly in the 
highest WC quartile indicating higher risk of developing the disease among females than males with 
high WC, albeit, males and females were no different in their CVD risk with same absolute WC 
values. The currently used WC cut-offs either gives an underestimation of risk in women or an 
elevated risk in men in this population. Therefore, these WC cut-offs might not be applicable to this 
Aboriginal community. Adjusting the WC cut-off values to suit Aboriginal men and women will be 
beneficial to make their risks of CVD comparable. 
There may be questions around the accuracy of prediction attained with using only WC and age 
rather than a combination of factors as seen in previous studies (224, 282). The purpose of this 
study was to examine the relationship between WC and CVD in relation to age. Moreover, our 
models based on the current data suggest that WC could be a better predictor than BMI and WHR in 
females for developing hospital diagnosed CVD in this population (8). On the other hand, for males, 
our findings concur with a previous Canadian study in concluding that WC was a better predictor of 
CVD than BMI but not WHR (283). Our results on WC as the best measure compared to WHR 
and/or BMI in identifying individuals with CVD risk are in agreement with earlier studies (170, 
283). Dalton et al., in a previous Australian national study presented a contrasting result to ours 
when they demonstrated WHR was a more useful obesity measure than WC and BMI to identify 
individuals with CVD (158). However, they focused on non-Aboriginals and used a cross-sectional 
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study design which might not present the causal association between the measures and CVD. While 
we are not comparing WC, BMI and WHR in CVD risk prediction models in presenting a more 
accurate estimate, emphasis is being placed on the significant role that increasing WC plays in the 
development of CVD. Importantly, this is the first study assessing the role of WC to the CVD risk 
prediction in relation to age. 
Strengths and limitations 
To the best of our knowledge, this is the first CVD prediction model that will include waist 
circumference in an indigenous Australian population. Our study is population-based comprising of 
individuals from a homogenous population with over 80% of the eligible community members 
involved in the baseline screening survey. The prospective design and high rate of follow-up (up to 
20 years) minimized the potential for recall bias and loss to follow-up enabling the capture of a 
good number of CVD morbidity events in the community. Reverse causality bias is unlikely in our 
study since we excluded those with existing CVD at baseline and included only the first episode of 
CVD after baseline measurement. 
This study may be limited by WC measurements which were from routine examinations and were 
subject to measurement errors. Second, our end-point was limited as we excluded hyper- and 
hypotensive as well as haemorrhoids cases. However, we did a cross check to ensure that those with 
first episodes of the excluded events were free of CVD till end of the follow-up period; otherwise 
those who developed the disease were included in the analysis. Third, potential confounding effects 
of other variables (diet, physical activities and family history of CVD) were not adjusted for in the 
reported strong association between WC and CVD risk in this study as we do not have data on these 
important risk factors. Therefore, we could only analyse on data available to us (age, WC, smoking, 
gender, alcohol consumption) in our analysis. Fourth, there may be questions around the use of 
baseline WC measurement in the prediction of future CVD events without considering the changes 
in WC over the follow-up time. This is unlikely to affect our findings as the purpose is to relate WC 
measured at baseline with when CVD develops in the follow-up time. Moreover, WC estimates are 
not static but change with time depending on the age and lifestyle of individuals. Lastly, findings of 
this study may not be generalizable to other Aboriginal populations as results were based on just 
one Aboriginal community. As heterogeneity of body habitus profiles which includes WC vary in 
different Aboriginal communities, further research will be required to collect data from other 
Aboriginal communities and analysis carried out to assess whether results are comparable to the 
present study.  
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CONCLUSION 
Our results suggest that WC may be a valuable factor in the CVD risk prediction models 
particularly in Australian indigenous communities whose people have higher propensity for 
abdominal fat than Australians in general. Although the gender effect was quite small for the same 
absolute WC values in favor of females, the differences were not significant between males and 
females. Our findings suggest that currently used WC cut-off values in Australia will capture 
different absolute risks of CVD in Aboriginal men and women and may need to be re-evaluated; a 
lower cut-off for males and higher cut-off for females than the currently recommended WC cut-offs 
may be more appropriate for better reflection of risk of CVD. The findings of this study can be used 
by health professionals to communicate knowledge of the risk of high WC estimates to individuals 
in the community. This tool could serve to raise awareness of CVD among the people due to the 
significant burden of illnesses and premature deaths in the Indigenous population. 
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CHAPTER 6 
WAIST CIRCUMFERENCE AND TYPE 2 DIABETES RISK AMONG ABORIGINAL 
PEOPLE IN A REMOTE AUSTRALIAN COMMUNITY 
 
6.1 INTRODUCTION AND AIM 
The importance of waist circumference (WC) among other risk factors in the development of Type 
2 diabetes has been documented in the Aboriginal Australian population. Alerting Aboriginal 
people of the risk of elevated WC in association with this health outcome is crucial and could assist 
in reducing the risk of other complications of chronic diseases. A number of prediction models have 
been proposed to alert individuals and communities of the risk of diabetes. However, the majority 
of the existing studies have been conducted in populations with different body habitus profiles and 
it is unclear whether these tools apply to the Aboriginal population of Australia.  
In this chapter, we aimed to develop a model to predict future Type 2 diabetes according to WC and 
age in an Aboriginal Australian community. This simple tool can be used by individuals and health 
care workers to alert individuals of the risk of Type 2 diabetes associated with waist circumference 
and age. Furthermore, it will improve preventive treatment strategies for Aboriginal people in 
Australia.  
 
The objectives of this chapter are: 
1. To assess the association between WC and Type 2 diabetes. 
2. To examine which of WC, body mass index (BMI) and waist-to-hip ratio (WHR) has the 
strongest association with Type 2 diabetes in the study population. 
3. To provide a simple tool which shows changes in absolute risk of Type 2 diabetes with 
changes in WC. 
  
In this chapter, Section 6.2 details a summary of my contributions to the study. Results from the 
study have been published in a peer-reviewed journal. The reference for this publication is: 
Adegbija O, Hoy W and Z Wang. Predicting absolute risk of Type 2 diabetes using age and waist 
circumference values in an Aboriginal Australian community. PLoS One 2015; 10(4); p.1-10. 
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6.2 CONTRIBUTION TO THE STUDY 
With the guidance of Dr Wang, I developed the analysis plan to examine the association between 
WC and Type 2 diabetes. I was also responsible for the data management and I conducted the data 
analysis and the results interpretation in consultation with Dr Wang and Dr Hoy. I was responsible 
for writing the manuscript, taking into account the comments and suggestions of Dr Wang and Dr 
Hoy. 
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ABSTRACT 
 
Objectives 
To predict in an Australian Aboriginal community, the 10-year absolute risk of Type 2 diabetes 
associated with waist circumference (WC) and age on baseline examination. 
 
Method 
A sample of 803 diabetes-free adults (82.3% of the age-eligible population) from baseline data of 
participants collected from 1992 to 1998 were followed-up for up to 20 years till 2012. The Cox-
proportional hazard model was used to estimate the effects of WC and other risk factors, including 
age, smoking and alcohol consumption status, of males and females on prediction of Type 2 
diabetes, identified through subsequent hospitalisation data during the follow-up period. The 
Weibull regression model was used to calculate the absolute risk estimates of Type 2 diabetes with 
WC and age as predictors. 
 
Results 
Of 803 participants, 110 were recorded as having developed Type 2 diabetes, in subsequent 
hospitalizations over a follow-up of 12633.4 person-years. WC was strongly associated with 
subsequent diagnosis of Type 2 diabetes with P<0.0001 for both genders and remained statistically 
significant after adjusting for confounding factors. Hazard ratios of type 2 diabetes associated with 
1 standard deviation increase in WC were 1.7 (95% CI 1.3 to 2.2) for males and 2.1 (95% CI 1.7 to 
2.6) for females. At 45 years of age with baseline WC of 100 cm, a male had an absolute diabetic 
risk of 10.9%, while a female had a 14.3% risk of the disease.  
 
Conclusions 
The constructed model predicts the 10-year absolute diabetes risk in an Aboriginal Australian 
community. It is simple and easily understood and will help identify individuals at risk of diabetes 
in relation to WC values. Our findings on the relationship between WC and diabetes on gender will 
be useful for clinical consultation, public health education and establishing WC cut-off points for 
Aboriginal Australians. 
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INTRODUCTION 
Diabetes is one of the fastest growing chronic conditions in Australia, with an estimated 280 people 
developing the disease daily (284). Indigenous Australians (Aboriginals and Torres Strait Islanders) 
(147, 285) are at higher risk of developing the disease, and at earlier ages (286-288) than the non-
indigenous group. A large proportion of Aboriginals develop Type 2 diabetes (T2D) in their 
lifetime, with a lifetime risk in one community of one in two among men and two in three among 
women (254). Despite the preventive strategies aimed at controlling the development of Type 2 
diabetes through healthy diet and lifestyle or medication (289), there has been little, if any reduction 
in the high prevalence, high burden of mortality and complications imposed by this disease among 
Aboriginals (284).    
Several studies have shown relationship between excess abdominal fat and increased risk of T2D 
(284, 290, 291). In Australia, Aboriginals have the propensity for excessive abdominal fat which 
reflected in their higher waist circumference (WC) compared to non-Aboriginals (12, 273). 
Although, studies conducted in some Aboriginal communities have shown WC was a better 
predictor of T2D compared to body mass index (BMI) and waist-to-hip ratio (WHR) (9, 178), but 
WC cut-off points for Aboriginals to alert them of the risk of T2D and other chronic diseases have 
not been established. Prediction models for the risk of diabetes have been developed in a number of 
populations with the aim of predicting diabetes occurrences, while providing intervention (292-
294). Indeed, the Australian Type 2 diabetes risk assessment tool (AUSDRISK) included WC and 
ethnicity (Aboriginal or non-Aboriginal) as risk factors for estimating the risk of developing 
diabetes, suggesting the differences in the effects of WC on diabetes between Aboriginals and other 
Australians (295-297). However, due to low numbers of indigenous Australians in the AUSDRISK 
study, Aboriginals were grouped with southern Europeans and Asians to generate a high-risk group, 
which does not give a true representation of the level of diabetic risk among Aboriginals in 
Australia.  In this study, we reported the first 10-year absolute risk estimates of diabetes using WC 
and age in a remote Australian Aboriginal community. As there are no specific WC cut-off 
thresholds for Aboriginals in Australia, we categorised WC into gender-specific quartiles for 
analysis and developed a model using WC and age values. To quantify the impact of WC on the 
risk of developing diabetes, we developed a simplified tool that can be used by health professional 
and the general public to understand how diabetes risk varies with WC values. This tool can also be 
used to educate and alert individuals of the risk of developing diabetes according to WC and age. 
Furthermore, this tool will also be helpful for the planning and conducting obesity-related health 
education programs for the prevention and management of T2D in Aboriginal communities in 
Australia. 
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METHODS 
Study population 
The baseline characteristics of the study population have been described in detail elsewhere (9, 
258). From January 1992 to December 1998, a total of 935 adults (>=18 years, over 80% 
recruitment) were included in a community-wide screening program in a remote Aboriginal 
community in Australia’s Northern Territory. Written informed consents were obtained from all 
participants at baseline measurements. The baseline database (containing screening of 
anthropometric measurements) was merged with hospitalisation records to identify type 2 diabetes 
outcomes according to patients’ hospital registration numbers (HRN). Of the 935 individuals, 803 
were free of T2D at baseline examination, and were followed up on hospital records for up to 20 
years from 1
st
 February 1992 to 31
st
 May 2012. Follow-up stopped for an individual once he/she 
developed T2D or died. Prior to using the data, each participant was de-identified and given a 
unique study ID number (SIN). This original baseline database was approved by the Aboriginal 
community and Ethics Committee of the Menzies School of Health Research and Territory Health 
Services. The project was approved by the Behavioural and Social Science Ethical Review 
Committee of the University of Queensland (#2011001232).  
 
Outcome definition 
Participants were followed-up through hospitalization records. Each participant was identified by 
HRN and the patients’ health record ID codes. Our outcome was newly diagnosed (incident) T2D as 
recorded in hospitalization data records. We identified individuals with T2D using the International 
Classification of Diseases (9
th
 revision; ICD-9) code 250 and (10
th
 revision, ICD-10) code E11 as 
recorded in the hospitalization dataset.  Follow-up period for participants with incident T2D was the 
time from the baseline survey date to the diagnosis date. For individuals who did not develop T2D, 
the follow-up period was the interval between the baseline screening and the follow-up time. 
 
Exposure - Waist circumference 
WC was measured in centimetres (cm) at baseline screening and grouped into gender-specific 
quartiles for analysis. Quartiles for males: (Q1= 63-78 cm, Q2= 79-85 cm, Q3= 86-95 cm, Q4= 96-
138 cm). Quartiles for females: (Q1= 60-79 cm, Q2= 80-90 cm, Q3= 91-101 cm, Q4= 101.5-135 
cm). Q1 was the reference group for comparison. For the T2D absolute risk prediction, we included 
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WC and age in our model as they have been identified as risk factors for diabetes in Aboriginals (9, 
10, 178) and other populations outside Australia (116, 298).  
 
Statistical Methods 
Continuous variables were expressed as the mean +/- SD as appropriate. Categorical data were 
expressed as frequencies and percentages. To assess the association of baseline WC measures on 
the newly diagnosed T2D, the Cox proportional hazards models were used to estimate hazard ratios 
(HRs), adjusting for three confounding factors - age, smoking status and alcohol consumption 
status. Age (years) was included in the analysis as a continuous variable, smoking and alcohol 
status as categorical variables. The hazard ratios were computed for quartiles Q2, Q3 and Q4 as 
compared with the lowest quartile (Q1) in different Cox’s proportional hazards regression models. 
To compare the associations of WC with T2D between males and females, we converted original 
WC, BMI and WHR values into gender specific z scores for both genders while also controlling for 
age, smoking and alcohol consumption status. The Weibull regression model was used to predict an 
individual’s 10-year T2D risk in adult males and females using the formula: 
 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 = 1 − exp[−{𝑒𝑥𝑝(−𝛽0 −  𝑋𝑗 𝛽𝑗) 𝑡𝑗}
𝑝
] 
 
where β0 represented the baseline WC coefficient, βj was the coefficient for covariates (WC and 
age), Xj represented the covariates, t= time and p= the shape parameter. We constructed the 
regression coefficient based model by assigning β values as estimated regression coefficients (261). 
WC and age were fitted as continuous variables for the estimating the absolute risks of T2D. 
For all analyses, two-tailed P values of <0.05 were considered significant. All statistical analyses 
were performed with STATA version 12.0 (248) and analysis were done separately for males and 
females.  
 
 
RESULTS 
Baseline characteristics of study participants 
A total of 803 adults without diabetes at baseline records were included in the analysis. The 
baseline characteristics of participants are shown in Table 6.1. One hundred and ten participants (38 
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males and 72 females) were diagnosed as having new onset diabetes during the follow-up period of 
12633.4 person-years. The median follow-up time was 18 years. The overall diabetes incidence rate 
was 8.7 (95% CI: 7.2-10.5) per 1000 person-years, 5.6 (95% CI: 4.1-7.7) per 1000 person-years for 
males and 12.2 (95% CI: 9.7-15.4) per 1000 person-years for females. Figure 6.1 shows the 
cumulative incidence of diabetes (%) according to WC quartiles for males and females respectively 
in the follow-up time. As WC increased, the cumulative incidence also increased to about 18% for 
males and 37.5% for females in WC Q4 during the follow-up period. 
Participants that developed T2D at the end of the follow up period had mean age estimate of 37.5 
years, mean WC estimate of 97.3 cm and mean BMI estimate of 27.5 kg/m
2
. 25.7% of those who 
developed T2D were non-smokers while 44.0% were non-alcohol consumers. 
 
Table 6.1 Baseline Characteristics of study participants initially free of diabetes in study 
community followed up for up to 20 years (1992- 2012) 
 Males Females 
N 419 384 
Age (18- 76 years) 32.1 (10.7) 35.0 (12.9) 
Waist circumference (cm) 85.9 (12.3) 89.0 (14.5) 
Body mass index (kg/m
2
) 23.0 (4.4) 24.2 (6.0) 
Waist-to-hip ratio 1.0 (0.1) 0.9 (0.1) 
Smoking status 
Non-smokers 
Smokers 
 
76 (18.3) 
339 (81.7) 
 
132 (35.1) 
244 (64.9) 
Alcohol consumption 
Non-drinkers 
Drinkers 
 
58 (14.0) 
357 (86.0) 
 
237 (63.2) 
138 (36.8) 
*Data are means (standard deviation) for continuous variables or n (proportions-%) for dichotomous variables. 
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Figure 6.1 Gender-specific cumulative incidence of diabetes (%) by waist circumference 
quartiles 
 
 
 
Association between WC and Type 2 diabetes  
The crude HR for developing T2D with WC as a continuous variable was not significantly different 
between males and females. HR for 1 cm increase in WC was 1.04 (95% CI: 1.02-1.06, P<0 0001) 
for males and 1.05 (95% CI: 1.04-1.07, P<0.0001) for females. Crude and adjusted HRs for WC 
quartiles are shown in Table 6.2. The observed median follow-up times were 18.6, 18.2, 18.1 and 
17.3 years for males and 18.2, 18.1, 16.8 and 15.9 years for females in WC quartiles Q1, Q2, Q3 
and Q4 respectively.  
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Table 6.2 Crude and adjusted hazard ratios and 95% confidence intervals of association 
between T2D and WC quartiles 
WC Quartiles Crude HR (95%CI) P-value Adjusted HR 
(95%CI) 
P-value 
Males     
Q1 1 0.0002 1 0.0003 
Q2 1.4 (0.3-6.2)  1.2 (0.3-5.8)  
Q3 4.9 (1.4-17.2)  4.1 (1.2-14.7)  
Q4 6.8 (2.0-23.2)  5.9 (1.6-21.4)  
Females     
Q1 1 <0.0001 1 <0.0001 
Q2 1.4 (0.5-4.2)  1.4 (0.5-4.2)  
Q3 5.3 (2.1-12.9)  4.9 (2.0-12.3)  
Q4 7.6 (3.2-18.0)  7.2 (3.0-17.4)  
*Adjusted for age, smoking status and alcohol drinking status. 
Waist circumference (WC). Quartile 1 (Q1). Quartile 2 (Q2). Quartile 3 (Q3). Quartile 4 (Q4). 
 
 
The HR was 6.8 (95% CI: 2.0-23.4) for males in the highest (Q4) WC quartile compared to those in 
the lowest (Q1) WC quartile, with P=0.0002.  After adjusting for confounding variables of age, 
smoking and alcohol status, this association remained statistically significant (HR= 5.9, 95% CI: 
1.6-21.4, P=0.0003). The crude HR for females in Q4 WC quartile was HR= 7.6, (95% CI: 3.2-
18.0, P<0.0001). Again, after adjusting for confounding variables, the association remained 
statistically significant for females, with HR= 7.2 (95% CI: 3.0-17.4, P<0.0001).  
Table 6.3 shows the crude and adjusted HR of T2D corresponding to 1 standard deviation increase 
in WC, BMI and WHR (z-scores). The crude hazard ratio for males were 1.7 (95% CI: 1.3-2.2), 1.6 
(95% CI: 1.2-2.1) and 1.3 (95% CI: 1.0-1.6) for WC, BMI and WHR respectively. For females, 
corresponding WC, BMI and WHR crude hazard ratios were 2.1 (95% CI: 1.7-2.6), 1.9 (95% CI: 
1.6-2.4) and 1.3 (95% CI: 1.0-1.6). Associations remained statistically significant independently for 
WC and BMI in both genders after controlling for age, smoking and alcohol consumption. The 
interaction term between gender and WC was not statistically significant (P=0.22). Likewise, 
incorporating an interaction term between age and WC was not statistical significant (P=0.08).  
The association of WC and T2D was mostly affected by age rather than smoking and alcohol 
consumption. Adjusting for age alone in the model testing for the association of WC and T2D 
resulted in HRs of 1.5(95%CI: 1.1-2.0) and 2.0(95%CI: 1.6-2.5) for males and females respectively. 
Each of the covariates had minimal impact on the association between BMI and T2D, and WHR 
and T2D (results not shown). 
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Table 6.3 Crude and adjusted WC, BMI and WHR z-scores and T2D hazards 
 Crude HR 
(95%CI) 
P-value Adjusted HR (95%CI) P-value 
Males     
Waist circumference (cm) 1.7 (1.3-2.2) <0.0001 1.7 (1.2-2.3) 0.001 
Body mass index (kg/m
2
) 1.6 (1.2-2.1) <0.0001 1.6 (1.2-2.2) <0.0001 
Waist-to-hip ratio 1.3 (1.0-1.6) 0.03 1.3 (0.9-1.6) 0.17 
     
Females     
Waist circumference (cm) 2.1 (1.7-2.6) <0.0001 2.0 (1.6-2.5) <0.0001 
Body mass index (kg/m
2
) 1.9 (1.6-2.4) <0.0001 1.9 (1.6-2.5) <0.0001 
Waist-to-hip ratio 1.3 (1.0-1.6) 0.05 1.2 (1.0-1.5) 0.10 
*Adjusted for age, smoking status and alcohol drinking status. 
HR (Hazard ratio); 95%CI (95% confidence interval). 
 
 
6.1.3 Absolute risk of diabetes by WC and age 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑀𝑎𝑙𝑒𝑠) = 1 − exp [−{𝑒𝑥𝑝(−8.8008 −  (−0.0300 ∗ 𝑊𝐶 − 0.0353 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1323
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐹𝑒𝑚𝑎𝑙𝑒𝑠)
= 1 − exp [−{𝑒𝑥𝑝(−7.6955 − (−0.0369 ∗ 𝑊𝐶 − 0.0066 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.13307
] 
 
Based on the coefficients of the final Weibull models above, we estimated 10-year absolute risks 
according to age and WC values. This was illustrated in Figures 6.2 & 6.3, showing a 10-year 
absolute diabetes risk (incidence of a first T2D event) of males and females respectively at different 
WC and age values.  Diabetes risk increased with higher WC and older age. For males, the lowest 
diabetes risk (<=2%) was for those younger than 30 years with WC less than 73 cm. For females, 
those with WC less than 75 cm at any age presented the lowest diabetes risk (<=2%). Absolute 
diabetes risk of 32-34% was observed in males over 60 years with WC greater than 110 cm and for 
females over 55 years of age with WC greater than 113 cm. 
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Figure 6.2 Absolute risk (%) of type 2 diabetes for males, using waist circumference (cm) and 
age (years) 
 
 
 
 
Figure 6.3 Absolute risk (%) of type 2 diabetes for females, using waist circumference (cm) 
and age (years) 
 
 
 
DISCUSSION 
Using long-term cohort data from a remote community, we have developed a simple model to 
estimate 10-year risk of T2D in an Aboriginal Australian community based on two variables: WC 
and age. The results are based on a maximum of 20 years follow-up (median, 18 years) and 
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ascertainment of T2D incidence cases. The values for the two predictors used can easily be obtained 
by individuals and in clinical practice. The absolute risk chart we developed is simple to use and 
understand. The availability of the simple tool to predict future risk of T2D should improve the 
understanding of WC on T2D risk and identify high-risk individuals based on WC and age. It can 
also serve as an adjunct for planning and conducting public health education programs for T2D and 
augment preventive strategies for Aboriginal communities.  
Our approach based on the absolute risk method calculated from Weibull regression takes into 
account the synergetic effects of risk factors of disease of interest (272). This approach took into 
account the different follow-up time of all participants in the study to predict the risk of the disease. 
We have presented the prediction to a 10 year period as the goal of this study is to assess how risk 
of T2D change with WC values with a given age to assist in alerting individuals of the risk of T2D 
with increasing WC. While T2D is a complex multifactorial disease, and the cause originates from 
interactions among a number of risk genetic and environmental predictors, increased risk in 
Australia has been associated with increasing age, family history of diabetes, overweight 
(particularly with extra weight around the waist region), of indigenous Australian descent, lack of 
physical activity, unhealthy diet and high blood pressure (53). Unfortunately, we have no available 
data for family history of diabetes, physical activity and diet. The focus of this study was to 
calculate gender-specific absolute risk estimates for a community of Aboriginal Australians 
according to WC and age while adjusting for age, smoking and drinking in the multivariate 
analysis. Central obesity measured by WC has been known to increase the risk of T2D in the 
Australian Aboriginal population (9, 288). In the present study, we showed WC was a slightly 
better predictor of T2D than BMI and was much better at predicting T2D than WHR. This is 
consistent with the study conducted by Wang and Hoy (2004) in the same community presenting 
the odds ratio for diabetes after adjusting for age and sex to be 2.16, 1.80, 1.41, 1.81 and 1.84 for 
WC, BMI, weight, WHR, and hip circumference, respectively (9). As there are no WC cut-off 
points for Australian Aboriginals, we categorised WC into gender-specific quartiles for the analysis 
and presented a range for WC (65-115 cm) and age (25-65 years) for the prediction to enable easy 
use of the information from this study. Age has also been a commonly used single risk factor for 
detecting undiagnosed diabetes, more importantly, when used in addition to one or more risk factors 
such as obesity, family history of diabetes and hypertension, has the capacity to identify more 
individuals with undiagnosed diabetes (299). An Australian study assessed the relationship of 
increasing prevalence of diabetes with population ageing and obesity (300). They considered age 
group and BMI classification, and found that the greatest relative percentage increases over time 
were observed among those with normal BMI aged 60 years or older (148%), and those who were 
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obese and less than 60 years of age (139%). While BMI is mostly widely used in Australia, very 
few studies give reports of WC measured. 
A previous Australian diabetes-prediction tool (Australian type 2 diabetes risk assessment tool- 
AUSDRISK) identified WC, age and ethnicity as risk factors in the prediction of incident diabetes 
(295, 296). However, Aboriginals in the AUSDRISK were grouped with Southern Europeans and 
Asians to generate a high-risk group which does not reflect a true representation of the level of 
diabetic risk among Aboriginals in Australia. Therefore, the validity and applicability of the tool to 
Aboriginals in Australia is questionable as they were derived from populations with different risk-
factor profiles and ethnicities. The uniqueness of our study lies on our focus on one Aboriginal 
community; to estimate how the diabetes risk varies according to WC and age values, both have 
been reported as predictors of diabetes (8, 9).  
In our study, the lowest T2D incidence was observed among persons in the lowest WC quartile, and 
we observed the strongest relationship between WC and T2D in the highest WC quartile. There was 
statistical significant association between WC and diabetes for both males and females in this 
population.  Our estimates of cumulative incidence in Figure 6.1 suggest a high incidence of 
diabetes with high WC particularly among females (37.5%). Based on point estimates, our findings 
revealed females had higher WC values, and were at higher risk of T2D with increasing WC 
compared to males. The interaction terms incorporated among the variables used showed no 
statistical significance. A potential reason for this could be our relatively small sample size resulting 
in insufficient power to our study in detecting the interactions. 
 
Strengths and limitations 
Our study has a number of strengths. First, to our knowledge, this is the first diabetes prediction 
model specifically developed for an Aboriginal population in Australia. We focused on Aboriginals 
in a remote Aboriginal community where they were culturally homogenous (>80% ascertainment of 
the population). Also focusing on one Aboriginal community minimised the impact of 
heterogeneity in body habitus, as epidemiological studies on WC in the indigenous population of 
Australia have shown that there is substantial variation across communities (12). Second, the 
prospective study design used minimised systematic error introduced by the recall bias that cross-
sectional and case-control studies are subject to. With a follow-up period of up to 20 years with 
high participation and follow-up rates, there was a robust ascertainment of diabetes events.  
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A few limitations of our study need to be acknowledged. First, T2D was only ascertained through 
recording of a T2D diagnosis reported among the diagnoses for a hospitalization episode.  As most 
diabetes patients at the early stage or without any severe complications are usually managed without 
being hospitalized, it is likely that some people with diabetes were not hospitalised in the 
community during the study period, so the absolute risk presented in this study could underestimate 
the true risk in the population. Second, data on other important risk factors of diabetes such as 
physical activities, diet and family history of diabetes were not available. Therefore, we could only 
analyse on data available to us (age, WC, smoking, gender, alcohol consumption) in our analysis. 
Potential confounding effects of other variables (physical activities, family history of diabetes and 
diet) were not adjusted in the reported strong association between WC and diabetes risk in this 
study. Third, since our data were from one community, we were unable to generalise our findings 
about WC-associated absolute risks of T2D in other Australian Aboriginal communities. Due to our 
relatively small sample size (803 participants and 110 newly developed T2D), we could not assess 
internal validation by using subset of individuals from the study sample. However, our findings can 
be further replicated in other Aboriginal communities to assess the generalizability of our findings. 
Fourth, there may have been inaccuracies of WC measurements at baseline, resulting in the 
misclassification of participants into WC quartiles and attenuating the observed associations for 
WC.  
 
CONCLUSION 
We have constructed a simple tool for predicting the 10- year diabetes risk using WC and age as 
covariates, and this model focused on Aboriginals in an Australian remote community. This simple 
tool would assess how absolute risk of T2D changes with WC values. It is also helpful for 
identifying individuals at risk of T2D from high WC, and developing strategies for preventing 
diabetes in Aboriginal Australians. Our prediction tool will benefit from further validation with the 
inclusion of other important risk factors such as family history of diabetes, physical activity and 
diet. 
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CHAPTER 7 
BODY MASS INDEX, WAIST CIRCUMFERENCE AND MORTALITY RISK AMONG 
ABORIGINAL PEOPLE IN A REMOTE AUSTRALIAN COMMUNITY 
 
7.1 INTRODUCTION AND AIM 
Epidemiological studies have shown that body mass index (BMI) and waist circumference (WC) 
are associated with risk of mortality in several populations of the world. However, there is scarcity 
of information on the associations of BMI and WC with mortality in the Aboriginal Australian 
population.  
The aims of this chapter are: 
1. To follow up on an earlier study conducted in the sample population to examine the 
association of BMI with the risk of mortality. 
2. To assess the association of WC with all-cause mortality. 
3. To examine which of BMI or WC has stronger association with all-cause mortality. 
 
In this chapter, Section 7.2 provides a summary of my contributions to the study. Results from the 
study have been published in a peer-reviewed journal. The reference for this publication is: 
Adegbija O, Hoy WE, Dong B, Wang Z. Body mass index and waist circumference as predictors of 
all-cause mortality in an Aboriginal Australian community.  Obesity Research & Clinical Practice 
2016. Doi: 10.1016/j.orcp.2016.06.003 
 
7.2 CONTRIBUTION TO STUDY 
Under the guidance of Dr Wang and Dr Hoy, I developed the analysis plan to examine the 
association between WC and all-cause mortality. I was responsible for the data management and I 
conducted the data analysis and interpreted the results in consultation with Dr Wang and Dr Hoy. I 
was responsible for writing the manuscript, taking into account the comments and suggestions of Dr 
Wang, Dr Hoy and Dr Dong. 
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ABSTRACT 
Objective 
Although elevated body mass index (BMI) and waist circumference (WC) have been identified as 
risk factors for mortality, data from the Australian Aboriginal communities are scarce. This study 
examined the associations of BMI and WC with all-cause mortality in an Australian Aboriginal 
community. 
 
Methods 
A total of 934 Aboriginal adults, aged 18 to 76 years, who participated in a community-wide 
screening program in Australia’s Northern Territory from 1992 to 1998, were followed-up 
prospectively for up to 18 years for death outcomes. The hazard ratios for mortality were estimated 
by baseline BMI and WC. Age, sex, smoking and alcohol consumption status were adjusted for in 
multivariable analysis. 
 
Results 
In 14,750 person-years of follow-up, 216 deaths were recorded. For each standard deviation 
increase in BMI, the risk of all-cause mortality decreased by 9% (95% CI: 0.80-1.05); whereas for 
each SD increase in WC, the risk of all-cause mortality increased by 17% (95% CI: 1.03-1.33). The 
risk of mortality was lower in the 3
rd
 BMI tertile compared to the 1
st
 tertile for mortality after 
adjusting for WC, age, sex smoking and alcohol consumption. Risk of death was higher in WC 
tertile 3 compared to tertile 1 after adjusting for BMI, age, sex, smoking and alcohol consumption. 
  
Conclusions 
The risk of all-cause mortality among participants increased with higher WC, while participants 
with relatively higher BMI had a lower mortality risk. WC had stronger association with mortality 
than did BMI. The results indicate the importance of assessing WC measures in studies conducted 
in Aboriginal Australia.  
 
Keywords: body mass index; waist circumference; all-cause mortality; Aboriginal people 
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INTRODUCTION  
There is a significant gap in the life expectancy of Australian Aboriginal people compared to non-
Aboriginals, estimated to be 10.6 years and 9.5 years lower for Aboriginal males and females 
respectively compared to their non-Indigenous counterparts (301). Although there is accumulating 
evidence pointing to the detrimental effects of high body mass index (BMI) and elevated waist 
circumference (WC) on mortality risk (302, 303), evidence is limited on the relationship of these 
two measures with mortality among Australian Aboriginal people. There have been reports that 
Aboriginal people have different body habitus profile which includes BMI and WC, in comparison 
to non-Aboriginals (12, 98). This Australian group have considerably higher WC measurements 
relative to their body weight, and particularly among females who have significantly higher WC 
estimates compared to non-Aboriginal females (12). Also, BMI and WC vary significantly in 
different Aboriginal communities (12). Therefore, there have been suggestions that generalising and 
stereotyping BMI and WC in Aboriginal people might not be appropriate due to the heterogeneity 
in the distribution and estimates of these measures in various Aboriginal communities (12, 98, 304). 
Furthermore, reports have indicated the currently advocated classification of BMI (overweight- 25.0 
to 29.9 kg/m
2
 and obesity- ≥30kg/m2)  (94) and WC (overweight- 94 for men and 80 cm for women, 
and obesity- 102 for men and 88 cm for women) (115) unsuitable for Aboriginal people (11, 98).  
A number of epidemiological studies have reported on the association of BMI with all-cause 
mortality in some Asian populations (305, 306), the United States (307, 308) and in Australia (309). 
In addition, there have been studies linking high WC to a high risk of death in some other 
populations (72, 310-313). Furthermore, a few studies have assessed the relationship of both BMI 
and WC with the risk of death (312, 314-316), albeit in predominately European populations. 
Previously, Wang and Hoy in a 9-year follow-up period of Aboriginal people in a remote 
community in Australia’s Northern Territory, observed that BMI was inversely associated with all-
cause mortality; higher BMI was associated with lower mortality risks over the low and modest 
range of BMIs (309). The present study has taken a step further to assess the relationships of BMI 
and WC with all-cause mortality, using a follow-up time of up to 18 years in the same Aboriginal 
population. We sought to examine if there are changes to the inverse association between BMI and 
all-cause mortality with a longer follow-up time. Furthermore, we assessed the association of WC 
with all-cause mortality, and the combined associations of BMI and WC and mortality in the 
Aboriginal community. Understanding the role of BMI and WC in the risk of death might provide 
insights and assist in targeting appropriate strategies for individual communities and groups. 
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METHODS 
Study participants 
The original cohort consisted of 1490 people that participated in a community-wide screening 
program from 1992 to 1998 in a remote Northern Territory (NT) Aboriginal community in 
Australia. The NT is a federal Australian territory in the centre and central northern regions. 
Baseline data was collected through interview questionnaires at the community screening program 
where participants underwent anthropometric measurements (weight, height and WC), and provided 
some basic information such as age, sex, smoking (smokers and non-smokers) and alcohol 
consumption (drinkers and non-drinkers) status. Further details of the baseline examinations have 
been described elsewhere (8). Of the original baseline cohort, 514 were children (age<18 years), 
and 42 adult individuals did not have baseline WC and BMI measures, and these were not included 
in the study. In total, the study included 934 (474 males and 460 females) adult participants (aged ≥ 
18 years) who had BMI and WC measurements at baseline, whose course was followed up for up to 
18 years, to December 2010. This adult cohort represented over 85% of all adults in the study 
community (317).  A unique study identification number was given to each study participant record 
at the start of the study. 
Outcome variable 
End point was all-cause mortality, defined as all deaths during the follow-up period from January 
1992 to December 2010. The mortality data was collected through community networks and death 
registry records, and deaths were ascertained from records at the local clinics and hospital records.  
 
Measurements 
BMI was calculated as baseline weight divided by baseline height squared (kg/m
2
). Baseline WC 
was measured in centimetres (cm) between the lowest ribs and the iliac crest using a tape measure. 
All measurements were single measurements made by one field worker and two Aboriginal health 
workers. As the currently recommended BMI and WC thresholds have been suggested to be 
inappropriate for Aboriginal people in Australia (11, 98), participants were categorised by baseline 
BMI and WC into sex-specific tertiles to make them comparable for the purpose of the analysis. 
BMI tertiles for males were as follows: (tertile 1= 14.20-20.98 kg/m
2
, tertile 2= 20.99-25.10 kg/m
2
 
and tertile 3= 25.11-41.80 kg/m
2
). BMI tertiles for females were as follows: (tertile 1= 13.58-21.14 
kg/m
2
, tertile 2= 22.22-27.12 kg/m
2
 and tertile 3= 27.14-43.74 kg/m
2
). WC tertiles for males were 
as follows: (tertile 1= 63-80 cm, tertile 2= 81-90 cm, tertile 3= 93-138 cm). WC tertiles for females 
were as follows: (tertile 1= 60-83 cm, tertile 2= 84-98 cm, tertile 3= 99-135 cm). Variables such as 
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age, sex (male/female), smoking (smokers, non-smokers) and alcohol consumption (drinkers, non-
drinkers) obtained at baseline examination were covariates in this study.  
Ethical Standards 
All participants gave written informed consent prior to the start of the baseline examination. This 
original baseline database was approved by the Aboriginal community and Ethics Committee of the 
Menzies School of Health Research and Territory Health Services. The project was approved by the 
Behavioural and Social Science Ethical Review Committee of the University of Queensland 
(#2011001232).  
Statistical analysis 
Means (standard deviations) were calculated for continuous variables such as age, BMI and WC. 
Categorical variables, including smoking and alcohol consumption, were expressed as numbers 
(percentages). The Pearson’s correlation co-efficient was used to evaluate the correlation between 
baseline BMI (kg/m
2
) and WC (cm). The baseline and mortality datasets were merged after 
participants were de-identified. Participants were followed up from date of baseline examination till 
the date of death as recorded on mortality dataset. Those who died during the follow-up time were 
considered to have had the event, while those who had not reached the endpoint were considered 
‘censored’ at the end of the follow up period (December 2010). Incident mortality rate (calculated 
per 1,000 person years of follow-up) for each baseline tertile of BMI and WC was obtained using 
the number of deaths divided by the person-years of follow-up. The Cox proportional hazards 
regression was used to present estimates of hazard ratios (HRs) with 95% confidence intervals (CIs) 
of mortality in relation to BMI and WC. Due to our relatively small sample size, sex was considered 
as a group, and was adjusted for in regression models. We converted original BMI and WC values 
into sex-specific z-scores thereby eliminating the differences in units to ensure that the magnitude 
of the HR results for both measures were directly comparable (262). Hazard ratio for each standard 
deviation change in BMI was 4.6 kg/m
2
 for males and 5.9 kg/m
2
 for females, and WC was 13 cm 
for males and 14.5 cm for females. HRs and their 95% confidence intervals of the risk of mortality 
associated with BMI alone, WC alone, and BMI and WC together were presented. HRs by BMI and 
WC tertiles were estimated while controlling for age, sex, smoking and alcohol consumption. BMI 
or WC was used as a continuous variable when adjusted for in multivariable models. The 1
st
 tertile 
of BMI and/or WC was used as the reference group for all analysis. Proportional hazards 
assumptions were tested on the basis of Schoenfeld residuals (318). Linear associations between 
BMI and WC and mortality were tested.  An interaction term was included in the model to examine 
the difference between males and females in the association between BMI, WC and mortality (265). 
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Statistical significance was defined at the level of P<0.05 (two-tailed). Data analysis was conducted 
using Stata/SE 13.1 (319). 
 
RESULTS 
Baseline characteristics of study participants 
Overall, 934 adult participants with BMI and WC measurements at baseline were followed up for 
up to 18 years and generated a total of 14,750 person-years. On average, baseline age, BMI and WC 
measurements were higher for females than males, as shown in Table 7.1. Males showed higher 
weight mean estimates compared to females. On average, males were about 10.7 cm taller than 
females. Males were more likely to smoke and consume alcohol than females. During the follow-up 
period, 216 deaths occurred. There were no statistical significant differences between males and 
females in the risk between BMI and mortality (P=0.83) and WC and mortality (P=0.48). The 
correlation between BMI and WC at baseline was 0.86 (P<0.05). Participants that died at the end of 
the follow up period had mean age estimate of 43.5 years, mean WC estimate of 90.9 cm and mean 
BMI estimate of 23.5 kg/m
2
. 19.9% of those who died were non-smokers while 37.7% were non-
alcohol consumers. 
 
 
Table 7.1 Baseline characteristics of the study participants; 934 adults, aged 18 years and 
above by gender 
 Males (n=474) Females (n=460) 
 Mean SD Mean SD 
Age, years 33.6 11.5 36.4 13.1 
Body mass index, (kg/m
2
) 23.5 4.6 24.5 5.9 
Waist circumference, (cm) 87.3 13.0 90.8 14.5 
Weight, (kg) 69.3 14.8 63.5 15.9 
Height, (cm) 171.6 6.3 160.9 5.8 
     
 N % n % 
Tobacco smokers 376 80.0 300 66.4 
Alcohol drinkers 397 84.5 156 34.6 
SD= standard deviation 
 
Associations of BMI, WC and all-cause mortality from results of z-scores 
Table 7.2 presents mortality rates with study participants ordered according to sex-specific BMI and 
WC for deaths from all causes. The mortality rates varied across BMI tertiles and the highest rates 
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were observed in the 2
nd 
BMI tertile. On the other hand, rates of all-cause mortality increased as 
WC increased with the highest rate in the WC 3
rd
 tertile. 
 
 
Table 7.2 Rates (95% confidence intervals) for all-cause mortality by baseline sex-specific 
tertiles of BMI and WC 
 Deaths Rate 95% Confidence Interval 
Body mass index    
1
st
 tertile 77 15.8 12.6-19.7 
2
nd
 tertile 80 16.7 13.4-20.7 
3
rd
 tertile 59 11.7 9.0-15.0 
Waist circumference    
1
st
 tertile 56 10.9 8.4-14.2 
2
nd
 tertile 77 15.8 12.6-19.7 
3
rd
 tertile 83 17.5 14.1-21.7 
*Rates are in 1000 person-years 
Note: BMI tertiles for males were as follows: (tertile 1= 14.20-20.98 kg/m
2
, tertile 2= 20.99-25.10 kg/m
2
 and tertile 3= 
25.11-41.80 kg/m
2
). BMI tertiles for females were as follows: (tertile 1= 13.58-21.14 kg/m
2
, tertile 2= 22.22-27.12 
kg/m
2
 and tertile 3= 27.14-43.74 kg/m
2
). WC tertiles for males were as follows: (tertile 1= 63-80 cm, tertile 2= 81-90 
cm, tertile 3= 93-138 cm). WC tertiles for females were as follows: (tertile 1= 60-83 cm, tertile 2= 84-98 cm, tertile 3= 
99-135 cm). 
 
 
The hazards regression that had independent and combined analysis of BMI and WC z-scores 
assessing which had the stronger association with mortality are shown in Table 7.3. In the model 
conducted that included BMI only, while crude results showed no statistically significant 
association between BMI and mortality, adjusted analysis for all covariates showed an inverse 
relationship between BMI and all-cause mortality. In the model conducted on the sample that 
included WC only, crude results showed increase in the risk of death as WC increased and result 
was statistically significant; however, after adjustment for all the covariates, there was no statistical 
significance in the association between WC and mortality.  Age, rather than smoking or alcohol 
consumption had the greatest impact on the association between BMI and mortality, HR= 0.81 
(95%CI: 0.70-0.93, P<0.05), and the association between WC and mortality HR= 0.95 (95%CI: 
0.82-1.09) (Results not included in tables).  
The results of the z-scores showed higher HR for WC than BMI. When BMI and WC were 
combined in the model, BMI was inversely associated with mortality, while the risk of all-cause 
mortality increased as WC increased, and results were statistically significant in both crude and 
adjusted analyses. 
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Table 7.3 Hazard ratios (95% confidence intervals) for all-cause mortality by baseline sex-
specific z-scores of BMI and WC 
   BMI and WC 
 BMI WC BMI WC 
Mortality HR(95%CI) HR(95%CI) HR(95%CI) HR(95%CI) 
Crude 0.91(0.80-1.05) 1.17(1.03-1.33) * 0.46(0.37-0.58) * 2.22(1.79-2.75) * 
Adjusted 0.85(0.73-0.99) * 0.98(0.85-1.14) 0.60(0.46-0.79) * 1.50(1.15-1.94) * 
Note: BMI and WC were included in models as continuous variables, and hazard ratios were computed for each 
standard deviation change in BMI and WC. 
Adjusted for age, sex, smoking and alcohol consumption status 
*Statistically significant (P<0.05) 
 
Table 7.4 shows the crude and adjusted hazard ratios for all-cause mortality by BMI and WC 
tertiles.  After adjusting for WC as a continuous variable, the risk of mortality was lower in the 3
rd
 
BMI tertile compared to the 1
st
. When BMI, WC (continuous variable), age, sex, smoking and 
alcohol consumption status were included in the same regression model, the risk of death was lower 
in the 3
rd
 BMI tertile compared to the 1
st
 tertile. 
On the other hand, with adjustment for BMI as a continuous variable, risk of death was higher in the 
3
rd
 WC tertile compared to the 1
st
 tertile, and results were statistically significant. After including 
WC, BMI (continuous variable), age, sex, smoking and alcohol consumption status in the same 
multivariable analysis, the risk of death was higher in the 3
rd
 WC tertile compared to the 1
st
 tertile. 
 
Table 7.4 Hazard ratios (95% confidence intervals) for all-cause mortality by baseline sex-
specific tertiles of BMI and WC 
 Crude Adjusted
1
 Adjusted
2
 
 HR 95% CI HR 95%CI HR 95% CI 
BMI        
      1
st
 tertile 1  1*  1*  
      2
nd
 tertile 1.05  0.77-1.43 0.66 0.47-0.94 0.69  0.48-0.98 
      3
rd
 tertile 0.73 0.52-1.02 0.25 0.15-0.42 0.44  0.26-0.73 
WC        
      1
st
 tertile 1  1*  1*  
      2
nd
 tertile 1.44  1.02-2.03 2.32 1.59-3.39 1.26  0.85-1.87 
      3
rd
 tertile 1.58 1.13-2.22 4.57 2.80-7.46 2.03 1.22-3.39 
Adjusted
1
: included BMI and WC in the multivariable analysis 
Adjusted
2
: included BMI, WC, age, tobacco smoking status and alcohol consumption status in the multivariable 
analysis. 
Note 1: adjusted BMI or WC was a continuous variable. 
Note 2: BMI tertiles for males were as follows: (tertile 1= 14.20-20.98 kg/m
2
, tertile 2= 20.99-25.10 kg/m
2
 and tertile 
3= 25.11-41.80 kg/m
2
). BMI tertiles for females were as follows: (tertile 1= 13.58-21.14 kg/m
2
, tertile 2= 22.22-27.12 
kg/m
2
 and tertile 3= 27.14-43.74 kg/m
2
). WC tertiles for males were as follows: (tertile 1= 63-80 cm, tertile 2= 81-90 
cm, tertile 3= 93-138 cm). WC tertiles for females were as follows: (tertile 1= 60-83 cm, tertile 2= 84-98 cm, tertile 3= 
99-135 cm). 
*Statistically significant (P<0.05) 
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DISCUSSION 
The results of this study provide evidence that the risk of all-cause mortality increased with higher 
WC; whereas, higher BMI was associated with lower mortality risk after adjusting for WC. 
Furthermore, WC had stronger association with all-cause mortality than BMI. These findings have 
significant implications for Aboriginal people as WC has rarely been used to explore the risk of 
mortality in their communities.  
 
Consistency with other studies 
Our study confirms findings from prior investigations by Wang and Hoy in the study community 
that reported an inverse association between BMI and mortality, stating that individuals with 
relatively higher BMI had a lower risk of death (309). A large Australian cohort study- the 
Melbourne Longitudinal Studies on Healthy Ageing (MELSHA) with a sample of 1,000 men and 
women and 409 deaths, found low BMI was associated with a higher risk of death with adjusted 
HR= 2.15 (95% CI: 1.15-4.02) for BMI<18.5kg/m
2
 using the second BMI group (18.5-24.9 kg/m
2
) 
as the reference category (320). Although the MELSHA study was focused on the ageing 
population (+65 years) and participants were predominantly from English-speaking backgrounds 
and do not represent the Australian Aboriginal population, their result on low BMI and high risk of 
death was similar to the results of the present study. As BMI measures overall adiposity and cannot 
differentiate between weight from muscle and fat (321), it was difficult to speculate on mechanisms 
of our findings on low BMI and high mortality risk as we have no data on diet, physical activity and 
physical fitness which have been shown to be independent contributors to obesity-related mortality 
(322). Pre-existing illness has also been known to contribute to increased mortality risk among 
individuals with low BMI (308), so there is the possibility that individuals with low BMI at baseline 
had a history of existing disease that contributed to the increased risk of death observed among low 
BMI participants.  
The association between high WC and increased risk of all-cause mortality have been reported in 
previous studies (72, 310). Recently, an Australian study used the Melbourne Collaborative Cohort 
Study (MCCS) to compare five adiposity measures as predictors of all-cause mortality (313). In 
their sample of 41,313 men and women aged 25 to 75 years and 2,822 deaths over the follow-up 
years, they reported 30% higher risk of all-cause mortality for the highest WC group for men 
(WC>102 cm) and women (WC>88 cm), and 30% and 20% higher death risk for the lowest BMI 
category (<23 kg/m
2
) for men and women respectively. Using the second pre-defined sex-specific 
category as the referent group, they also found the highest risk of death for women was at the 
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highest WC quintile, HR= 1.5 (95% CI: 0.9-2.4). These results are consistent with our findings of 
higher risk of death associated with increasing WC and low BMI. However, participants of the 
MCCS were mainly Anglo-Celtic with about 25% southern Europeans (323) and generally do not 
represent the Aboriginal population.   
While there are no proposed WC standards specifically for Aboriginal people, BMI ranging from 17 
to 22 kg/m
2
 has been suggested as normal instead of the currently used guidelines (94, 324). In the 
present study, BMI as well as WC were categorised into tertiles for the purpose of analysis to make 
them comparable and observe the trend and pattern of mortality. Although Australian Aboriginal 
people, particularly females tend to have a preference for abdominal fat (12, 149); interventions on 
weight loss need to be considered with caution. As high BMI showed lower risk of death from the 
findings of the present study, it seems a challenge proposing weight loss in a population where there 
is a likelihood, although unproven, that high WC is genetic (168), and reducing weight will likely 
further lower their BMI, which might increase the risk of mortality. The present result supports the 
presence of an “obesity paradox” where individuals with high BMI have a lower risk of dying than 
those with low BMI (325, 326). Future studies on BMI, WC and mortality in Aboriginal Australians 
should focus on a larger population to examine the relationship between the indices and mortality, 
and also examine changes in weight and the implication on independent BMI and/or WC 
associations with mortality. 
 
 Strengths and limitations 
Strengths of this study include the prospective nature of the study design, population-based 
recruitment and use of a long-term 18-year mortality follow-up to assess the association BMI and 
WC have with all-cause mortality. Also, this study was based on data from an Aboriginal Australian 
population where little is known on the association of BMI, WC and mortality. In addition, we 
focused on one Aboriginal community with a high participation rate (over 85% of eligible 
community members were participants at the baseline screening examination). Due to variations in 
WC in different Aboriginal communities (12, 149), using data from one community improved the 
internal validity of our findings. However, this may also be a limitation to this study in terms of the 
generalizability of our findings to other Australian Aboriginal communities. The generalizability of 
the findings from this study should be further assessed in future studies. Despite the high 
participation rate in the study community, our sample size was still relatively limited. This could be 
a potential reason for the results regarding BMI, as results of the crude BMI and mortality analysis 
did not show a particular trend as the highest HR was found in the 2
nd
 BMI tertile. However, after 
adjusting, the trend showed lower risk of death in the highest BMI tertile. Also, due to our limited 
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sample size, pre-existing diseases such as stroke, cancer and chronic obstructive pulmonary disease 
were not excluded. This could be a potential reason for the association of low BMI and increased 
risk of death observed in this study, with a possibility of history of pre-existing illnesses among the 
low BMI tertile. Furthermore, we do not have baseline data on physical fitness or activity and diet, 
so it is unclear if the protective association between BMI and mortality was paradoxically due to 
muscularity (321). Nevertheless, we were able to show the importance of WC measures by 
demonstrating the stronger relationship it has with mortality risk over BMI. 
 
CONCLUSION 
High WC was a risk factor for all-cause mortality in the study population. The risk of mortality was 
lower with high BMI after adjusting for WC. WC had stronger association with mortality compared 
to BMI. Our results underscore the importance of assessing WC measures in studies conducted in 
Aboriginal Australia. We recommend WC as a preferred obesity measurement to capture mortality-
high risk individuals in the Aboriginal community. 
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CHAPTER 8 
WAIST CIRCUMFERENCE VALUES EQUIVALENT TO BODY MASS INDEX POINTS 
FOR PREDICITING ABSOLUTE CARDIOVASCULAR DISEASE RISKS 
 
8.1 INTRODUCTION AND AIMS 
Despite the high risk of cardiovascular diseases (CVD) associated with elevated waist 
circumference (WC) in Aboriginal population, there is a lack of WC thresholds for identifying 
Aboriginal individuals at high risk of the disease. While the presently recommended WC cut-off 
points for overweight (≥94 cm for men, ≥80 cm for women) and obesity (≥102 cm for men, ≥88 cm 
for women) are suitable for Australians of European descent, the applicability for Aboriginal people 
have been questioned due to variations in WC profiles.  
In this chapter, we aimed to evaluate WC values corresponding to body mass index (BMI) points 
with equal absolute CVD, coronary artery disease and heart failure risks in an Australian Aboriginal 
community. The WC values generated will assist future research by contributing to the evidence 
needed for the recommendation of waist circumference cut-off points appropriate to the Aboriginal 
Australian population. 
 
In this chapter, Section 8.2 provides a summary of my contributions to the study. Results from the 
study have been published in a peer-reviewed journal. The reference for this publication is: 
Adegbija O, Hoy WE, Wang Z. Waist circumference values equivalent to body mass index points 
for predicting absolute cardiovascular disease risks among adults in an Aboriginal community: a 
prospective cohort study. BMJ Open 2015. 5:e009185. doi:10.1136/bmjopen-2015-009185. 
 
8.2 CONTRIBUTION TO THE STUDY 
In addition to my contributions to linking baseline data to hospitalization data, I was responsible for 
the data management for this study. I conducted the analysis, produced the relevant tables and 
figure, and drafted the manuscript. Dr Wang and Dr Hoy contributed expertise by providing 
comments and suggestions to the final published article. 
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ABSTRACT 
Objective 
There have been suggestions that currently recommended waist circumference (WC) cut-off points 
for Australians of European origin may not be applicable to Aboriginal people who have different 
body habitus profiles. We aimed to generate equivalent WC values that correspond to body mass 
index (BMI) points for identifying absolute cardiovascular disease (CVD) risks.  
 
Design  
Prospective cohort study. 
 
Setting  
An Aboriginal community in Australia’s Northern Territory. 
 
Participants  
From 1992 to 1998, 920 adults without CVD, with age, WC and BMI measurements were 
followed-up for up to 20 years. 
 
Outcome measures 
Incident CVD, coronary artery disease (CAD) and heart failure (HF) events during the follow-up 
period ascertained from hospitalization data. We generated WC values with 10-year absolute risks 
equivalent for the development of CVD as BMI values (20 to 34 kg/m
2
) using the Weibull 
accelerated time-failure model.  
 
Results 
There were 211 incident cases of CVD over 13,669 person-years of follow up. At the average age 
of 35 years, WC values with absolute CVD, CAD and HF risks equivalent to BMI of 25 kg/m
2
 were 
91.5, 91.8 and 91.7 cm respectively for males, and corresponding WC values were 92.5, 92.7 and 
93 cm for females. WC values with equal absolute CVD, CAD and HF risks to BMI of 30 kg/m
2
 
were 101.7, 103.1 and 102.6 cm respectively for males, and corresponding values were 99.2, 101.6 
and 101.5 cm for females. Association between WC and CVD did not depend on gender (P=0.54).  
 
Conclusions 
WC ranging from 91 to 93 cm was equivalent to BMI 25 kg/m
2
 for overweight, and 99 to 103 cm 
was equivalent to BMI of 30 kg/m
2
 for obesity in terms of predicting 10-year absolute CVD risk. 
96 
 
Replicating the absolute risk method in other Aboriginal communities will further validate the WC 
values generated for future development of WC cut-off points for Aboriginal people.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
INTRODUCTION 
The importance of waist circumference (WC) in health assessment in relation to chronic diseases 
such as cardiovascular disease (CVD) prevention is well recognised in current guidelines and 
policies in Australia. These guidelines include the “National guide to a preventive health evaluation 
in Aboriginal and Torres Strait Islander peoples” by National Aboriginal Community Controlled 
Health Organisation (NACCHO), and the ‘Clinical Practice Guidelines for the Management of 
Overweight and Obesity in Adults’ by the National Health and Medical Research Council. The 
Central Australian Rural Practitioners Association (CARPA) Standard Treatment Manual 
recommends WC measures be included in all yearly Adult Health Checks (219). Although this is a 
major achievement in creating awareness of the importance of WC, which is often not the foremost 
focus of most studies assessing anthropometric indices, the previously mentioned guidelines have 
been unable to recommend WC cut-off points for Aboriginal people who have higher CVD risk 
(327) and have elevated WC (12) compared with non-Aboriginals in Australia. Recently, the 
Australian, States and Territories Government sponsored the Measure-Up Campaign targeted at 
measuring WC in an effort to reduce chronic disease risk for Australians by recommending WC 
cut-off levels of 94 and 102 cm for men and 80 and 88 cm for women derived from body mass 
index (BMI) of 25 and 30 kg/m
2
, respectively. Despite their efforts in presenting these WC cut-offs 
in multilingual booklets for various ethnic Australian groups, the recommended thresholds were 
particularly relevant to populations of European origin and might not reflect the true health risk in 
Aboriginal people who differ in body composition from other Australians (11, 12, 149).  
CVD has been reported as the leading cause of death among Aboriginal people who are 1.3 times as 
likely to develop the disease as other Australians (327). Elevated WC has been known to increase 
the risk of any CVD (8, 98, 155) , coronary artery disease (CAD) (328) and heart failure (HF) (329, 
330). Aboriginal people, particularly females, have body composition characterised by relatively 
higher WC compared with non-Aboriginals, which has been associated with increased risk of CVD. 
(8, 98, 155) Although WC has been reported to have stronger association with CVD than BMI in 
Aboriginal communities (8), both WC and BMI are useful predictors of CVD (328, 331). Using a 
longitudinal follow-up study design, we aimed to evaluate WC values corresponding to BMI points 
with equal absolute CVD, CAD and HF risks in an Aboriginal community in Australia. The WC 
values generated will assist future research by contributing to the needed evidence for the 
recommendation of WC cut-off points applicable to the Aboriginal population. 
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METHODS 
Study setting and participants 
The study was a prospective cohort study which included two phases: the baseline and follow-up. 
At a baseline community screening programme conducted from 1992 to 1998 in a remote 
Aboriginal community in the Northern Territory of Australia, age as well as anthropometric indices 
such as WC, weight, height and BMI were recorded, details have been discussed elsewhere.(8)  
A total of 976 adults (aged 18 years and above) participated in the baseline screening programme of 
whom 934 had records of age (years), as well as WC and BMI measurements. Out of the 934 adults, 
920 were free from known CVD at baseline and were eligible for the present study. They 
represented over 90% of adults in the study sample. These 920 adults (468 males and 452 females) 
were included in the study and prospectively followed up for up to 20 years (until 31 May 2012) to 
identify hospital-diagnosed new incident cases of CVD through hospitalisation data obtained from 
public hospitals in the Northern Territory.  
 
Anthropometric measurements 
Baseline WC in centimetres was measured midway between the lower border of the ribs and the 
iliac crest. Baseline BMI was calculated as baseline weight (kilograms) divided by the square of 
baseline height (metres).  
 
Outcomes measurements 
The hospitalisation database included hospital and emergency admission records of individuals in 
the Northern Territory. The CVD cases during the follow-up period were determined from the 
hospitalisation records using the following International Classification of Diseases (ICD) codes. 
CVD outcomes were classified as hypertensive heart and renal diseases, coronary artery disease, 
pulmonary circulation, cardiac arrest, heart failure, myocardial infarction, stroke, cerebrovascular 
disease, diseases of arteries and veins, which were identified by patient hospitalization records 
using ICD-9 and ICD-10 codes presented in Table 8.1. 
 
Table 8.1 ICD 9 and 10-AM codes for CVD, CAD and HF 
Disease ICD 9 code ICD 10 code 
CVD 402-404, 410-417, 427.5, 428, 430-459 I11-I13, I20-I28, I50, I60-I89 
CAD 410-414 I20 to I25 
HF 428 I50 
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Although, CVD comprised of CAD and HF, we further separated each of CAD and HF to assess 
their risks with BMI and WC. For the purpose of this study, we excluded rheumatic fever and 
diseases as well as hypotension, haemorrhoids and other CVDs, that WC has not been found to have 
a causal relationship. On the other hand, we included hypertensive heart disease and hypertensive 
renal disease due to their associations with the complications of high blood pressure to which BMI 
(332, 333) and elevated WC (205, 334) have been documented as risk factors. Death records were 
checked for CVD cases that were not recorded in the hospital data. The follow-up time for each 
participant was calculated from baseline screening to date of disease diagnosis according to the 
hospital record, or date of death, or end of follow-up, whichever occurred first. Over 82% of the 
study participants were hospitalised for any ailment during the follow-up period as evidenced by 
hospitalisation records; therefore, we are positive of a robust follow-up ascertainment. 
 
Ethics statement 
The protocol of the baseline screening programme was approved by the Ethics Committee of the 
Menzies School of Health Research and Territory Health Service, and the Aboriginal community. 
The Behavioural and Social Science Ethical Review Committee of the University of Queensland 
(#2011001232) gave approval of this study. All participants gave informed consent to participate. 
 
Statistical analysis 
Data were analysed separately for males and females. Mean and SD for continuous variables or 
frequency and percentages for categorical variables were calculated. The Weibull accelerated 
failure-time model was used to estimate the absolute CVD risk using the formula: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 = 1 − exp[−{𝑒𝑥𝑝(−𝛽0 −  𝑋𝑗 𝛽𝑗) 𝑡𝑗}
𝑝
] 
where β0 represented the baseline  BMI or WC coefficient, βj was the coefficient for covariates 
(BMI or WC and age), Xj represented the covariates, t = time and p= shape parameter (261). 
The absolute risk method was employed to obtain estimates of equivalent WC values that 
corresponded to BMI values from 20 to 34 kg/m
2
 for a 10-year CVD risk in males and females at 
the average age of 35 years. Interaction was tested for gender in relation to WC and risk of CVD 
using fractional polynomial regression (265). In addition, we independently assessed CAD and HF 
to obtain WC points from BMI with equivalent absolute risks. Statistical analyses were performed 
with STATA statistical software version 13.0 (319). The tests were two-tailed and we used P<0.05 
as the level of statistical significance.  
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RESULTS 
Characteristics of the participants 
The study sample comprised 920 participants, including 452 (49%) females. Compared with males, 
the average age, WC and BMI were higher in females. Table 8.2 shows the baseline characteristics 
of the study participants. During an average follow-up time of 14.8 years, a total of 211 participants 
developed CVD. A total of 140 CAD and 81 HF incident cases were recorded. In general, a greater 
proportion of females than males had CVD (23.7-22.2%), CAD (15.7-14.7%) and HF (10.2-7.5%)  
 
Table 8.2 Baseline characteristics of study participants 
 Males (n=468) Females (n=452) Total (n=920) 
Age, years-mean (SD) 33.5 (11.5) 36.2 (13.0) 35.0 (12.3) 
WC, cm-mean (SD) 87.3 (13.1) 90.6 (14.5) 88.9 (13.9) 
BMI, kg/m
2
-mean (SD) 23.5 (4.6) 24.5 (5.9) 24.0 (5.3) 
    
Any CVD outcome, n (%) 104 (22.2) 107 (23.7) 211  (22.9) 
CAD, n (%) 69 (14.7) 71 (15.7) 140 (15.1) 
HF, n (%) 35 (7.5) 46 (10.2) 81 (8.7) 
Abbreviations: WC, waist circumference; CVD, cardiovascular disease; CAD, coronary artery disease; HF, heart 
failure; BMI, body mass index. 
 
Results presented in Table 8.3 show the population profile of participants according to the study 
outcomes. Participants who developed CAD and HF were not different in age, WC and BMI 
estimates. 
 
Table 8.3 Population profile of participants by CVD, CAD and HF 
 CVD CAD HF 
    
Age, years-mean (SD) 39.4(12.3) 40.1(11.8) 40.8(11.6) 
WC, cm-mean (SD) 94.3(14.2) 96.0(13.9) 96.4(13.7) 
BMI, kg/m
2
-mean (SD) 25.3(5.7) 26.0(5.6) 25.9(6.0) 
Sex- n (%)    
              Males 104(49.3) 69(49.3) 35(43.2) 
                 Females 107(50.7) 71(50.7) 46(56.8) 
Abbreviations: WC, waist circumference; CVD, cardiovascular disease; CAD, coronary artery disease; HF, heart 
failure; BMI, body mass index. 
 
Tables 8.4 and 8.5 show the estimated 10-year absolute CVD risks according to baseline BMI 
values of 20-34 kg/m
2
 and corresponding WC values with equivalent risks, with age being fixed to 
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35 years, the average age of the study sample. For males, 10-years CVD absolute risk was 10.62% 
for BMI of 20 kg/m
2
 compared with 21.47% for BMI of 34 kg/m
2
. Corresponding values for WC 
associated with similar CVD risks in females were 11.97% and 17.46% for BMI of 20 and 34 kg/m
2
 
respectively. Similar patterns were observed for CAD and HF as shown in Tables 8.4 and 8.5. 
Figure 8.1 shows WC values corresponding to same absolute CVD risks with BMI points were 
similar for CVD, CAD and HF. The maximum differences for specific WC values generated ranged 
from -2.2 to +4.3 cm for CVD, CAD and HF. 
For the currently recommended BMI for overweight at 25 kg/m
2
, WC values with equivalent CVD 
risk were 91.5 cm (absolute risk=13.72%) and 92.5 cm (absolute risk=13.71%) for males and 
females respectively (Tables 8.4 and 8.5). For CAD, corresponding WC values to BMI of 25 kg/m
2
 
were 91.8 cm (absolute risk=6.07%) and 92.7 cm (absolute risk=7.42%) for males and females 
respectively. For HF, WC values with equal absolute risk with BMI of 25 kg/m
2
 were 91.7 cm 
(absolute risk=3.24%) for males and 93.0 cm (absolute risk=3.99%) for females. 
For the recommended BMI for obesity at 30 kg/m
2
, WC values with the same CVD risk were 101.7 
cm (absolute risk=17.64%) for males and 99.2 cm (absolute risk=15.70%) for females. For CAD, 
WC values with equal risk to BMI of 30 kg/m
2
 were 103.1 cm (8.97%) and 101.6 cm (absolute 
risk=9.53%) for males and females respectively. For HF, corresponding WC values to BMI of 30 
kg/m
2
 for HF risk were 102.6 cm (absolute risk=4.45%) and 101.5 cm (absolute risk=5.12%) for 
males and females, respectively. 
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Table 8.4 Estimated absolute risks associated with CVD types using equivalent WC points 
corresponding to BMI values for males at the age of 35 years 
Males CVD Coronary artery disease Heart failure 
BMI (kg/m
2)
 WC (cm) AR (%) WC (cm) AR (%) WC (cm) AR (%) 
20 81.3 10.62 80.5 4.09 81.0 2.37 
21 83.3 11.18 82.8 4.43 83.1 2.52 
22 85.4 11.77 85.0 4.79 85.2 2.68 
23 87.4 12.39 87.3 5.19 87.5 2.86 
24 89.4 13.04 89.5 5.61 89.6 3.05 
25 91.5 13.72 91.8 6.07 91.7 3.24 
26 93.5 14.43 94.1 6.57 93.9 3.45 
27 95.6 15.19 96.3 7.10 96.1 3.68 
28 97.6 15.97 98.6 7.68 98.3 3.92 
29 99.7 16.79 100.8 8.29 100.4 4.17 
30 101.7 17.64 103.1 8.97 102.6 4.45 
31 103.8 18.54 105.4 9.69 104.7 4.73 
32 105.8 19.47 107.6 10.46 106.9 5.03 
33 107.8 20.45 109.9 11.29 109.1 5.36 
34 109.9 21.47 112.1 12.18 111.2 5.70 
Abbreviations: AR, absolute risk CVD, Cardiovascular disease; WC, waist circumference; BMI, Body mass index. 
 
Table 8.5 Estimated absolute risks associated with CVD types using equivalent WC points 
corresponding to BMI values for females at the age of 35 years 
Females CVD Coronary artery disease Heart failure 
BMI (kg/m
2)
 WC (cm) AR (%) WC (cm) AR (%) WC (cm) AR (%) 
20 85.9 11.97 83.7 5.74 84.1 3.11 
21 87.3 12.30 85.5 6.04 86.1 3.27 
22 88.6 12.64 87.3 6.36 87.8 3.43 
23 90.0 12.99 89.0 6.70 89.5 3.61 
24 91.2 13.35 90.9 7.05 91.2 3.79 
25 92.5 13.71 92.7 7.42 93.0 3.99 
26 93.9 14.09 94.4 7.79 94.6 4.19 
27 95.2 14.48 96.3 8.20 96.4 4.41 
28 96.5 14.87 98.0 8.62 98.1 4.64 
29 97.8 15.27 99.8 9.06 99.8 4.88 
30 99.2 15.70 101.6 9.53 101.5 5.12 
31 100.5 16.12 103.4 10.02 103.2 5.38 
32 101.9 16.55 105.2 10.54 104.9 5.66 
33 103.2 16.99 107.0 11.07 106.7 5.95 
34 104.5 17.46 108.8 11.64 108.4 6.25 
Abbreviations: AR, absolute risk; CVD, cardiovascular disease; WC, waist circumference; BMI, Body mass index. 
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Figure 8.1 The body mass index and waist circumference relationship predicting equivalent 
10-year absolute risk for CVD, CAD and HF at the age of 35 years 
Note: CVD, cardiovascular disease; CAD, coronary artery disease; HF, heart failure. 
 
 
The Weibull models below include coefficients used to estimate WC values from BMI points with 
equivalent absolute risks of CVD, CAD and HF.  
Cardiovascular diseases (CVD) 
For Males: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼)
= 1 − exp [−{𝑒𝑥𝑝(−6.3630 −  (−0.0481 ∗ 𝐵𝑀𝐼 − 0.0336 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1380
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶)
= 1 − exp [−{𝑒𝑥𝑝(−7.1311 −  (−0.0235 ∗ 𝑊𝐶 − 0.0287 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1431
] 
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For Females:  
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼)
= 1 − exp [−{𝑒𝑥𝑝(−6.5302 −  (−0.0306 ∗ 𝐵𝑀𝐼 − 0.0416 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
0.9537
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶)
= 1 − exp [−{𝑒𝑥𝑝(−7.7402 −  (−0.0230 ∗ 𝑊𝐶 − 0.0376 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
0.9578
] 
 
Coronary artery disease (CAD) 
For Males: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼)
= 1 − exp [−{𝑒𝑥𝑝(−5.7600 −  (−0.0488 ∗ 𝐵𝑀𝐼 − 0.0162 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.6587
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶)
= 1 − exp [−{𝑒𝑥𝑝(−6.3726 −  (−0.0216 ∗ 𝑊𝐶 − 0.0119 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.6595
] 
For Females:  
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼)
= 1 − exp [−{𝑒𝑥𝑝(−7.0271 −  (−0.0472 ∗ 𝐵𝑀𝐼 − 0.0357 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1168
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶)
= 1 − exp [−{𝑒𝑥𝑝(−8.1433 −  (−0.0264 ∗ 𝑊𝐶 − 0.0313 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1159
] 
 
Heart Failure (HF) 
For Males: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼)
= 1 − exp [−{𝑒𝑥𝑝(−5.7964 −  (−0.0391 ∗ 𝐵𝑀𝐼 − 0.0124 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.6368
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶)
= 1 − exp [−{𝑒𝑥𝑝(−6.3449 −  (−0.0181 ∗ 𝑊𝐶 − 0.0083 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.6333
] 
For Females:  
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼)
= 1 − exp [−{𝑒𝑥𝑝(−7.6541 −  (−0.0434 ∗ 𝐵𝑀𝐼 − 0.0443 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1788
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶)
= 1 − exp [−{𝑒𝑥𝑝(−8.8370 −  (−0.0255 ∗ 𝑊𝐶 − 0.0406 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1685
] 
105 
 
DISCUSSION 
In our study of adults in an Aboriginal cohort, we have provided gender-specific WC values from 
corresponding BMI points with equivalent 10-year absolute CVD risk. WC with equivalent CVD 
risk as BMI of 25 kg/m
2
 for males and females ranged from 91 to 93 cm, and varied from 99 to 103 
cm for BMI of 30 kg/m
2
. There were no significant differences between males and females in their 
association between WC and CVD risk. When assessing absolute risks for CAD and HF, we found 
that the absolute risk values for CAD and HF were lower than those for CVD. However, the WC 
values for those conditions equivalent to BMI values were not much different with a maximum 
difference of -2.2 to +4.3 cm.  The absolute risks are convenient and useful for health education by 
health professionals and Aboriginal individuals. Furthermore, the absolute CVD risks associated 
with the estimated WC values in this study are useful contributions to the development of WC cut-
offs for Aboriginal people in Australia. 
Although Australian guidelines have made efforts to create awareness of the role of WC by 
recommending WC cut-off values as a health assessment tool to reduce the risk of chronic diseases 
(219), no consensus has emerged on the appropriate cut-offs for Aboriginal people, whose risk of 
CVD is higher than non-Aboriginals (335). Following the statement by Lear et al (2010) that the 
currently used WC cut-off points derived from European populations may not be appropriate for 
other ethnic populations (11), several population studies have provided evidence of WC cut-off 
points derived from BMI overweight and obesity thresholds to monitor the risk of developing 
chronic disease in adults. There have been no reports providing evidence of WC cut-off points for 
the Aboriginal population. The most commonly used methods for generating WC cut-off which 
involves optimising sensitivity and specificity whereby WC cut-off values are highly correlated 
with population mean values (13) might not be appropriate for Aboriginal people due to substantial 
variations of WC mean values among different Aboriginal communities (12). There have been 
suggestions on applying alternative methods, such as the absolute risk method (13) particularly in 
heterogeneous populations as Australia. Previously, the absolute risk method has been used to 
assess how risk of CVD changes with different WC values (155). In the present study, the absolute 
risk method was employed to generate WC values from BMI with equivalent absolute CVD risk. 
The WC values for overweight and central obesity from BMI determined in this study will 
contribute to evidence required for WC cut-off if the risk is considered high enough to take actions 
(13).  
Although there have been earlier suggestions that the appropriate BMI range for Aboriginal people 
is between 17 and 22 kg/m
2
, with increased risk of metabolic conditions above 22 kg/m
2
, (93, 94) 
this is yet to be confirmed for in the population. In the present study, WC values equivalent to the 
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risk of CVD at BMI of 22 kg/m
2
 were about 85 cm for males and 87-88 cm for females. A 
proportion of 69.7% (69.2% in males and 70.1% in females) CVD events occurred in individuals 
with BMI≥22 kg/m2 (results not presented), indicating higher CVD events among individuals with 
and over this BMI threshold. Owing to the heterogeneity in body composition of Aboriginal people 
in different communities, further research is required to confirm the healthy BMI range for CVD in 
the population.  
One important implication of the present study is that unique BMI and WC classifications is 
required for Aboriginal people as they are a diverse group with varying WC (12) and BMI estimates 
across gender and regions. Variations in BMI of Aboriginal people across Australian regions have 
potentially been attributed to differences in socio-economic and nutritional status (304, 336). Our 
study results were based on gender-specific BMI and WC measures of Aboriginal people in a 
community in the Northern Territory. Our observations of higher BMI and WC mean estimates 
among females compared with males are consistent with the observations made in an earlier study 
involving Aboriginal people in three remote communities in the Northern Territory (12). However, 
results of the study from remote communities in central Australia and north Queensland showed 
Aboriginal males in the cohort had slightly higher WC mean estimates than females (98). The WC 
cut-off values from European populations for overweight (94 cm in males and 80 cm in females) 
and obesity (102 cm in males and 88 cm in females) are 14 cm higher for males than for females. In 
our calculation of the 10-year absolute risks of CVD, we found that corresponding overweight WC 
for BMI (≥25 kg/m2) ranged from 91 to 93 cm, and obesity from BMI (≥30 kg/m2) ranged from 99 
to 103 cm for males and females. The generated WC values for these BMI thresholds were 
relatively similar for males and females with differences ranging from 0.9 to 2.5 cm for CVD, CAD 
and HF. This suggests that analyses using the currently proposed categories of BMI and WC may 
not identify the appropriate WC range with sufficient degree of precision. 
The main strength of the present study is that it is the first to provide WC values that correspond to 
equivalent BMI points for CVD risk in an Aboriginal population. Our choice of WC as a measure of 
adiposity was based on previous findings from recent studies in the same study population 
suggesting WC is a better predictor of CVD compared with BMI and WHR (155). Second, the 
prospective nature of our study enabled calculating absolute risk based on future CVD events which 
provided proof of the WC values generated from BMI points (115). Third, the data on which our 
results are based were derived from an Aboriginal community and are likely specific to this 
Northern Territory community. While this is advantageous due to population homogeneity, caution 
needs to be exercised when generalising findings to other Aboriginal communities due to 
heterogeneity of WC estimates in different Aboriginal communities. In addition, while over 80% of 
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eligible community members were involved in the baseline survey, our sample size was still 
limited. Further work could focus on validating the WC values generated in a larger Aboriginal 
sample or in more Aboriginal communities. Another limitation is the use of only hospital-diagnosed 
CVD which may present an incomplete and potentially biased assessment of incident CVD 
outcomes in the community. There is a possibility that participants could have accessed care in 
alternative healthcare facilities instead of the public hospitals, thereby underestimating the actual 
CVD numbers in the study population. However, we are confident that we captured a reliable 
number of CVD morbidity outcome representative of the study population as over 82% of 
participants were hospitalised during the follow-up period evidenced by hospital records for any 
ailment during the follow-up period. Future studies should include records from private and primary 
healthcare systems for more robust CVD outcomes. 
 
CONCLUSION 
Our study provides new and interesting observations of WC values with absolute risk of CVD 
equivalent to BMI values in an Aboriginal population. The association between WC and CVD in 
this study did not depend on gender. Our study suggests additional research using the absolute risk 
method in other Aboriginal communities will further validate the WC values generated in this 
study. Our findings provide valuable information to healthcare providers and evident contribution to 
expert committee members responsible for developing guidelines for WC cut-off points for 
Aboriginal people in Australia. 
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CHAPTER 9 
WAIST CIRCUMFERENCE VALUES EQUIVALENT TO BODY MASS INDEX POINTS 
FOR PREDCITING ABSOLUTE TYPE 2 DIABETES RISKS 
 
9.1 INTRODUCTION AND AIM 
Based on the lack of waist circumference (WC) cut-off points for Australian Aboriginal people who 
suffer higher risk of Type 2 diabetes than non-Aboriginals, this chapter used data from the Tiwi 
Islands, of adult participants with body mass index (BMI) and WC values at baseline screening to 
present models to: 
1. Evaluate WC values corresponding to BMI points with equal absolute Type 2 diabetes. The 
WC values generated will assist future research by contributing to the evidence needed for 
the recommendation of WC cut-off points appropriate to the Aboriginal Australian 
population. 
 
In this chapter, Section 9.2 provides a summary of my contributions to the study. Results from the 
study have been published in a peer-reviewed journal. The reference for this publication is: 
Adegbija O, Hoy WE, Wang Z. Corresponding waist circumference and body mass index values 
based on 10-year absolute Type 2 diabetes risk in an Australian Aboriginal community. BMJ Open 
Diabetes Research and Care 2015; 3:e000127. doi:10.1136/bmjdrc-2015-000127. 
 
9.2 CONTRIBUTION TO THE STUDY 
I was responsible for the data management and I conducted the data analysis and the results 
interpretation in consultation with Dr Wang and Dr Hoy. I was responsible for writing the 
manuscript, taking into account the comments and suggestions of Dr Wang and Dr Hoy. 
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ABSTRACT 
Objective 
There is a lack of waist circumference (WC) thresholds to identify Aboriginal individuals at high 
risk of Type 2 diabetes. We generated gender-specific WC values with equivalent 10-years absolute 
risk of Type 2 diabetes as body mass index (BMI) points in an Australian Aboriginal community to 
contribute to guidelines needed for establishing WC cut-off points for Aboriginals. 
 
Research design and method 
A cohort of 803 adult participants without Type 2 diabetes in an Aboriginal community was 
followed up for up to 20 years. We derived WC values with absolute risks equivalent for the 
development of Type 2 diabetes as BMI values (20 to 35 kg/m
2
) using the Weibull accelerated 
failure-time model. 
 
Results 
After a mean follow-up of 15.7 years, 110 participants developed Type 2 diabetes. Absolute risk of 
Type 2 diabetes increased as WC increased, ranging from 3.52% (WC=77.5 cm) to 14.14% 
(WC=119.9 cm) in males, and 5.04% (WC=79.5 cm) to 24.25% (WC=113.7 cm) for females. In 
males, WC values with same absolute risks of Type 2 diabetes as BMI values were 77.5 cm for 
BMI=20 kg/m
2
, 91.5 cm  for BMI=25 kg/m
2 
(overweight threshold), 105.7cm for BMI= 30 kg/m
2 
(obesity threshold) and 119.9 cm for BMI=35 kg/m
2
. In females, WC values were 79.5 cm for 
BMI=20 kg/m
2
, 90.9cm for BMI=25 kg/m
2
, 102.3cm for BMI=30 kg/m
2
 and 113.7 cm for BMI=35 
kg/m
2
. Interaction between WC and gender was not statistically significant (P=0.53). 
Conclusions 
The absolute risk of Type 2 diabetes increased with higher WC measured at baseline screening. 
Males were not significantly different from females in the association between WC and Type 2 
diabetes. Our findings are useful contributions for future establishment of WC cut-off points for 
identifying high risk individuals in Aboriginal people.  
 
Keywords: waist circumference, body mass index, type 2 diabetes, absolute risk, Aboriginals 
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INTRODUCTION 
Central obesity measured by waist circumference (WC) is a known and reported risk factor for 
Type 2 diabetes in the Aboriginal population (9, 10, 156). Risk thresholds for WC derived from 
body mass index (BMI) in predominantly European populations have been proposed for use in 
Australia. However, these standards might not necessarily be applicable to the Aboriginal 
population who experience a disproportionately greater burden of Type 2 diabetes (337, 338) and 
display a body habitus that is different from non-Aboriginals in Australia (12). Aboriginals, 
particularly females have a tendency for preferential abdominal fat deposition (12, 149), of which 
the cause is complex and multifactorial, and to which genetics, lifestyle, inflammation and 
infections have been suggested to be contributory (168). Although the International Diabetes 
Federation (IDF) has recommended that investigations be performed to determine WC cut-off 
values for clinical practice in different ethnic regions (339), there is no consensus on WC cut-off 
points to identify individuals at high risk of chronic diseases in Aboriginal Australians.  
The conventional sensitivity and specificity approach used by most studies to determine cut-off 
values has been questioned and the absolute risk approach has been recommended (13). 
Furthermore, WC has been found to be a better predictor of Type 2 diabetes than BMI in the 
Aboriginal population (9, 156), which provides the basis for conducting this study. The present 
study aimed to estimate the absolute risks of Type 2 diabetes prospectively by following up 
participants without Type 2 diabetes at baseline examination to derive WC values with absolute 
risks of Type 2 diabetes equivalents to body mass index (BMI) points. The estimates generated 
from this study will contribute to the establishment of WC cut-off points to identify individuals at 
increased risk of developing Type 2 diabetes in the Aboriginal population. 
 
METHODS 
We conducted a prospective cohort study of adults (aged 18-76 years) using data collected during a 
community screening program (baseline screening) in an Aboriginal community in the Northern 
Territory of Australia. The baseline data of eligible participants included age, BMI and WC (8). WC 
was measured in centimetres halfway between the lowest ribs and the iliac crest, while BMI was 
calculated by participant’s weight in kilograms divided by their height in meter-squared (kg/m2). A 
total of 976 adults participated in the baseline community screening program from 1992 to 1998. Of 
the 976 adults, 803 had records of age (years), as well as BMI and WC measurements and were free 
from Type 2 diabetes at baseline. They represented over 80% of the adults in the study population. 
We followed up the eligible 803 adults on hospitalization records until 31 December, 2012 to 
111 
 
identify new incident Type 2 diabetes cases using the International Classification of Diseases (ICD) 
codes: 250 (ICD-9) and E11 (ICD-10). Our study outcome was hospital-diagnosed Type 2 diabetes 
before or by 31 December 2012. For participants identified with Type 2 diabetes, their follow-up 
time was calculated from the time of their baseline screening to their first episode of Type 2 
diabetes according to the hospitalization records. Those who had not developed Type 2 diabetes by 
31 December 2012 were ‘censored’.  
Participants volunteered for the baseline screening examinations, and written informed consent was 
obtained from each participant prior to the data collection. The Ethics Committee of the Menzies 
School of Health Research and Territory Health Service, and the Aboriginal community approved 
the original baseline datasets used for this study. The Behavioural and Social Science Ethical 
Review Committee of the University of Queensland (#2011001232) gave approval of this study. 
 
Statistical analysis 
Data were analysed and presented as means with SD and frequencies as appropriate. Interaction 
between gender and WC was assessed for their association with Type 2 diabetes using fractional 
polynomial regression. The Weibull accelerated failure-time model was used to estimate the 
absolute Type 2 diabetes risk using the formula: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 = 1 − exp[−{𝑒𝑥𝑝(−𝛽0 −  𝑋𝑗 𝛽𝑗) 𝑡𝑗}
𝑝
] 
  
where β0 represented the baseline  BMI or WC coefficient, βj was the coefficient for covariates 
(BMI or WC and age), Xj represented the covariates, t is the time and p the shape parameter (261). 
The gender-specific estimates of equal WC values that corresponded in absolute risks to BMI 
values from 20 to 35 kg/m
2
 for a 10-year risk for Type 2 diabetes, at a population average age of 35 
years were obtained. All statistical analyses were performed using Stata statistical software V13.0 
(319). Tests were two-tailed and a P-value of 0.05 was used to indicate statistical significance.   
 
RESULTS 
Our study included 803 participants (419 males and 384 females). The mean age at baseline was 
32.1(SD 10.7) years for males and 35.0(SD 12.9) years for females. In females, the mean values of 
baseline WC (89.0 cm) and BMI (24.2 kg/m
2
) were higher than in males (WC= 85.9 cm and BMI= 
23.1 kg/m
2
). Participants were followed up for 12,633.5 person-years with mean follow-up time of 
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15.7 years. There were 110 cases of incident Type 2 diabetes (38 males and 72 females) during the 
follow-up period. 
Table 9.1 presents results of the WC values generated from BMI for a 10-year Type 2 diabetes 
absolute risk, at the average age of 35 years. Absolute risk of Type 2 diabetes increased with 
increasing WC values. The interaction between WC and gender showed no statistical significance 
(P=0.53). The absolute risk equations used to generate the values on table 9-1 are presented below: 
 
For Males: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼) = 1 − exp [−{𝑒𝑥𝑝(−8.3367 −  (−0.0855 ∗ 𝐵𝑀𝐼 − 0.0392 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1281
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶) = 1 − exp [−{𝑒𝑥𝑝(−8.8008 −  (−0.0300 ∗ 𝑊𝐶 − 0.0353 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.1323
] 
 
For Females: 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝐵𝑀𝐼) = 1 − exp [−{𝑒𝑥𝑝(−6.6145 −  (−0.0837 ∗ 𝐵𝑀𝐼 − 0.0122 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.3388
] 
𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑟𝑖𝑠𝑘 (𝑊𝐶) = 1 − exp [−{𝑒𝑥𝑝(−7.6955 −  (−0.0369 ∗ 𝑊𝐶 − 0.0066 ∗ 𝐴𝑔𝑒) ) ∗  𝑡𝑗}
1.3307
] 
 
In males, WC values with same absolute risks of Type 2 diabetes as BMI-specific values ranged 
from 77.5 cm for BMI of 20 kg/m
2
 (absolute risk=3.52%) to 119.9 cm for BMI of 35 kg/m
2
 
(absolute risk=14.14%). Derived WC values of 91.5 and 105.7 cm had similar absolute risks of 
Type 2 diabetes with BMI of 25 (overweight threshold) and 30 kg/m
2 
(obesity threshold) 
respectively. Likewise, for females, WC values ranged from 79.5 cm for BMI of 20 kg/m
2
 (absolute 
risk=5.04%) to 113.7 cm for BMI of 35 kg/m
2
 (absolute risk=24.25%). WC=90.9 and 102.3 cm had 
equivalent absolute Type 2 diabetes risk as BMI of 25 and 30 kg/m
2
, respectively. 
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Table 9.1 Estimated 10-year gender-specific absolute risks of Type 2 diabetes using equivalent 
WC values corresponding to BMI points at the age of 35 years 
 Males Females 
BMI (kg/m
2
) WC (cm) AR (%) WC (cm) AR (%) 
20 77.5 3.52 79.5 5.04 
21 80.0 3.87 81.8 5.62 
22 83.0 4.25 84.1 6.27 
23 85.8 4.67 86.4 6.99 
24 88.7 5.14 88.7 7.78 
25 91.5 5.64 90.9 8.66 
26 94.4 6.20 93.2 9.63 
27 97.2 6.80 95.5 10.72 
28 100.0 7.46 97.8 11.91 
29 102.9 8.19 100.1 13.22 
30 105.7 8.98 102.3 14.67 
31 108.5 9.84 104.6 16.26 
32 111.4 10.79 106.9 18.00 
33 114.2 11.81 109.2 19.91 
34 117.1  12.93 111.5 21.99 
35 119.9 14.14 113.7 24.25 
AR, absolute risk; BMI, body mass index; WC, waist circumference. 
 
DISCUSSION 
The major findings in this study were the estimated WC values which were equivalent to BMI 
values from 20 to 35 kg/m
2
 for predicting the absolute risks of Type 2 diabetes for Aboriginal 
people. Also of importance is the absolute Type 2 diabetes risk increased as WC increased, ranging 
from 3.52% (WC=77.5 cm) to 14.14% (WC=119.9 cm) in males and 5.04% (WC=79.5 cm) to 
24.25% (WC=113.7 cm) in females. WC of 91.5 cm and 90.9 cm for males and females, 
respectively, corresponded with BMI of 25 kg/m
2
 (overweight threshold), while WC of 105.7 cm in 
males and 102.3 cm in females corresponded with obesity threshold (BMI=30 kg/m
2
). Although, on 
average, females had higher WC compared with males (approximately 3.1 cm mean difference) and 
the absolute risks tend to be higher in females for each derived WC than in males, the association 
between WC and Type 2 diabetes was not dependent on gender. While there appeared to be 
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widening difference between gender-derived WC at BMI>30 kg/m
2
, with greater increase in males, 
interactions did not show statistical significance (results not shown). This could potentially be due 
to the fewer numbers of those with BMI above 30 kg/m
2
 and incident Type 2 diabetes outcomes at 
that level. 
There is limited evidence of contribution to the development of WC cut-offs for identifying 
individuals at high risk of chronic disease for Aboriginals in Australia. Although a few studies have 
shown the link between WC and Type 2 diabetes, we are not aware of any study that has 
determined using either cross-sectional or cohort design what levels of WC increased the risk of 
Type 2 diabetes among Aboriginals. Potential reasons for this lack may be due to the diversity in 
WC estimate levels existing in Aboriginal communities and the specific statistical technique 
required to testing this heterogeneity. This study has taken a step in overcoming these two 
challenges by making some contributions to whatever guidelines will be required in future research 
to attain this goal. There could be debates on the need for WC thresholds for Type 2 diabetes in the 
Aboriginal population as high WC appears to be a phenomenon with reported tendency for central 
obesity even at younger ages (340). However, the evidence linking WC with Type 2 diabetes is 
strong and consistent in the Aboriginal population (9, 10, 156). Furthermore, WC has been found to 
be a better predictor of Type 2 diabetes compared with BMI, waist-to-hip ratio, as well as weight 
and hip circumference in the Aboriginal population (9, 156). There have been reports evidenced by 
improved or completely normalized metabolic abnormalities of Type 2 diabetes among Aboriginals 
after a short reversion to traditional hunter-gatherer lifestyle which entailed high physical activity 
and low-fat diets resulting in weight loss (341). Although preventing excessive weight gain among 
Aboriginals is a complex process due to the strong link between poverty and obesity (342), the 
hypothesis that weight loss results in reduced WC, and also, controlling risk of complications that 
have been associated with risk of Type 2 diabetes are supported by trial studies outside Australia 
(343, 344). Therefore, operational definition of central obesity is important and necessary for health 
promotion in this population. As WC is easy to measure with no required calculations, unlike BMI, 
and has been found to have stronger association with Type 2 diabetes than BMI and other 
anthropometric indices (9, 156), establishment of threshold WC values in the Aboriginal population 
will be beneficial for individuals and healthcare workers to help reduce the prevalence of Type 2 
diabetes among this Australian group.  
As the Aboriginal Australian population is heterogeneous in their WC levels, varying from one 
community to another, future studies using the absolute risk approach should be assessed 
prospectively in other Aboriginal communities to examine the similarities or differences between 
males and females in the association between WC and Type 2 diabetes. Furthermore, the absolute 
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risk method used in this study would benefit the diverse Aboriginal population by demonstrating 
the applicability of our findings in WC-homogeneous communities.  
The use of prospective study design with a long-term follow-up period is the main strength of this 
study. However, the findings from an Aboriginal community may not be generalizable to all 
communities due to the heterogeneity in WC levels among different Aboriginal groups. Replicating 
this study using the absolute risk method in other Aboriginal communities or larger Aboriginal 
groups will further confirm the generalizability of our findings.  
 
CONCLUSION 
The absolute risks of Type 2 diabetes increased as WC increased. For overweight defined as BMI of 
25 kg/m
2
, WC was 91.5 cm for males and 90.9 cm for females, while for obesity (BMI of 30 
kg/m
2
), WC were 105.7 and 102.3 cm for males and females respectively. Males and females did 
not differ remarkably in the relationship between WC and Type 2 diabetes. This similarity was also 
reflected in the derived WC estimates with equal absolute risks of Type 2 diabetes as corresponding 
overweight and obesity BMI values. The findings of this study will be useful for health 
professionals and public health workers when evaluating the risk of elevated WC in association 
with type 2 diabetes. Also, our results are important and useful for future research in the 
development of WC cut-off points in the Aboriginal population.  
 
 
Main Message 
1. Using the absolute risk method, we derived for overweight defined as BMI of 25 kg/m2, WC 
of 91.5 cm for males and 90.9 cm for females; and for obesity (BMI of 30 kg/m
2
), WC was 
105.7 cm and 102.3 cm for males and females respectively. 
2. There were no significant differences between males and females in the association of WC 
and Type 2 diabetes. 
3. The generated WC values with similar risk as specific BMI points can contribute to the 
development of WC cut-off points for Aboriginals in Australia. 
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Research questions left to be answered as a result of this study include: 
1. Are the values of WC derived in this study similar in other Aboriginal communities or in a 
larger Aboriginal study? 
2. Are there gender differences in the relationship between WC and Type 2 diabetes in other 
Aboriginal communities? 
3. Are the absolute risks of Type 2 diabetes for overweight and obese high enough for the 
establishment of waist circumference cut-off points for Australian Aboriginals? 
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CHAPTER 10 
THESIS DISCUSSION 
The studies presented within this thesis assessed the waist circumference (WC) of Aboriginal 
Australians in relation to two major chronic diseases with high prevalence- cardiovascular disease 
(CVD) and Type 2 diabetes, and with mortality. In light of the scarce documented evidence on 
ethnic-appropriate WC cut-off points for identifying Aboriginal individuals at high risk of chronic 
diseases, two of the studies were designed to: 
1. Create tools to examine changes in risks of CVD and Type 2 diabetes at different WC 
points using the absolute risk method, and 
2. Identify WC values from body mass index (BMI) cut-off points predicting the same 
absolute risks of CVD and Type 2 diabetes 
This final chapter summarises the main findings, discusses the strengths and limitations of the 
available data, and highlights further research that would be beneficial to clarify the generalizability 
of the findings in the Australian Aboriginal population. 
 
Summary of key findings  
Chapters 5 and 6 assessed the associations of WC with CVD and Type 2 diabetes among 
participants. These studies found that WC had statistically significant associations with CVD and 
Type 2 diabetes in the study population. Furthermore, WC compared to BMI or waist-to-hip ratio 
(WHR) had stronger associations with CVD in females, and Type 2 diabetes in males and females 
in the study population. In addition, these chapters showed that the 10-year absolute risk of CVD 
and Type 2 diabetes increased as WC increased. The studies highlighted the importance of WC in 
the Aboriginal community and presented simple tools for predicting future risk of CVD and Type 2 
diabetes according to changes in WC at different ages.  
Chapter 7 examined the relationship of BMI and WC with all-cause mortality. Results showed that 
WC was associated with the risk of all-cause mortality, and the risk of mortality increased as WC 
increased. In addition, WC compared to BMI had stronger associations with all-cause mortality. 
Chapter 8 generated equivalent WC values from corresponding BMI points for the 10-year absolute 
risk of CVD, coronary artery disease (CAD) and heart failure (HF). Results of the study are as 
follows: at the average age of 35 years, WC values with absolute CVD, CAD and HF risks 
equivalent to BMI of 25 kg/m
2
 were 91.5, 91.8 and 91.7 cm respectively for males, and 
corresponding WC values were 92.5, 92.7 and 93 cm for females. WC values with equal absolute 
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CVD, CAD and HF risks to BMI of 30 kg/m
2
 were 101.7, 103.1 and 102.6 cm respectively for 
males, and corresponding values were 99.2, 101.6 and 101.5 cm for females.  
Chapter 9 presented equivalent WC values from corresponding BMI points for the 10-year absolute 
risk of Type 2 diabetes. Derived WC for overweight (BMI of 25 kg/m
2
) was 91.5 for males and 
90.9 cm for females; and for obesity (BMI of 30 kg/m
2
), derived WC values were 105.7 cm and 
102.3 cm for males and females respectively. These predicted WC values are useful contributions to 
future guideline in the establishment of WC cut-off points for Aboriginal people. 
Overall, there were no significant differences between males and females in their association 
between WC and risk of disease (CVD and Type 2 diabetes) and mortality. Furthermore, the 
derived WC representing overweight and obese did not differ much between males and females, as 
maximum differences ranged from -2 to 3.5 cm. 
 
Consistency with other studies 
Several studies conducted in and outside Australia, in Aboriginal and non-Aboriginal groups, have 
demonstrated the risk of CVD and Type 2 diabetes associated with elevated WC (8, 9, 170, 328). 
Prior to this research work, Wang and Hoy examined the relationship between WC and CVD and 
Type 2 diabetes (8, 9). Those results were based on cross-sectional studies with potential inherent 
limitations such as difficulty in establishing temporal association between exposure and outcome, 
but the findings suggest the importance of WC in the study community. Findings using prospective 
study design as used in this thesis would be considered more informative. McDermott et al followed 
up 225 Aboriginal adults for 6 years and found higher rates of Type 2 diabetes among those with 
high WC compared with lower WC, despite their small sample size (10).  
A few studies have documented on the stronger associations of WC with CVD and Type 2 diabetes 
compared with BMI and/or WHR. In rural communities in the Far North Queensland of Australia, 
WC was better than BMI, but not as good as WHR in predicting cardio-metabolic risk factors which 
include diabetes (146). In a 7-year prospective study of Mexican-American, WC but not BMI or 
WHR was found to be the best predictor of diabetes (345). Pouliot et al concluded that WC rather 
than WHR is an important index in the assessment of CVD risk (170).   
There is a shortage of studies on absolute risk of diseases using WC as an exposure variable 
alongside other factors; therefore, it was difficult to compare the findings on absolute risks. 
Nonetheless, some other studies have used other methods to present WC values that best reflected 
disease risk in some Aboriginal communities (146, 178). Bambrick in 2005 using the sensitivity and 
specificity method suggested that reducing WC threshold to ≥90 cm for men would better reflect 
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disease risk (178). Their suggested WC threshold is consistent with WC values (>91 cm) generated 
from BMI in chapters 8 & 9 from equivalent absolute risks for both CVD and Type 2 diabetes in 
males. Also, Li and McDermott used the ROC curve method in rural communities in north 
Queensland to generate optimal WC cut-off values for predicting cardio-metabolic risks, and results 
ranged from 87.5 to 91.2 cm (146). These findings are similar to the results of this thesis on WC 
generated from overweight BMI (25 kg/m
2
). The world Health Organisation (WHO) recommended 
WC thresholds for identifying overweight and obese individuals indicate a difference of 14 cm 
between males and females (115). This thesis showed WC difference range of -2 to 3.5 cm between 
the genders, with no significant differences between males and females in the association between 
WC and disease outcome.  
 
Strengths and limitations 
Strengths 
1. First, this is the first study to conduct a systematic review and meta-analysis comparing 
gender-specific WC of Aboriginals and non-Aboriginals in Australia. 
2. Second, this is also the first study to present prediction models to assess changes in risk of 
CVD and Type 2 diabetes at different WC levels and age values using the absolute risk 
method in an Aboriginal Australian population. 
3. Third, no other report has provided evidence of WC values derived from BMI points for any 
disease outcome as a contribution to future guidelines for generating WC cut-off points for 
Aboriginal people in Australia. 
4. Fourth, this is also the first study in an Aboriginal Australian population to assess risk of all-
cause mortality with WC as a risk factor. 
Although some of the strengths of the population data utilized for analyses have been addressed in 
each of chapters 5, 6, 7, 8 and 9, a brief summary of the major strengths are: 
1. The focus on Tiwi Islands where over 80% of the population are of Tiwi origin indicates 
homogeneity both culturally and ethnically, limiting bias due to heterogeneous body size 
composition 
2. There was a good participation rate as over 80% of the eligible community members were 
involved in the baseline community screening survey 
3. The prospective follow up of individuals with baseline WC to identify future CVD and Type 
2 diabetes risks as well as deaths ascertained by hospitalization and mortality records 
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respectively, established a temporal relationship and limited the misclassification of 
exposure and outcome, thereby reducing the possibility of bias 
4. The length of follow-up (up to 20 years) of this work allowed monitoring to ascertain as 
many incident outcome events as possible, ensuring a good number of events representative 
of the study population. 
  
Limitations 
The Tiwi Island Study Data 
The endpoints were ascertained from hospitalization and mortality records, thus there is a 
possibility that this study focused on more severe end of disease spectrum. If some individuals with 
chronic disease did not present to the hospital, they would not have contributed to the study and 
would have been falsely classified as not having the endpoints. This would have underestimated the 
number of disease cases. This is especially likely for Type 2 diabetes, which is usually discovered 
and managed in outpatient clinic environment). However, with the long term follow-up, this study 
captured a good number of affected individuals, generating significant results. Furthermore, there is 
the probability of underestimated incidence because of the long lead time between development of 
Type 2 diabetes and hospitalisation.   
The WC measurements used in this study were from individuals in one Aboriginal Island, and 
results may not generalise to the entire Aboriginal population. As mentioned in most of the studies, 
there is a significant heterogeneity in WC across Aboriginal communities and a one-size-fit-all 
estimate might not be representative. Further research will be necessary to assess the absolute risk 
of CVD and Type 2 diabetes according to WC levels in other Aboriginal communities.  
With regards to the data, first, the sample size used is relatively small. There is the possibility that 
the indistinctive difference between males and females in the association between WC and 
outcomes is due to the limited sample size. Furthermore, the limited sample size could be 
responsible for the indistinctive association between BMI and mortality.   
There is a potential for measurement bias in the WC measurements. Results may vary depending on 
persons carrying out the measurements.  
Previous studies in other populations have linked WC with the risk of other chronic conditions such 
as sleep apnoea/ sleep disordered breathing (212), certain cancers (132, 346)  and gall stone disease 
(210, 211). However, the hospitalization data included very few numbers these conditions. 
Therefore, we could not include them to fully address the spectrum of chronic illnesses associated 
with high WC.  
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Furthermore, important confounding factors such as physical activities, family history of diseases, 
education levels and socio-economic status were not available in the baseline data. Therefore, 
relevant factors such as age, smoking and alcohol consumption were controlled for in the analysis. 
The use of baseline WC measurement in the prediction of future disease event gives no 
consideration for changes in WC over the follow-up time. This is unlikely to affect this study as the 
purpose was to relate WC measured at baseline with the future risk of a disease. Previous 
prospective studies have provided systematic comparisons of WC measured at baseline and 
development of chronic diseases related to central obesity after long follow-up periods (116, 347, 
348).  
 
Study Implications 
Public health implications 
Given the association of WC with chronic diseases among Aboriginal people, it is important that 
appropriate health promotion guidelines relating to WC be provided. The findings of this thesis 
have several significant implications. The results support the hypothesis that central obesity, for 
which WC is a marker, is associated with CVD and Type 2 diabetes. Also provided, were absolute 
risks of CVD and Type 2 diabetes according to different WC levels, and generated WC absolute 
risk values equivalent to disease risks corresponding to various BMI values. The absolute risk 
approach gave simple and easily-understood evidence for establishing helpful guidelines for 
Aboriginal people in the study community. Compared to males, females appeared to have higher 
WC and risk of CVD, Type 2 diabetes and mortality. However, results were not significantly 
different between both genders in the risks of WC and study outcomes. The 14 cm gap between 
males and females in the standard WC cut-off points (115) is significantly higher than the 
differences observed in the present study (-2 to 3.5 cm). The findings of this thesis suggest for 
males and females in the study population, WC of 91 to 93 cm for overweight BMI and WC of 99 
to 102 cm for obese BMI for CVD; and WC of 91 cm for overweight BMI and WC of 102 to 105 
cm for obese BMI for Type 2 diabetes.  
 
Policy implications 
The Measure-Up Campaign sponsored by the Australian Government aimed to reduce the risk of 
chronic diseases among Australians, and the central measurement of the Campaign for guiding the 
public to take actions was WC (349). The focus of the campaign was to create awareness of the 
need for healthy living by being physically active and healthier eating habits to maintain a healthy 
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WC. The WC thresholds recommended in the Campaign were 94/102 cm for men and 80/88 cm for 
women to indicate overweight and obesity. While the Campaign achieved its aim of impacting on 
the knowledge and behaviours relating WC measurement to healthy diet, the focus was on the 
general Australian public with no specific target for Aboriginal people. The present findings focuses 
on Aboriginal people and the WC results generated have the potential to contribute significantly to 
future policies in the Aboriginal population in the prevention of chronic diseases. 
Also, as there is no previously established underlying biological link of WC to CVD and Type 2 
diabetes, the earlier stated potential mechanisms in chapter 2 are important factors to consider in the 
relationship between high WC and these two chronic conditions in the study community.  
 
 
Directions for future research 
More deliberate focus on waist circumference in epidemiological studies 
There are considerable opportunities for further research on the role of high WC in the development 
of CVD, Type 2 diabetes and other chronic conditions (gall bladder disease, sleep apnoea and 
cancers) as well as mortality in a larger Aboriginal Australia population. Additional research also 
needs to focus on WC in understanding the observed high levels among females in this Australian 
group. This should involve epidemiological studies on dietary patterns and physical activity levels 
while monitoring changes in WC and risk of chronic illnesses. 
Further clarification on the use of the absolute risk method in other Aboriginal communities 
Future studies examining WC in Aboriginal communities should employ the absolute risk method 
to assess the risk of disease while observing changes in WC, with a further step to provide WC 
points that correspond to BMI values with equivalent absolute disease risk. Results from other 
Aboriginal communities would contribute to the evidence required for future WC-threshold for 
Aboriginal people. 
Further clarification on the role of other confounders on the relationship between WC and CVD 
and Type 2 diabetes 
Potential confounders such as diet, physical activity, socio economic status and family history of 
disease should be considered in future studies assessing the relationship between WC and future 
risk of chronic diseases and mortality. Disentangling the effects of potential confounders and the 
role of potential effect modifiers such as pre-existing co-morbidities by stratified analyses should 
produce the direct effect of high WC.  
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Conclusions 
The findings imply WC as a valuable factor in the chronic disease risk prediction models in the 
Aboriginal population. The results can potentially contribute to future development of guidelines 
and establishment of WC cut-off points in the Aboriginal Australia population. Furthermore, the 
findings can be used by general practitioners, Aboriginal health workers and other health 
professionals to communicate knowledge of the risk of high WC estimates associated with chronic 
diseases to individuals in the community via primary care. Ultimately, the WC and risk of disease 
tools developed could serve to raise awareness of morbidity and mortality outcomes of CVD and 
Type 2 diabetes in the Indigenous population.  
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